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Abstract 
 
Altering maternal nutrition affects fetal development and can have long-
lasting effects on the offspring, potentially predisposing them to later 
metabolic disease. These effects can occur without affecting birth weight, 
although small for date offspring appear to be at increased risk. One 
mechanism linking changes in the maternal environment to an increased 
risk of later disease is enhanced exposure to glucocorticoids (GC). Tissue 
sensitivity to cortisol is regulated, in part, by the GC receptor (GR) and 11-
beta-hydroxysteroid GHK\GURJHQDVH ǃ+6' W\SHV  DQG  6HYHUDO
studies have shown the effects of maternal nutrient restriction on the 
programming of GC action in the offspring, however, dietary excess is far 
more characteristic of the diets consumed by contemporary pregnant 
women. The aim of this thesis was to provide a novel insight into the 
effects of moderate changes in the macronutrient ratio, within the 
maternal diet fed to pigs (whilst maintaining energy content), on offspring 
growth, development and liver metabolism until adolescence.  
 
Fat supplementation (Fat supplemented (FS): 9 %; Control (C): 2.5 %) 
from day 0 until 110 of gestation, reduced maternal glucose tolerance at 
term and decreased the survival rate of piglets after birth, possibly due to 
hypoglycaemia. In addition, supplementing the maternal diet with protein 
(Protein supplemented (PS): 16.3 %; C: 12.3 %) also increased the 
incidence of postnatal mortality, with surviving offspring demonstrating an 
up-regulation of mRNA transcripts involved in GC sensitivity i.e. GC 
UHFHSWRU DQG ǃ+6'-1, in the liver. Furthermore, this thesis 
demonstrated no negative effects of accelerated postnatal growth on low-
birth weight piglets as others have suggested.  
 
In conclusion, this thesis has demonstrated a detrimental effect of fat and 
protein supplementation until day 110 of gestation on postnatal mortality. 
These findings could have profound consequences for the pig industry 
where reducing piglet mortality is of economic importance. In addition, an 
increased level of protein in the diet during gestation increases GC 
sensitivity in the offspring which may be indicative of excess GC exposure 
in utero. These types of adaptations could have significant implications in 
determining the programming effects of maternal diet on adult disease 
risk. 
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1 
 
Chapter 1 ± Literature review 
 
This thesis reports a study of supplementing the gestational diet of pigs 
with either fat or protein on offspring growth and development, particularly 
focussing on liver metabolism. The introductory chapter will highlight the 
role of maternal nutrition on fetal programming, specifically the effects of 
fat and protein. It will be followed by an outline of the use of animals as 
models for humans in nutritional programming studies, particularly 
focussing on the pig. Finally, the liver structure and function will be 
described in detail.  
 
1.1 Maternal nutrition and programming of adult disease 
It is now well established that a sub-optimal environment in utero can 
have pronounced effects on the development of the fetus and thus confer 
greater risk of disease in later life. The process whereby a stimulus or 
insult at a sensitive or critical period of development has long term effects 
is termed programming. This was first investigated by the retrospective 
FRKRUWVWXGLHVRI'DYLG%DUNHUDQGFROOHDJXHVGXULQJWKHODWH¶VZKR
established that individuals with low-birth weight, who were short or thin 
at birth, or who were small in relation to placental size, were at increased 
risk of metabolic disease such as hypertension and impaired glucose 
tolerance in adulthood (Figure 1.1) (Barker et al., 1990, Hales et al., 
1991). 
 
It is presumed that low-birth weight or disproportionate body size, are 
indicative of a lack of nutrients or oxygen during gestation, reflecting the 
adaptations that the fetus has made to sustain its normal development 
(Barker, 1995). The highest prevalence of impaired glucose tolerance and 
Type 2 Diabetes were seen in individuals who were small at birth and 
became obese as adults (Hales et al., 1991) suggesting that it is actually 
the mismatch between the pre and postnatal environment that causes 
these effects. This is further supported by later studies using the sheep as 
a model for maternal under-nutrition which have shown similar detrimental 
outcomes on the metabolism of the offspring who are adequately 
nourished, without any change in birth weight (Goplakrishnan et al., 2004, 
Gardner et al., 2005). 
 
2 
 
 
Figure 1.1 Odds ratio for developing impaired glucose tolerance or type 2 diabetes 
according to birth weight, among 370 men aged 64 years born in Hertfordshire 
(adjusted for body mass index) (Hales and Barker, 2001) 
 
1.2 Maternal low-protein diets  
Following on from these findings by Barker and colleagues, work began to 
investigate the cellular and molecular mechanisms behind this 
programming effect. Due to the importance of protein in growth and 
development, many studies, particularly in rats, focussed on the effects of 
maternal protein restriction on the offspring.  
 
Protein restriction during pregnancy in rats has been shown to produce 
low-birth weight offspring with higher blood pressure in early adulthood 
(Table 1.1) (Langley-Evans et al., 1996, Langley-Evans et al., 1998, 
Bertram et al., 2001). In addition, another study which follows the pups to 
18 months of age has demonstrated a reduction in offspring insulin 
sensitivity and perturbed triglyceride metabolism, shown by the increase in 
plasma cholesterol, and plasma and hepatic triglycerides, when rats where 
fed a low-protein diet (Table 1.1) (Ehruma et al., 2007). However, in 
contrast to the previous studies, birth weight was unaffected by maternal 
diet (Ehruma et al., 2007). Surprisingly, these changes have been 
demonstrated to take place despite no changes in overall energy intake of 
the mothers (Langley-Evans et al., 1998, Ehruma et al., 2007) or 
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differences in body weight or fat mass of the offspring (Ehruma et al., 
2007). 
 
1.2.1 The role of glucocorticoids (GC) 
The precise mechanisms linking maternal under-nutrition, particularly low-
protein diets, to adverse outcomes on the offspring are still unknown. 
However, studies in both sheep and rats have strongly suggested that 
glucocorticoids (GC) play a key role (Langley-Evans et al., 1996, Bertram 
et al., 2001, Whorwood et al., 2001). It is thought that fetal overexposure 
to maternal GC may trigger programming events in utero that establish 
persistent increases in GC hormone action in the offspring throughout life 
(Bertram et al., 2001, Whorwood et al., 2001).  
 
GC are catabolic hormones, they promote gluconeogenesis and antagonise 
the actions of insulin to increase the concentration of glucose in the blood 
(Dimitriadis et al., 1997b). In addition, they are potent regulators of fetal 
growth and development, and are critical for promoting the maturation of 
fetal tissues, particularly the lung, to allow for adaptations to postnatal life 
(Ballard and Ballrad, 1972, Rheinisch et al., 1978). They also promote 
increased blood pressure by enhancing the activity of vasoactive hormones 
such as angiotensin II (Tangalakis et al., 1992).  
 
GC excess has been linked to the clinical observations associated with the 
metabolic syndrome (Covar et al., 2000, Arnaldi et al., 2003). For 
H[DPSOHSDWLHQWVZLWK&XVKLQJ¶VGLVHDVHZKRKDYHLQFUHDVHGVHFUHWLRQRI
cortisol, normally due to a pituitary tumour, can develop abdominal 
obesity, hypertension, hyperlipidemia, and insulin resistance (Arnaldi et 
al., 2003). Also, clinical administration of GC to treat acute and chronic 
inflammatory diseases has been associated with similar adverse metabolic 
effects (Covar et al., 2000). It therefore seems likely that programmed 
alterations in GC sensitivity may play a role linking maternal nutrient 
availability, fetal growth and metabolic disease risk.   
 
Cortisol, the principal GC in humans, sheep, and pigs, but not rodents, is 
regulated by the activity of the hypothalamic pituitary adrenal (HPA) axis, 
a neuro-endocrine feedback loop, and is secreted in response to 
nutritional, physical and/or emotional stress, or low levels of circulating 
cortisol (Figure 1.2) (Bamberger et al., 1996). The first step of the HPA 
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axis is hypothalamic secretion of corticotrophin releasing hormone (CRH), 
which in turn triggers pituitary secretion of adrenal corticotrophic hormone 
(ACTH). ACTH is carried in the circulation to the adrenal cortex were it 
stimulates the secretion of cortisol. Most serum cortisol is bound to 
FRUWLFRVWHURLGELQGLQJJOREXOLQ&%*DQGRQO\µIUHH¶FRUWLVROLVDFWLYH 
 
GC are also highly regulated at a tissue specific level by intracellular 
expression of GC receptor (GR), and the ǃ-hydroxysteroid  
dehydrogenasH ǃ-HSD) enzymes at the level of gene transcription 
(Figure 1.2) (Bamberger et al., 1996). There are two isoforms of 11ß-HSD, 
both are found in the endoplasmic reticulum (ER) and are responsible for 
the tissue-specific inter-conversion of cortisone to cortisol. 11ǃ-HSD1 
behaves as an 11-oxo-reductase, catalysing the conversion of cortisone to 
bioactive cortisol (Stewart and Krozowski, 1997). Conversely 11ß-HSD2 
behaves as an 11-oxo-dehydrogenase and catalyses the opposite reaction 
(Stewart and Krozowski, 1997). The two isozymes are products of two 
different genes and haYH GLVWLQFW WLVVXH GLVWULEXWLRQV ZLWK ǃ-HSD1 
H[SUHVVHGSULPDULO\LQWKHOLYHUDGLSRVHWLVVXHNLGQH\DQGEUDLQDQGǃ-
HSD2 mainly in the kidney and salivary glands (Walker and Stewart, 2003, 
Wang, 2005).  
5 
 
 
 
 
Figure 1.2 Diagrammatic representation of cortisol secretion via the hypothalamic pituitary adrenal (HPA) axis and its regulation at a tissue specific 
level. CRH = corticotrophin releasing hormone; ACTH = adrenal corticotrophic hormonH ǃ-+6'   ǃ-hydroxysteroid dehydrogenase; GR = 
glucocorticoid receptor 
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ǃ-HSD2 is expressed at high levels in feto-placental tissues and is 
thought to play a key role in protecting the fetus from overexposure to 
maternal cortisol (Stewart et al., 1995, Edwards et al., 1996, Langley-
Evans et al., 1996, Condon et al., 1998, Whorwood et al., 2001). In the 
rat, the effects of the maternal low-protein diet on reducing offspring birth 
weight and programming of hypertension and dysregulation of glucose 
metabolism are thought to be mediated by the inhibition RISODFHQWDOǃ-
HSD2 (Langley-Evans et al., 1996, Langley-Evans, 1998, Bertram et al., 
2001, Ehruma et al., 2007). This is also seen in human studies were a 
SRVLWLYHUHODWLRQVKLSEHWZHHQSODFHQWDOǃ-HSD2 activity and fetal weight 
has been identified (Stewart et al., 1995).  
 
Studies in both rats and sheep have shown that maternal diet programs 
increased GC sensitivity, at a tissue-specific level in both the fetal, 
neonatal and adult offspring (Bertram et al., 2001, Whorwood et al., 
2001). This is determined by an increase in GR mRNA and protein 
expression and a reduction in 11ǃ-+6' DQGRU ǃ-HSD1 gene 
expression and/or activity. It is thought that this increase in GC sensitivity 
is due to a reduction in placental mRNA expression and enzyme activity of 
ǃ-HSD2 (Bertram et al., 2001, Whorwood et al., 2001). In sheep, GR 
mRNA and protein expression is increased in the adrenals, liver, lungs, 
perirenal adipose tissue, and kidney of neonatal offspring born to ewes 
who were nutrient restricted during early-mid gestation (Table 1.1) 
(Whorwood et al., 2001). In addition, there was a 50 percent reduction in 
ǃ-HSD2 mRNA expression in all tissues in which this key enzyme was 
found to be abundant, such as in the kidneys and adrenals (Whorwood et 
al., 2001)ǃ-HSD1 expression was unaffected by maternal diet, except 
in perirenal adipose tissue, where there was a two-fold increase in mRNA 
abundance (Whorwood et al., 2001). Importantly, these effects were 
observed without any significant alterations in the maternal or fetal 
metabolic or endocrine environment (Clarke et al., 1998, Brameld et al., 
2000).  Similar findings were shown in rat studies when dams were protein 
restricted throughout gestation (Table 1.1) (Bertram et al., 2001). These 
offspring were shown to have decreased mRNA expression of ǃ-HSD2 in 
the kidney from birth until adulthood (5 months of age), with no effect on 
ǃ-HSD1 (Bertram et al., 2001). In addition, GR mRNA and protein 
expression were increased in peripheral tissues, such as the kidneys and 
lungs, from both late fetal (day 20) and neonatal offspring up to 12 weeks 
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of age (Bertram et al., 2001). Therefore, an increase in GC sensitivity in 
the offspring due to sub-optimal maternal nutrition is associated with an 
increased risk of metabolic disease (Figure 1.3) (Bertram et al., 2001, 
Whorwood et al., 2001). 
 
 
Figure 1.3 Role of maternal low-protein diet and glucocorticoids in the 
programming of offspring metabolic disease. ǃ-+6'   ǃ-Hydroxysteroid 
dehydrogenase; GR = Glucocorticoid receptor; Adapted from: (Bertram et al., 
2001)    
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Table 1.1 Summary of effects of a maternal low-protein diet or nutrient- restriction during pregnancy on offspring development 
  Placenta 
 
Offspring 
Source Species and diet composition Size ǃ-HSD2 Birth weight Age analysed GC sensitivity Phenotype 
Bertram et al.  
(2001) 
Rats throughout pregnancy 
C: 18 % protein  
LP: 9 % protein  
n/a љ mRNA љ Birth to 5 months јGR mRNA + protein 
(peripheral tissues) 
љ ǃ-HSD2 mRNA 
(kidney)  
ј Blood pressure 
Erhuma et al.  
(2007) 
 
 
Rats throughout pregnancy 
C: 18 % protein  
LP: 9 % protein  
n/a n/a n/a 1, 19 and 18 
months 
n/a No difference in BW 
ј Insulin resistance 
ј Liver TAG  
Langley-Evans et al.  
(1996 & 1999) 
 
 
Rats throughout pregnancy 
C: 18 % protein  
LP: 9 % protein 
ј љ љ 7 weeks n/a No difference in BW 
ј Blood pressure 
Whorwood et al.  
(2001) 
 
 
Sheep, days 28-77 of gestation 
C: 110 % Requirements 
NR: 50 % Requirements 
ј љmRNA No difference Fetal (d77) and 
birth 
јGR and љ ǃ-HSD2 mRNA 
(peripheral tissues) 
ј Kidney weight 
C = Control; LP = Low-protein; NR = Nutrient restricted; BW = Body weight; ј = Increased in low-protein or nutrient restricted gestational groups; љ = Increased in low-
protein or nutrient restricted gestational groups; *& *OXFRFRUWLFRLGǃ-+6' ǃ-Hydroxysteroid dehydrogenase; GR = Glucocorticoid receptor; TAG = Triglyceride  
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1.3 Maternal high-fat diets 
This literature review has already discussed the link between maternal 
nutrition and programming of metabolic disease in the offspring. Human 
epidemiological studies first indicated WKDWLI\RXOLYHGLQDµSRRU¶LQGXVWULDO
area your nutritional status was likely to be decreased (Barker and 
Osmond, 1986). This initiated several investigations, focussed on the 
associations of maternal protein-restriction or global under-nutrition, with 
birth weight and later disease. However, fetal nutrition and development 
may also be compromised by the imbalance of macronutrients in the 
maternal diet, with less obvious or measurable changes in neonatal 
phenotype.  
 
1.3.1 High-fat intake and insulin resistance 
The most common dietary imbalance in Western populations is excessive 
intake of dietary fat. There is widespread evidence in both human and 
animal studies to suggest that consumption of a high-fat diet increases the 
risk of developing insulin resistance, sometimes without an increase in fat 
mass (Maegawa et al., 1986, Storlien et al., 1986, Kraegen et al., 1991, 
Mayer et al., 1993,  Mayer-Davis et al., 1997,  Lovejoy, 2002, Storlien et 
al., 2006). Often this occurs without any change in energy intake 
(Maegawa et al., 1986, Kraegen et al., 1991), particularly in rodent 
studies, where, despite high-fat diets having an increased energy content 
(Maegawa et al., 1986), calorie intake between groups is often the same, 
or even reduced, perhaps due the reduction in palatability of the diets or 
the ability of the animals to effectively regulate their own energy intake.  
 
Under normal conditions, pregnancy is an insulin resistant state due to 
constant utilisation of glucose by the fetus, resulting in maternal 
hypoglycaemia and progressive alterations in glucose metabolism 
(Frienkel, 1980, Leturque et al., 1980, Pere and Dourmad, 2000, Pere and 
Etienne, 2007). In addition, extra fat is deposited in the maternal body in 
preparation for increased energy demand during lactation, thus 
contributing to the insulin resistance (Jen et al., 1987). Consumption of a 
high-fat diet during pregnancy is thought to exaggerate this effect, shown 
by an increase in fasting plasma insulin concentrations in rats on day 20 of 
gestation (Table 1.2) (Guo and Jen, 1995, Taylor et al., 2003), resulting in 
an increase in glucose: insulin ratio (Guo and Jen, 1995). This occurred 
despite no difference in body weight of the dams (Guo and Jen, 1995, 
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Taylor et al., 2003). However, there was a larger fat mass in the dams fed 
a high-fat diet during pregnancy (Guo and Jen, 1995). In addition, fasting 
plasma corticosterone (rodent equivalent of cortisol) was significantly 
increased when dams were fed a high-fat diet during pregnancy (Taylor et 
al., 2003).  
 
Maternal fat supplementation during pregnancy has also been shown to 
effect litter size, but with conflicting results between studies. Previous 
investigations have shown that feeding a high-fat diet to rats throughout 
gestation results in a reduction in litter size, although the reasons for this 
are not clear (Table 1.2) (French et al., 1952, Buckley et al., 2005). 
However, the amount of protein was slightly reduced in these studies, so 
this may be a contributing factor. Although, the improved quality of the 
protein in the high-fat diet should minimise this difference (French et al., 
1952). Similarly, another study showed that feeding a high-fat diet 
throughout pregnancy and lactation, resulted in a reduction in the number 
of successful pregnancies by 12 percent (Table 1.2) (Khan et al., 2003). 
However, other studies have reported no effects of high-fat diet on litter 
size (Table 1.2) (Guo and Jen, 1995, Taylor et al., 2003, Taylor et al., 
2005).  
 
The effect of maternal fat supplementation on offspring birth weight is also 
subject to some controversy, with some studies reporting a reduction in 
birth weight (Table 1.2) (French et al., 1952, Taylor et al., 2003), whilst 
others showed no difference (Table 1.2) (Guo and Jen, 1995, Taylor et al., 
2005, Buckley et al., 2005). Such a response is surprising, since in 
humans, gestational diabetes (characterised by impaired glucose tolerance 
during pregnancy in women without previously diagnosed diabetes), which 
is associated with maternal obesity (Chu et al., 2007),  has been shown to 
result in fetal macrosomia (Figure 1.4) (Jovanovic and Pettitt, 2001, 
Schmidt et al., 2001, Franks et al., 2006). This is due to maternal 
hyperglycaemia which results in nutrient excess, as well as stimulating 
hyperinsulinemia (Calvo et al., 1998). Insulin-like growth factor-1 (IGF-1) 
production ultimately results in excess fetal growth (Menon and Sperling, 
1996).  
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Figure 1.4 Association between maternal third-trimester plasma glucose following 
an oral glucose challenge (after 2 hours), and offspring birth weight in Pima Indians 
(Franks et al., 2006) 
 
When evaluating the effects of fat supplementation during pregnancy, it is 
important to closely examine the composition of the diets fed to the rats. 
Most studies try to mimic the fat composition of the human diet (around 30 
percent) which results in an unnaturally high fat content that would not 
usually be seen in the wild and would normally contain only 4-5 percent fat 
(French et al., 1952, Guo and Jen, 1995, Khan et al., 2003, Taylor et al., 
2003, Taylor et al., 2005). The source and type of fat may also have 
important effects on the pregnancy outcomes, with many studies using 
animal lard as the fat supplement, in comparison to the control which uses 
vegetable oil (Khan et al., 2003, Taylor et al., 2003, Taylor et al., 2005). 
Finally, it is often not only the fat content of the diet which changes 
between the control and experimental groups, but also other components 
of the diet such as protein and carbohydrate quantities which would also 
be expected to affect the birth outcomes. For example, the high-fat diet in 
one study also had sucrose and corn starch added, and there was a 
reduction in fibre content in comparison the control diet (Guo and Jen, 
1995). In addition, even if the carbohydrate and protein contents appear 
to be similar between experimental groups, the reduction in feed intake 
often caused by fat supplementation will significantly reduce the amount of 
carbohydrate or protein in relation to the control group (Khan et al., 2003, 
Taylor et al., 2003, Taylor et al., 2005).  
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Table 1.2 Summary of effects of maternal fat supplementation in rats throughout gestation 
Source Diet composition Calorie 
intake 
Maternal 
body weight 
Maternal 
insulin 
Litter size Birth weight 
Buckley et al. (2005) 
 
C: 12 % fat 
HF: 59 % fat (safflower oil) 
 
n/a n/a n/a Ļ No difference 
French et al. (1952) 
 
C: 100 % control diet (4 % fat) 
HF: 80 % control diet plus 20 % corn oil 
 
No difference n/a n/a Ļ Ļ 
Guo & Jen (1995) C: 45g/Kg fat (unknown source) 
HF: 400 g/Kg  fat (vegetable oil) 
 
Ļ No difference 
Ĺ Fat mass 
Ĺ No difference No difference 
Khan et al. (2003) C: 5 % fat (vegetable oil) 
HF: 25 % fat (animal fat) 
 
No difference n/a n/a Ļ n/a 
Taylor et al. (2003) C: 5 % fat (vegetable oil) 
HF: 25 % fat (animal fat) 
 
No difference No difference Ĺ No difference Ļ 
Taylor et al. (2005) C: 5 % fat (vegetable oil) 
HF: 25 % fat (animal fat) 
 
No difference n/a n/a No difference No difference 
C = Control; HF = High-fat; ј = Increased in high-fat group; љ = Decreased in high-fat group 
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1.3.2 High-fat maternal diet and offspring development  
There is now growing evidence to suggest that consumption of a high-fat 
diet during pregnancy may also contribute to metabolic abnormalities in 
the offspring. In humans, it is well documented that mothers with 
gestational diabetes, perhaps due to consumption of a high-fat diet or 
maternal obesity, have an increased risk of their offspring being of very 
high-birth weight and developing of obesity and impaired glucose tolerance 
at an early age (Figure 1.5) (Boney et al., 2005, Franks et al., 2006).  
 
 
Figure 1.5 Cumulative incidence of type 2 diabetes stratified by category of 
maternal third trimester plasma glucose concentrations following a glucose 
tolerance test (2 hours after 75g oral glucose challange) (Franks et al., 2006) 
 
Similar effects have been demonstrated by high-fat feeding in rats, where 
pups showed characteristics of the metabolic syndrome seen in humans, 
including; hypertension, hyperlipidemia and impaired glucose tolerance, 
despite no changes in birth weight (Table 1.3) (Khan et al., 2003, Khan et 
al., 2005, Taylor et al., 2005). At birth, rat pups born to mothers fed a 
high-fat diet during pregnancy and lactation have significantly lower fasting 
glucose concentrations, with an increase in liver triglycerides (Table 1.3) 
(Guo and Jen, 1995). Similarly in another study, feeding a high ǔ-6 poly-
unsaturated fat and low carbohydrate diet during pregnancy resulted in an 
increase in insulin secretion after an oral glucose challenge, increased 
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abdominal fat mass and a higher liver triglyceride content in males at 3 
months of age (Table 1.3) (Buckley et al., 2005).  
 
High-fat feeding throughout pregnancy and lactation, has been shown to 
increase the risk of hypertension (Table 1.3) (Khan et al., 2003, Khan et 
al., 2005) and reduce glucose tolerance (Taylor et al., 2005) in female 
offspring at 6 months and 1 year of age. This was accompanied by an 
increase in; body weight, adiposity and fasting plasma glucose and 
triglycerides (Khan et al., 2003, Taylor et al., 2005). These findings are 
similar to the outcomes shown in rat offspring born to mothers who were 
fed a low-protein maternal diet (Section 1.2) (Langley-Evans et al., 1996, 
Langley-Evans et al., 1998, Bertram et al., 2001).  
 
 
Figure 1.6 Role of maternal high-fat diet in the programming of offspring 
metabolic disease; C: Control; HF: High-fat; Adapted from (Khan et al., 2003, 
Taylor et al., 2005). 
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Table 1.3 Summary of effects of maternal fat supplementation in rats throughout gestation on offspring outcome 
Source Maternal diet composition Age and sex analysed Phenotype Plasma profile Liver TAG 
Buckley et al.  
(2005) 
 
 
Throughout pregnancy  
C: 12 % fat 
HF: 59 % fat (safflower oil) 
Males 
3 months 
ј Risk of insulin resistance 
ј Fat mass 
No difference in fasting glucose and insulin  
ј Insulin AUC, no difference in glucose AUC 
ј   
Guo & Jen  
(1995) 
Throughout pregnancy and lactation 
C: 45g/Kg fat (unknown source) 
HF: 400 g/Kg fat (vegetable oil) 
 
 
Males and females 
Birth and weaning  
ј Fat mass No difference in insulin or TAG at birth 
љ Glucose at birth 
ј Glucose and TAG at weaning 
ј  
Khan et al.  
(2003) 
Throughout pregnancy and lactation 
C: 5 % fat (vegetable oil) 
HF: 25 % fat (animal fat) 
 
Males and females 
6 months and 1 year 
ј Blood pressure in females No difference n/a 
Khan et al.  
(2005) 
Throughout pregnancy and lactation 
C: 5 % fat (vegetable oil) 
HF: 25 % fat (animal fat) 
 
Males and females 
6 months  
ј Blood pressure in females 
ј Fat mass 
No difference in lipid or glucose 
ј Insulin 
n/a 
Taylor et al.  
(2005) 
C: 5 % fat (vegetable oil) 
HF: 25 % fat (animal fat) 
 
Females  
6 months and 1 year 
ј Insulin resistance (1 year) 
ј Fat mass 
ј Insulin and glucose 
ј TAG and љHDL (1 year) 
n/a 
C = Control; HF = High-fat; ј = Increased in high-fat group; љ = Decreased in high-fat group; AUC, Area under the curve; TAG = Triglycerides; HDL = High-density 
lipoprotein 
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1.4 High-protein diets 
1.4.1 Maternal protein supplementation 
Following on from the investigations into the effects of maternal low-
protein diets in rats on the programming of offspring, studies began into 
the effects of a high intake of protein during pregnancy. It was conceivable 
that if maternal consumption of a low-protein diet resulted in reduced birth 
weight and increased risk of hypertension, than a high-protein diet may 
produce the opposite and perhaps beneficial effects on the offspring. 
Surprisingly, in rats this appears not to be the case and an isocaloric 
maternal diet with increased protein ratio (high-protein: 40 % protein; 
control: 20 % protein) was associated with a reduction in birth weight of 
male offspring, followed by accelerated postnatal growth (Daenzer et al., 
2001). In contrast to this, another study which fed a similar isocaloric, 
high-protein diet (high-protein: 40 % protein; control: 20 % protein) 
throughout gestation and lactation, demonstrated no effects on offspring 
birth weight (Thone-Reineke et al., 2006). However, the male offspring 
developed significantly higher blood pressure between 4 and 22 weeks of 
age (Thone-Reineke et al., 2006). In addition, glucose tolerance was 
measured in these animals at 22 weeks of age, with no significant 
difference between groups (Thone-Reineke et al., 2006).  Another study in 
rats demonstrated no significant effects of a high protein, increased energy 
maternal diet (high protein: 54 % protein; control: 20 % protein) on 
offspring birth weight and blood pressure from 5 to 30 weeks of age 
(Zimanyi et al., 2002). This lack of significant findings could, perhaps, be 
due to the significant reduction in food intake seen in the high-protein fed 
dams, so that energy and protein intake was similar between groups 
(Zimanyi et al., 2002).  
 
There is insufficient evidence in humans that increased protein intake or 
dietary protein supplementation during pregnancy affects offspring birth 
weight or postnatal growth due to the conflicting outcomes of 
epidemiological studies (Mathews et al., 1999, Kramer and Kakuma, 
2003). 
 
To date, no studies have examined the effect of a high-protein maternal 
diet on GC sensitivity in the offspring to see if it mimics the effects of a 
low-protein diet. This is probably due to the lack of a differential phenotype 
caused by maternal high-protein feeding.  
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1.4.2 High-protein intake in early life 
There have been several investigations into the dietary manipulations 
during early life and the effects on growth and body composition of 
children as they age (Rolland-Cachera et al., 1995, Hoppe et al., 2004). 
Focus has been on the influence of protein in the diet, which, increases 
dramatically in infants during the period of complimentary feeding and the 
transition to the family diet (Alexy et al., 1999). In addition, formula-fed 
infants grow at a faster rate than breast-fed infants, perhaps due to an 
increase in protein intake in the formula-fed infants (Heinig et al., 1993).  
 
It has been suggested that a higher than average protein intake (% of 
energy intake) at 2 years of age could increase the risk of adiposity by the 
age of 10 (Rolland-Cachera et al., 1995).  The proposed mechanism behind 
this is that high-protein intake triggers secretion of IGF-1 and thereby 
accelerates growth and increases adipose tissue and muscle mass 
(Wabitsch et al., 1995, Dardevet et al., 1991). In contrast, a Dutch cohort 
study  found no significant association between protein intake at 9 months 
of age and adiposity by 10 years, despite a significant association with 
body weight and IGF-1 concentrations (Hoppe et al., 2004). This difference 
in study outcome may be due to the differences in time that protein intake 
was measured during early life i.e. at 9 months compared with 2 years. 
This is further supported by Rolland-Cachera et al. (1995) who 
demonstrated no association between protein intake and later adiposity at 
8 months of age. One potential limiting factor of these studies is the 
reliance on food diaries to record protein intake, and so the true protein 
intake may not have been accurately recorded. In addition, the role of 
breast-feeding versus formula feeding in early life may play a crucial role 
in determining adiposity and body weight in later childhood.   
 
1.4.3 Benefits of high-protein diets in obese subjects 
Obesity is often associated with insulin resistance, hyperlipidemia, 
hypertension and fatty liver disease (Grundy et al., 2004). This cluster of 
metabolic disorders, collectively known as metabolic syndrome, is known 
to increase the incidence of type 2 diabetes and cardiovascular disease 
(Grundy et al., 2004). Due to the growing rise in the incidence of obesity in 
the developed world, studies have begun to focus on the manipulation of 
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the macronutrient content of the diet to try and improve weight loss in 
obese individuals (Piatti et al., 1994). 
 
Substituting dietary carbohydrate with protein has been shown to produce 
beneficial effects when combined with calorie restriction (Piatti et al., 1994, 
Parker et al., 2002). For example, insulin sensitivity and fat free-mass has 
been shown to increase in obese subjects who consumed a calorie 
restricted (3347 KJ/day) high-protein diet (high-protein: 45 % protein: 35 
% carbohydrate) when compared to an isocaloric high-carbohydrate diet 
(control: 20 % protein: 60 % carbohydrate) for 21 days (Piatti et al., 
1994).  Similar effects were seen in obese women with type 2 diabetes 
who consumed a low-energy (6994 KJ/day), high-protein diet (high-
protein: 30 % protein: 40 % carbohydrate; control: 16 % protein: 35 % 
carbohydrate) for 8 weeks followed by a 4 week energy-balanced period, 
however, this finding was not consistent in men (Parker et al., 2002). In 
contrast, energy restriction (6276 KJ/day) and an increased protein to 
carbohydrate ratio (high-protein: 30 % protein: 45 % carbohydrate; 
control: 16 % protein: 57 % carbohydrate) had no effects on insulin 
sensitivity or fat-free mass in obese patients with hyperinsulinemia, 
although, these patients were all normoglycemic (Farnsworth et al., 2003).  
 
Similar findings were shown in obese rats where feeding a high-protein 
(high-protein: 59 % protein: 14 % starch; control: 21 % protein: 53 % 
starch, calorie restricted (30 %) diet reduced abdominal obesity, and 
plasma and hepatic triglycerides, to normal levels (Uebanso et al., 2009). 
Interestingly, feeding a similar high-protein and low-carbohydrate diet 
(high protein: 45 % protein: 19 % starch; control: 15 % protein: 41 % 
starch) to non-obese rats from 8-17 weeks results in no significant 
differences in glucose tolerance or body weight (Okitolonda et al., 1988). 
 
To elucidate the cellular mechanisms underlying the effects of diet on 
obese subjects, the expression of genes involved in lipid homeostasis in 
the rat liver was examined (Uebanso et al., 2009). Genes involved in the 
regulation of fatty acid oxidation such as peroxisome proliferator-activated 
receptor (PPAR)-ǄFRDFWLYDWRU-Į3*&-ĮDQG33$5ĮZHUHXS-regulated 
in the liver of high-protein fed rats (Uebanso et al., 2009). In contrast, 
expression of genes involved in lipogenesis such as acetyl-CoA carboxylase 
(ACC) and fatty acid synthase (FAS) were reduced (Uebanso et al., 2009). 
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Furthermore, genes involved in fatty acid transport such as fatty acid-
binding protein 1 (FABP1) were also expressed at levels that were 
significantly higher in the protein fed rats (Uebanso et al., 2009).  
 
1.5 Animal models for nutritional programming 
Animal models are required to examine the underlying physiological, 
biochemical, and molecular biological mechanisms behind the nutritional 
programming of offspring disease in a manner that would be unethical in 
humans (Litten-Brown et al., 2010). An advantage of using animal models 
is that the effect of nutrition can be assessed independently from 
confounding factors such as genetics and social status under controlled 
conditions. In general, animal responses to experimental procedures are 
qualitatively similar to humans, thus allowing more extreme dietary 
manipulation in animals to be used to predict what may happen in humans 
(Litten-Brown et al., 2010).  
 
Various species have been used as models to study the effects of nutrition 
on fetal programming, the most common being the rat and the sheep 
(McMullen and Mostyn, 2009). Primates are the ideal animal model due to 
their similarities to humans, but long lifespan, expensive housing, and 
ethical considerations, limit their use (McMullen and Mostyn, 2009). 
Although rodents are small, inexpensive, and are ideal in multivariate 
experiments, there are numerous differences between rodents and humans 
(McMullen and Mostyn, 2009). One of the major limitations is that rodents 
are altricial animals, born with an undeveloped brain and endocrine 
system, with significant maturation of organs during the weaning period 
(McMullen and Mostyn, 2009). In contrast to the rat, sheep have a similar 
rate of pre- and postnatal growth to humans, and only produce one or two 
offspring, weighing between 3 and 6 kilograms, not unlike humans 
(McMullen and Mostyn, 2009). 
 
Due to the differences in the digestive system of sheep and humans, with 
sheep being ruminants, they have been used mainly to look at the effects 
of global under-nutrition during pregnancy rather than specific 
macronutrient manipulations such as low-protein or high-fat, seen in rat 
studies. The main difference between ruminants and non-ruminants is that 
they have a four-compartment stomach, ideally suited to digestion of fibre, 
particularly cellulose (McDonald et al., 1981). The first two chambers, the 
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rumen and reticulum, contain dense populations of microbes which secrete 
celulases that hydrolyse the beta-glycosidic bonds in fibre (McDonald et 
al., 1981). Break down of the fibre by these microbes produces volatile 
fatty acids (VFA) which are absorbed through the rumen wall and are the 
main energy source for ruminants (McDonald et al., 1981). The three main 
VFA are acetate, butyrate and propionate. Acetate and propionate can be 
transformed to ketones, which, if required, can then be converted to 
acetyl-coA and enter the citric acid cycle. In addition, VFA can be used for 
fatty acid syntheses and gluconeogenesis. Dietary protein is also 
fermented by the microbes predominantly producing ammonia, which the 
bacteria require for synthesising microbial protein, making it an efficient 
symbiotic relationship (McDonald et al., 1981). 
 
The digested material from the rumen-reticulum then moves into the 
omasum where water is added and many inorganic materials are absorbed 
into the blood stream. Carbohydrates, such as sugars and starch, and 
proteins (including microbes) not digested in the rumen are transferred to 
the abosamum (McDonald et al., 1981). This is the direct equivalent to the 
monogastric stomach (for example that of the pig and human) and 
digestion occurs here in much the same way. The digestion of fat is limited 
in the rumen and most occurs in the small intestine (McDonald et al., 
1981). 
 
1.5.1 The pig as a model for nutritional programming 
In recent years, the pig has become increasingly popular as an animal 
model for human disease (Litten-Brown et al., 2010). In this thesis the pig 
was used due to its similarities with humans in terms of the physiology and 
anatomy of the digestive system (Miller and Ullrey, 1987, Pond, 1991). The 
general architecture of the gastrointestinal tract of the pig and the human 
are similar. Notable differences include a higher proportion of cardiac 
mucosa lining the stomach of the pig, and the presence of a cecum in the 
pig compared with only the appendix in the human (Pond, 1991). The 
digestive functions of each segment of the gastrointestinal tract are similar 
with comparable enzyme activities and organ secretions (Pond, 1991). In 
addition, the endocrine and paracrine control of gastrointestinal tract 
growth, motility and overall function, appear to be similar (Pond, 1991). 
Finally, both pigs and humans are able to utilise some fibre as a source of 
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energy due to the fermentation that occurs in the large intestine (Pond, 
1991). 
 
The nutrient requirements during infancy, growth, reproduction, and 
lactation, are similar between the human and pig (Miller and Ullrey, 1987, 
Pond, 1991, Pond and Mersmann, 2001). In addition the neonatal pig is 
similar to the human infant with respect to the stage of development and 
function of several organs systems. The large litter size, which allows for 
multiple comparisons and birth weight studies, and the high growth rate 
after birth, also makes the pig an attractive candidate for nutritional 
intervention studies.  
 
Table 1.4 A comparison of reproductive and general anatomical/physiological 
factors between humans and pigs; Adapted from (Litten-Brown et al., 2010) 
 Human Pig 
Type of placenta Disocid  
haemochorial 
Diffuse  
epithelial chorial 
Placental transfer   
   Glucose Occurs Occurs 
   Amino acids Occurs Occurs 
   NEFA Occurs Limited occurrence 
   Immunoglobulins Occurs Does not occur 
Length of gestation 38 weeks 115 days (16.5 weeks) 
Number of offspring 1 to 2 8-12 
Maturity at birth Precocious Precocious 
Weight of offspring (Kg) 3.2 1.5 
Possesses brown adipose tissue at birth Yes No 
Adipose tissue (% body weight) 14 <2 
Postnatal energy metabolism   
   Total available lipid (g/Kg body weight) 150 11 
   Total available hepatic glycogen (g/Kg body weight) 3.78 2.50 
Newborn period 28 days 14 days 
Infant period 0.08 to 2 years 15 to 75 days 
Juvenile period 3 to 13 years 76 to 115 days 
Age at puberty (males) 13 to 16 years 5 to 18 months 
Age at puberty (female) 11 to 14 years 6 months 
NEFA = Non-esterified fatty acid 
 
1.5.1.1 Placental structure 
A primary determinant of fetal growth and development is the nutrient 
supply across the placenta, which in turn depends on the size, morphology, 
blood supply and transporter abundance of the placenta, and on the 
synthesis and metabolism of nutrient and hormones by the uteroplacental 
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tissues (Fowden et al., 2006). There are two characteristics used for the 
classification of placental structure, which differs amongst species (Bowen, 
2000). These are; firstly, the gross shape of the placenta and the 
distribution of contact sites between fetal membranes and endometrium, 
and secondly, the number of layers of tissue between maternal and fetal 
vascular systems.  
 
Just prior to the formation of the placenta, there are a total of six layers of 
tissue separating the maternal and fetal blood (Figure 1.7) (Bowen, 2000). 
There are three layers of fetal extraembryonic membranes in the 
chorioallantoic placenta of all animals, all of which are components of the 
mature placenta. These include the endothelium lining allantoic capillaries, 
connective tissue in the form of chorioallantoic mesoderm, and the 
chorionic epithelium, the outermost layer of fetal membranes. There are 
also three layers on the maternal side, but the number of these layers that 
are retained, and not destroyed by the process of placentation, varies 
greatly among species (Bowen, 2000).  
 
 
Figure 1.7 Diagrammatic representation of the structure of the placenta (Bowen, 
2000) 
 
In the human, the surface area of the placenta is limited to a discoid 
region, and belongs to the hemochorial category ((Litten-Brown et al., 
2010, Bowen, 2000). This means the fetal chorionic epithelium is bathed in 
maternal blood because chorionic villi have eroded through maternal 
endothelium (Bowen, 2000). In contrast, pigs have a diffuse placenta 
where almost the entire surface of the allantochorion is involved in the 
formation of the placenta (Hughes and Varley, 1980, Bowen, 2000, Litten-
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Brown et al., 2010). In addition, the chorionic epithelium of the pig fetus 
remains separated from the maternal blood by three layers of tissue 
(Bowen, 2000, Litten-Brown et al., 2010). There are also differences in the 
transport capabilities of both the human and pig placentas, and it is 
believed that there is limited transfer of non-esterified fatty acids (NEFA) in 
the pig (Mersmann and Pond, 2001). Another important difference is that 
the piglet is unable to acquire passive immunity from its mother in utero 
due to the inability to transport immunoglobulins across the placenta 
(Blecha, 2001). 
 
1.5.1.2 Fetal growth and development 
There is a well-defined, programmed, sequence of developmental changes 
that occur at specific times in the growth and development of the embryo 
and the fetus. The underlying principles of fetal maturation appear to be 
comparable between mammals, although there are quantitative differences 
between species (Litten-Brown et al., 2010).   
 
In most species, the majority of growth occurs during the second half of 
pregnancy. In the human, fetal growth rate is relatively slow up to the 20th 
week of pregnancy but accelerates to reach a maximum around 30-36 
weeks, declining thereafter until birth (Figure 1.8) (Book and Bustad, 
1974, Litten-Brown et al., 2010). At birth the pig has not reached its peak 
growth rate and therefore there is no pre-parturition decline (Figure 1.8) 
(Book and Bustad, 1974, Litten-Brown et al., 2010). In litter-bearing 
species, the number of developing fetuses is inversely proportional to the 
ultimate size of each individual at full time. The pattern of fetal growth in 
pigs is determined by several factors including; the genome of the 
developing fetus, maternal nutrition and health, uterine capacity, and fetal 
position within the uterine horn (Litten-Brown et al., 2010).  
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Figure 1.8 Comparison of the length of the human, pig and rat fetus as a function 
of gestational age; Adapted from (Book and Bustad, 1974) 
 
Protein accumulation tends to occur early in human fetal development to 
reach its maximum around week 35, and precedes fat accumulation, most 
of which is subcutaneous, and only exceeds the weight of protein 
deposition by week 38 (Book and Bustad, 1974, Shulman, 1993). By term, 
the human infant has substantially more fat than the piglet (Shulman, 
1993). In contrast to humans, body fat in the newborn pig is minimal, 
usually no more than 2 percent of body weight (Shulman, 1993), and most 
of this fat is structural and therefore unavailable for use as energy. 
However, within the first week of life, during the time of rapid growth, 
there can be a 10 to 20-fold increase in body fat (Pond and Mersmann, 
2001). Similarly, rates of protein deposition and lean tissue growth are 
also very high during this time (Pond and Mersmann, 2001). Well fed 
piglets can double their birth weight in 7-10 days, whereas the infant 
doubles its birth weight by about 5 months of age (Shulman, 1993), thus 
piglets can provide an excellent model of accelerated growth and 
development.  
 
1.6 Nutritional requirements of pigs 
The ultimate goal of commercial pig production is the economical 
production of muscle tissue that is both a nutritious, healthy and palatable 
source of dietary protein for human consumption (Mitchell et al., 2001). 
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Consequently, adipose tissue is an inefficient by-product. The most 
expensive aspect of pig production is feed, and feed that is diverted to fat 
deposition is an input that is not rewarded by a cost-effective product. 
However, some adipose tissue is necessary for the welfare of the pig as it 
is an important source of insulation and energy storage.   
 
Pigs are omnivorous, will consume most types of feed, have similar body 
composition to human adults, and have a propensity to obesity, making 
them excellent models for human nutrition (Pond, 1991, Yen, 2001). One 
major determinant of obesity in mammalian species, including humans and 
pigs, is energy intake. When energy intake exceeds energy utilisation, fat 
is deposited. Commercial pigs in developed countries are usually fed a low-
fat, high-carbohydrate diet (Mitchell et al., 2001). Excess energy intake 
from these types of diets can lead to obesity, due to WKHSLJ¶V capacity to 
synthesise long-chain fatty acids from carbohydrates, primarily glucose. 
Feeding a low-protein diet leads to more fat deposition than those fed 
adequate protein (Ewan, 1991, Mitchell et al., 2001). An excessively high 
protein diet will also increase fat mass because the amino acids not used 
for protein synthesis will be de-aminated for fatty acid synthesis (Ewan, 
1991, Mitchell et al., 2001).  
 
1.6.1 Maternal nutrition  
Optimal nutrient intake is not only the primary determinant of the normal 
growth and development, but is also important in reproduction and 
lactation. Until sexual maturity the nutrient requirements of pigs are 
largely designed to maximise growth and lean tissue deposition. The 
weight gain, and thus nutrient requirements, of the gestating sow should 
allow for the weight of the litter and the afterbirth, as well as maintenance 
of maternal body weight (Cunha, 1977, Ewan, 1991). The aim is that after 
parturition and lactation, sows should weigh approximately the same as 
they did prior to mating (Cunha, 1977). Gilts (1st parity sows) have greater 
requirements than mature sows as their diet has to provide enough energy 
for their own growth as well as the growth of their developing fetuses 
(Cunha, 1977). The optimum weight gains for gilts and sows will vary 
depending on the original condition of the animal, the type of feed fed, the 
breed and size of the animal, and the number of offspring expected to be 
produced (Cunha, 1977). Nutrient demands in the sow are greatest during 
the last third of gestation when fetal growth is at a ma
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1977, Ewan, 1991, Pluske et al., 1995). It is normal commercial practice to 
restrict the feed intake of the sow throughout gestation in order to prevent 
excessive growth and fattening (Ewan, 1991).  
 
The energy requirements to support lactation are three to four times 
greater than those of gestation (Cunha, 1977, Burrin, 2001). The nutrient 
requirements of the lactating period are a function of the sows need for 
growth and maintenance, plus the needs for milk production, which can 
represent 70 to 85 percent of the total energy required (Burrin, 2001). If 
insufficient energy is available, energy will be mobilised from the maternal 
tissues to sustain milk production, and weight loss will occur (Ewan, 1991). 
Generally, lactating sows are allowed ad libitum access to feed, and feed 
intake will determine if weight is gained or lost during lactation (Ewan, 
1991). 
 
1.6.2 Dietary energy sources 
1.6.2.1 Carbohydrate 
As mentioned previously, the major source of energy in a typical pig diet is 
carbohydrate. Carbohydrates are usually classified as simple 
(monosaccharides and disaccharides) or complex (oligosaccharides and 
polysaccharides). Simple carbohydrates are sugars and complex 
carbohydrates include starch, glycogen and cellulose (fibre).    
 
In most developed countries, carbohydrates in pig diets are supplied in the 
form of starch which is present in cereal grains and their by-products, such 
as corn (maize), wheat, barley, rice, rye and oats (Burrin, 2001). Fibre is 
also used as alternative source of carbohydrates and is used mainly to 
reduce feed costs. Sources in pig diets include alfalfa, soybean hulls, oats, 
and wheat bran (Burrin, 2001). Fibre is not typically included in the diets of 
neonatal or growing pigs because it reduces growth by diluting the nutrient 
density (Ewan, 1991, Burrin, 2001). The most common use of fibre is in 
gestating sows where it minimizes excessive weight gain and serves as a 
laxative (Burrin, 2001). 
 
1.6.2.2 Protein 
The second most abundant nutrient required in the pig diet is protein 
(Burrin, 2001) which is an organic compound, composed of amino acids 
arranged in a linear chain and folded in a globular form. Different proteins 
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vary considerably in their amino acid composition (Burrin, 2001). Pigs are 
able to synthesise some amino acids in the body and these do not need to 
be provided in the diet; these are referred to as non-essential amino acids 
(Wu, 2009). Other amino acids cannot be synthesised by pigs, or at least 
not at the rate required, and these are referred to as essential (Wu, 2009). 
Some amino acids are only essential dietary components in certain 
situations such as during pregnancy or in very young pigs; these are 
known as conditionally essential amino acids (Wu, 2009). These include 
arginine, cysteine, glutamine and proline (Wu, 2009). There are 20 
different amino acids that commonly occur in proteins, although only 10 of 
these are considered to be essential dietary components (Lewis, 1991, 
Burrin, 2001). The ideal amino acid composition is dependent on the 
physiological and reproductive function for which the amino acids are used, 
namely maintenance, growth, and milk synthesis (Table 1.5) (National 
Research Council (NRC), 1988). 
 
Table 1.5 Amino acid requirements (% of diet) of sows during gestation and 
lactation; Adapted from (NRC, 1988) 
Amino acid Gestation Lactation 
Arginine 0 0.40 
Histidine 0.15 0.25 
Isoleucine 0.30 0.39 
Leucine 0.30 0.48 
Lysine 0.43 0.60 
Methionine + Cystine 0.23 0.36 
Phenylalanine + Tyrosine 0.45 0.70 
Threonine 0.30 0.43 
Trytophan 0.09 0.12 
Valine 0.32 0.60 
 
Dietary protein requirements are similar to that of a human diet and range 
from around 26 percent in neonates to 13 percent in adult diets (Burrin, 
2001). Although pigs require amino acids for maintenance, growth, and 
reproduction, they are predominantly fed intact proteins to meet their 
requirements. As mentioned previously, cereal grains form the basis of 
most swine diets and these, as well as being a good source of starch, 
generally supply between 40 and 50 percent of the protein in the diets of 
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growing-finishing pigs (Lewis, 1991). The remaining protein usually comes 
from the addition of oilseed meals which are by-products of the oilseed 
industry (Seerley, 1991). In normal commercial practice, diets are often 
supplemented with crystalline amino acids such as lysine, tryptophan, 
methionine and valine, to obtain the ideal amino acid formulation (Lewis, 
1991, Burrin, 2001).  
 
1.6.2.2.1 Protein deficiency during gestation 
Adequate protein during pregnancy is important to reduce neonatal 
mortality and ensure optimal piglet birth weight and growth. However, 
during pregnancy, the sow, unlike other species such as the rat, can 
effectively buffer the developing fetus against protein restriction, so that 
the development of the conceptus takes priority and will develop at the 
expense of maternal tissue (Cunha, 1977, Miller and Ullrey, 1987, Ewan, 
1991). This is demonstrated by studies which demonstrate the effects of 
protein-restriction during pregnancy on the offspring. For example, a 
reduction in dietary protein content to 0.5 % in sows during pregnancy, 
whilst maintaining energy, content has no effects on litter size or piglet 
birth weight (Schoknecht et al., 1993, Schoknecht et al., 1994). In 
contrast, in gilts, the same protein restriction (0.5 % protein) has been 
shown to result in a reduction in piglet birth weight (Schoknecht et al., 
1993). This difference is probably because gilts are still growing and so 
both the fetus and mother are competing for limited nitrogenous 
substrates to meet their needs. However, if this protein restriction of gilts 
occurs either in just early (days 1-44) or late (day 81 to term) pregnancy 
by 25 weeks of age the offspring have caught up to control progeny and 
there are no differences in body weight (Schoknecht et al., 1993).  
 
Protein restriction during pregnancy, particularly in late gestation, appears 
to have a larger effect on subsequent milk production than birth weight, 
even if this restriction does not continue into lactation. This has been 
suggested because of the reduction in weaning weight when piglets were 
cross-fostered piglets from their control fed mothers onto those who were 
protein restricted (0.5 %) throughout gestation, despite no differences in 
birth weight (Schoknecht et al., 1993). 
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1.6.2.3 Fat 
Most of the lipid in pig diets is in the form of triacylglycerols (triglycerides), 
the true fats (Pettigrew and Moser, 1991). Triglycerides are tri-esters of 
glycerol and fatty acids. Fatty acids are chains of carbon and hydrogen 
atoms with a carboxylic acid group at one end and a methyl group at the 
other. The properties of specific fat molecules depend on the particular 
fatty acids that constitute it (McDonald et al., 1981). Different fatty acids 
compose a different number of carbons in their chain, with the highest 
numbered Carbon, at the methyl end, known as ǔ-C. In addition, fats can 
also be saturated or unsaturated (Figure 1.9). When a fat is saturated the 
carbon atoms are bonded to as many hydrogen atoms as possible meaning 
that the bonds between the carbon atoms are all single bonds. The 
unsaturated fatty acids contain either one (monoenoic), two (dienoic), 
three (trienoic), or many (polyenoic) double carbon to carbon bonds in 
their chain (McDonald et al., 1981). Polyunsaturated fatty acids are fatty 
acids that contain two or more carbon to carbon double bonds. Omega-3-
fatty acids have a double bond, three carbons away from the methyl 
carbon, whereas omega-6-fatty acids have it six carbons away. The main 
sources of polyunsaturated fatty acids are nuts, seeds, fish and leafy 
greens. Unsaturated fatty acids possess different physical properties from 
the saturated fatty acids; they have lower melting points and are 
chemically more reactive (McDonald et al., 1981).  
 
 
Figure 1.9 Examples of saturated (Stearate) and unsaturated fatty acids (Oleate) 
(Cooper, 2000) 
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The presence of a double bond in a fatty acid molecule means that the acid 
can exist in two forms depending on the arrangement of the hydrogen 
atoms attached to the carbon atoms of the double bond (McDonald et al., 
1981). When both of the hydrogen atoms lie on the same side as the 
double bond the acid is said to be in the cis form (Figure 1.9), whilst if they 
lie on opposite sides it is in the trans form. Most of the naturally occurring 
fatty acids are in the cis form (McDonald et al., 1981).  
 
There are three polyunsaturated fatty acids that are considered to be 
essential fatty acids (EFA); these are Į-linoleic acid (n-6), linolenic acid (n-
3), and arachadonic acid (n-6), which is synthesised from Į-linoleic acid 
(Aflin-Slater and Aftergood, 1968, McDonald et al., 1981). EFA, like 
essential amino acids, are those fatty acids that cannot be biologically 
synthesised, or are synthesised in inadequate amounts to meet the 
animal¶V nutrient needs for growth, maintenance, and proper functioning of 
many physiological processes (Aflin-Slater and Aftergood, 1968). Alpha-
Linoleic acid is the key essential fatty acid in the pig (Cunha, 1977). 
Arachadonic acid can be effective in preventing or curing a Į-linoleic acid 
deficiency (Cunha, 1977). Alpha-Linoleic deficiency in pigs results in loss of 
hair, scaly dandruff-like dermatitis and slower growth rate in weaned pigs, 
probably due to less efficient feed utilisation (Hill et al., 1961, Leat, 1962, 
Sewell and McDowell, 1966). These investigations have led to the 
recommendation of Į-linoleic acid requirements in swine by the National 
Research Council (NRC), which are around 0.1 percent of the total diet 
(NRC, 1988).  These requirements can usually be met with a level of 1-1.5 
percent fat in the diet (Cunha, 1977). Most diets consisting of grain and 
protein therefore, should supply enough Į-linoleic acid for the pig (Cunha, 
1977).      
 
As well as the essential fatty acid requirements already discussed, fats are 
included in pig diets to increase the energy density, increase growth and 
food conversion efficiency, improve palatability, improve neonatal pig 
survival, and reduce airborne dust (Pettigrew and Moser, 1991, Burrin, 
2001). However, as with other species, increased fat content will lead to 
increased fat deposition, even when there is equal energy intake (Mitchell 
et al., 2001). As mentioned previously, addition of fat to diet reduces feed 
intake without affecting the overall energy intake (Pettigrew and Moser, 
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1991). This reduction in feed intake may limit the intake of other essential 
nutrients.  
 
1.6.2.3.1 Manipulation of dietary fatty acids in sow diets 
Fats are found in various concentrations in major pig feedstuffs that are 
predominantly sources of carbohydrates and amino acids. Fats can also be 
added to the diet in the form of commercially available products such as 
animal fat and soy bean oil (Pettigrew and Moser, 1991). Most fats used in 
pig feeding contain longer-chain fatty acids of fourteen to twenty carbon 
molecules (Table 1.6) (Seerley, 1991). Fats and oils used in swine diets 
are derived from both animal and plant sources. Different fat sources differ 
in their fatty acid ratio (Table 1.6). Animal sources tend to be higher in 
saturated fatty acids, whilst those from plant sources are higher in 
polyunsaturated fatty acids (Table 1.6) (Burrin, 2001). The saturated to 
unsaturated ratio affects the melting point and energy value of fat as well 
as the fatty acid composition of the liver, fat, muscle, and milk (Seerley, 
1991). 
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Table 1.6 Estimated percentage of major fatty acids and unsaturated to saturated fatty acid ratio in some fat sources used in the swine industry 
(Seerley, 1991)  
 Carbons:  
Double bonds 
Coconut 
oil 
Palm  
oil 
Soy bean  
oil 
Corn  
oil 
Safflower  
oil 
Lard 
Unsaturated: Saturated   0:1 1:1 6:1 7:0 8:1 1:5 
Saturated fatty acids:        
   Caprylic 8:0 7      
   Capric 10:0 7      
   Lauric 12:0 48      
   Myristic 14:0 15 2    2 
   Palmitic 16:0 9 42 12 10 8 25 
   Stearic 18:0 2 4 2 2 3 10 
Unsaturated fatty acids:        
   Palmitoleic 16:1 6     2 
   Oliec 
Polyunsaturated fatty acids: 
18:1  43 28 26 14 45 
   Į-Linoleic (n-6) 18:2 1 9 50 56 75 11 
   Linolenic (n-3) 18:3   7 2   
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Nutrient requirements for pigs give no recommendations for n-3 essential 
fatty acid requirements (Rooke et al., 1998). In human nutrition n-3 fatty 
acids, particularly docosahexaenoic acid (22:6 n-3), are important in late 
gestation as this is the time for rapid tissue deposition in organs that are 
highly reliant on n-3 such as the brain and retina (Makrides et al., 1994).  
 
Commercial pig diets are based on cereals which are deficient in long-chain 
n-3 fatty acids. As the piglet also undergoes rapid brain tissue growth in 
late gestation n-3 fatty acids may also be important in sow nutrition 
(Passingham, 1985). One study has demonstrated the effects of the 
addition of tuna oil (30 g/kg), which is rich in n-3 fatty acids, instead of 
soy bean oil (30 g/kg) to an isocoloric sow diet from around 90 days of 
gestation until the end of the first week of lactation (Rooke et al., 1998). 
This study showed that tuna oil increased the proportion of n-3 fatty acids 
in both the maternal plasma and the milk. At birth, the offspring of these 
tuna oil fed sows had greater proportions of n-3 fatty acids in both their 
plasma and tissues such as the liver and the brain. This effect was thought 
to be independent of the colostrum intake as some piglets had not yet 
suckled at birth order was taken into account in the statistical model used. 
One explanation for this effect is that it is due to transfer of selected fatty 
acids across the placenta in late pregnancy, a process that was thought to 
be limited in pigs (Mersmann and Pond, 2001). Another study has 
demonstrated similar responses in plasma and tissue fatty acid proportions 
when diets containing an increased ratio of n-3 fatty acids in the form of 
salmon oil (0, 5, 10 and 20 g/ kg) to palm oil were fed from day 60 of 
gestation (Rooke et al., 2001a). 
 
It has been hypothesised that a contributing factor to low piglet viability at 
birth may be an imbalance or deficiency of n-3 fatty acid supply to the 
pregnant sow (Rooke et al., 1998). However, in one study, the viability of 
piglets born to sows fed a tuna oil supplemented diet (30 g/kg) was 
significantly decreased when compared to a soy bean oil control (Rooke et 
al., 1998). This is an opposite result to what was hypothesised and it is 
believed that it could be linked to gestation length. It is thought that 
gestation length may be increased by an increased intake of n-3 fatty acids 
in the diet and so by inducing farrowing on days 113 and 114 gestation, 
and so those fed the soy-bean oil may have been closer to their natural 
farrowing date (Rooke et al., 1998). Further studies agree with this and 
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have demonstrated an increase in gestation length when salmon oil (500 
g/kg) was added to the diet throughout gestation and lactation, with no 
effects on litter size (Rooke et al., 2001a). In addition, piglet birth weight 
was reduced when salmon oil was fed to the mothers, although surprisingly 
pre-weaning mortality was lower in these litters (Rooke et al., 2001a). 
 
1.7 Liver metabolism 
The liver was chosen in this thesis as the focus for further investigation 
into the effects of maternal diet on the offspring. This was due to its 
important role in whole body energy balance and metabolism. In addition, 
many studies have already shown an effect of nutritional programming on 
liver metabolism and gene expression in a range of species and models 
(Guo and Jen, 1995, Langley-Evans, 1996, Brameld et al., 2000, Bertram 
et al., 2001, Whorwood et al., 2001, Buckley et al., 2005, Ehruma et al., 
2007)The present section will give a brief outline of the structure of the 
liver and will then go on to discuss the liver functions in terms of 
carbohydrate, lipid and protein metabolism.   
 
1.7.1 Liver structure 
The pig is a good experimental model for investigations on the liver 
because of its similarities to human liver in terms of size and morphology 
(Court et al., 2003). The liver is the largest and most metabolically 
complex organ in the body. It consists of many microscopic functional 
units, known as lobules, the number and size of which varies among 
species. Hepatocytes are responsible for the livers central role in 
metabolism and make up the bulk of the cells in the lobules.  
 
Blood supply to the liver is from both the portal vein and hepatic artery 
(Figure 1.10). The blood entering the liver from the portal vein comprises 
all the blood returning from the small intestine, stomach, pancreas and 
spleen (Bowen, 2004), and makes up around 70 percent of the livers blood 
supply (Martin and Neuberger, 1957). This means that everything that is 
absorbed through the digestion process in the small intestine must pass 
through the liver, thus further highlighting its importance in metabolism. 
The remaining portion of the blood supply to the liver is from arterial blood 
via the hepatic artery, and so is rich in dissolved oxygen (Beath, 2003). 
After a meal, the portal vein delivers approximately twice the volume of 
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blood as the hepatic artery, equivalent to around 600 ml/min in an adult 
(Beath, 2003).  
 
The terminal branches of the hepatic portal vein and hepatic artery empty 
together and mix as they enter the sinusoids in the liver. The sinusoids are 
distensible vascular channels lined with highly permeable endothelial cells 
and are bounded circumferentially by hepatocytes. As blood flows through 
the sinusoids, a considerable amount of plasma is filtered out into the 
spaces between the endothelial cells and the hepatocytes, known as the 
µVSDFHRI'LVVH¶(Bowen, 2004). Blood from the sinusoids empties into the 
central vein of each lobule, these central veins merge into hepatic veins, 
which leave the liver and empty into the hepatic vena cava. Within the 
sinusoids are Kupffer cells, these play a very important role in the 
phagocytic system, which prevents invasion of the systemic circulation by 
bacteria (Bowen, 2002). 
 
Figure 1.10 Diagrammatic representation of the hepatic vascular system; red 
blood vessels indicate oxygenated blood and blue blood vessels indicate de-
oxygenated blood (Bowen, 2004) 
 
The biliary system is a series of channels and ducts that conveys bile, a 
secretory and excretory product of hepatocytes, from the liver and into the 
OXPHQRIWKHVPDOOLQWHVWLQH+HSDWRF\WHVDUHDUUDQJHGLQµSODWHV¶ZLWKWKHLU
apical surfaces facing and surrounding the sinusoids (Figure 1.11) (Yen, 
2001, Beath, 2003). The basal faces of adjoining hepatocytes are welded 
together by junctional complexes to form bile canaliculi (Figure 1.11) 
(Beath, 2003). The hepatocytes actively transport bile into the canaliculi, 
via specialised transport proteins, and those secretions flow parallel to the 
sinusoids but in the opposite direction to the blood (Beath, 2003). Bile 
collects in the bile ducts at the end of the canaliculi. Bile ducts thus begin 
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in close proximity to the terminal branches of the portal vein and hepatic 
artery, and this grouping is known as the portal triad (Yen, 2001).  
 
 
Figure 1.11 Structural arrangement of cells in the liver (Beath, 2003) 
 
Attached to the liver is the gall bladder which stores and concentrates the 
bile made in the liver. Bile is involved in the emulsification of fats in the 
intestine. In addition, it aids in the secretion of many unwanted 
endogenous and exogenous compounds or toxins from the liver into the 
intestine, where they will be ultimately eliminated by the kidney (Bowen, 
2001). Bile acids are derivatives of cholesterol, which is either ingested in 
the diet or synthesised in the liver (Bowen, 2001). Cholesterol is converted 
into the bile acids, cholic and chenodeoxycholic acids, which are then 
conjugated to an amino acid (Bowen, 2001). This is then actively secreted 
into the canaliculi.  
 
The liver has a pivotal role in lymph production in the body (Bowen, 2002). 
Lymph is a fluid which occupies the interstitial spaces between cells and 
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picks up unwanted materials such as fats and bacteria, and filters these 
substances out throughout the lymphatic system. Due to the large pores in 
the sinusoidal endothelial cells, fluid and proteins in the blood can flow 
freely through and into the space of Disse, forming lymph. Lymph flows 
through the space of Disse to collect in small lymphatic capillaries, which 
are associated with the portal triad, and from there into the systemic 
lymphatic system.  
 
1.7.2 Liver function and metabolism 
By birth, the architecture of the liver has been established for some time 
(Patten, 1948, Beath, 2003). In utero, it acts as the main source of red 
blood cell production, and even at birth, there are still active areas of 
haemotopoiesis (Beath, 2003). In human neonates, these areas usually 
disappear within six weeks after birth, being superseded by the bone 
marrow (Beath, 2003). 
 
After the initial adaptations to circulatory changes have taken place, the 
liver starts to fulfil its role in maintaining homeostasis (Beath, 2003). 
Within the hepatocytes virtually all the reactions of intermediary 
metabolism can take place (Pesch and Topper, 1963). They play critical 
roles in synthesising molecules that are utilised elsewhere, in converting 
molecules from one type to another, and in regulating energy balance. As 
a result of all these reactions, the liver acts as a vital processing organ 
where nutrients absorbed from the gastrointestinal tract are transformed 
into materials required by other tissues in the body.  
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Figure 1.12 Overview of metabolism in the liver; ADP = Adenosine diphosphate ; ATP = Adenosine triphosphate; (Ophardt, 2003a) 
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1.7.2.1 Carbohydrate metabolism  
The liver is the co-ordinating centre of carbohydrate metabolism. One of its 
major functions is to maintain plasma glucose concentrations within a 
normal range over both short (hours) and long (days and weeks) periods 
of time (Pesch and Topper, 1963, Bowen, 1995, Raddatz and Ramadori, 
2007). This is achieved by a tightly regulated system of enzymes 
controlling either the breakdown or synthesis of glucose in the hepatoytes. 
This process is under the control of glucoregulatory mediators among 
which insulin plays a key role (Raddatz and Ramadori, 2007).  
 
Excess glucose entering the blood, after the consumption of a large meal, 
is taken up by the liver and transformed to glycogen to be stored. This 
process is known as glycogenesis.  Although glycogen is found in most 
tissues of the body, the liver has the highest glycogen content (Pesch and 
Topper, 1963) and thus provides a dynamic storehouse of energy. 
Glycogen suits this function as it can be rapidly synthesised from all 
available nutrients and is a source of glucose that can be utilised by all 
body tissues for energy. Also, because glycogen metabolism is under 
hormonal control, it is readily adaptable to the changing body needs (Pesch 
and Topper, 1963). If blood glucose levels begin to decline, the liver can 
utilise these glycogen stores through glycogenolysis, and export glucose 
back into the blood for transport to other tissues. Liver glycogen stores will 
deplete rapidly after birth in the newborn in order to maintain 
normoglycemia before the commencement of suckling (Figure 1.13) (Pesch 
and Topper, 1963, Okai et al., 1978, Mitchell et al., 2001). When hepatic 
glycogen reserves become exhausted, glucose can be synthesised from 
non-glucose polymers such as the gluconeogenic amino acids via 
gluconeogenesis. All amino acids except Leucine and Lysine are 
gluconeogenic.  
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Figure 1.13 Tissue glycogen concentrations in piglets from birth to 2 days of age; 
adapted from (Okai et al., 1978) 
 
In type 2 diabetes, as well as in liver disease, alterations in hepatic glucose 
metabolism occur due to insulin resistance, and include increased post-
absorptive glucose production, together with diminished glucose uptake 
following carbohydrate ingestion (Raddatz and Ramadori, 2007). 
 
1.7.2.1.1 Glucose transport in the liver 
The transport of glucose across the plasma membrane is one of the most 
important cellular nutrient transport events, since glucose plays a vital role 
in cell homeostasis and metabolism. Virtually all mammalian cell 
membranes possess a facilitative transport system for the movement of 
glucose across the cell membrane down its chemical gradient either into or 
out of cells (Gould and Holmam, 1993). These transporters are specific for 
glucose and are not coupled to energy requiring components. Glucose 
transport into certain tissues is under acute and chronic control by 
circulating hormones. Defects in this transport system may underlie 
disease such as type 2 diabetes (Gould and Holmam, 1993). Glucose 
transport is mediated by a group of glucose transporters (GLUT) which are 
families of distinct genes and are expressed in a highly controlled tissue 
specific fashion (Table 1.7). 
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Table 1.7 Tissue specific expression of the glucose transporters (GLUT) in 
mammalian cells (Gould and Holmam, 1993) 
Isoform Tissue 
GLUT 1 Placenta, brain, blood-tissue barrier; low levels in adipose tissue, muscle an liver 
GLUT 2 Liver, pancreas, kidney and small intestine 
GLUT 3 Brain; low-levels in placenta, liver, heart and kidney  
GLUT 4 Muscle, heart and adipose tissue 
GLUT 5 Small intestine; low-levels in brain, muscle and adipose tissue 
GLUT 7 Hepatic microsomal glucose transporter  
           
The primary transporter in the liver is GLUT 2. This is a low-affinity, high 
capacity transporter involved in the transport of glucose into and out of 
hepatocytes (Gould and Holmam, 1993). This means that it requires a high 
concentration of glucose to become activated, but, once activated; it can 
quickly remove large amounts of glucose from the blood. Together with the 
enzyme glucokinase, GLUT 1 is thought to act as a glucose-sensing 
mechanism that plays a role in blood glucose homeostasis, by responding 
to changes in blood glucose concentration and altering the rate of uptake 
into liver cells. In addition low levels of GLUT1 and GLUT3 are also 
expressed in the liver. These function effectively as unidirectional 
transporters, and are thought to work in tandem with each other in 
conditions where demand for glucose transport is high (Gould and 
Holmam, 1993). GLUT 7 is involved in the intracellular transport of glucose 
in the liver. When glucose is produced through both gluconeogenesis and 
glycogenolysis it is confined to the ER. Thus GLUT 7 is required to facilitate 
the transport of glucose across the ER membrane so it can be taken out of 
the hepatocyte (Gould and Holmam, 1993).   
 
1.7.2.2 Lipid metabolism  
The liver plays a key role in lipid metabolism which involves several 
pathways. It is the hub of fatty acid synthesis and lipid circulation through 
lipoprotein synthesis (Favarger, 1963, Nguyen et al., 2008). In addition, 
the liver is the principal site for fatty acid breakdown, which makes it a 
target site for many circulating lipids (Favarger, 1963). Furthermore, the 
liver has a key role in the production of phospholipids and in cholesterol 
metabolism (Favarger, 1963).   
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Figure 1.14 Fatty acid transport into the liver, intracellular activation, and main 
pathways of activated fatty acids; NEFA = Non-esterified fatty acid; FABP = Fatty 
acid-binding protein; FATP = Fatty acid transport protein; FAT: Fatty acid 
translocase; ACBP; Fatty acyl-CoA binding protein; ACS = Fatty acid CoA 
synthetase; (Nguyen et al., 2008) 
 
The liver takes up NEFA from the blood directly in proportion to their 
concentration, usually through specialised transporters. Fatty acid 
transport proteins (FATP) are involved in uptake of long-chain fatty acids. 
Fatty acids taken up by FATP are preferentially channelled into triglyceride 
synthesis, suggestion a functional link between FATP fatty acid uptake and 
lipid storage (Kim et al., 2004). In addition, fatty acid translocase CD36 
(FAT/CD36) is also involved in fatty acid uptake into the cell when fatty 
acid and/or insulin plasma concentrations are raised (Bonen et al., 2004). 
FAT/CD 36 translocation to the hepatocyte membrane is significantly 
associated with insulin resistance and hyperinsulinaemia in patients with 
non-alcoholic fatty liver disease (Miquilena-Colina et al., 2011). 
 
Within the hepatocytes, these fatty acids are bound to FABP1 and acyl CoA 
binding protein, which transport them into intracellular compartments for 
metabolism (Nguyen et al., 2008).  In addition, they may also be taken 
into the nucleus where they regulate gene expression by controlling the 
activity or abundance of key transcription factors (Nguyen et al., 2008). 
Many transcription factors have been identified as prospective targets for 
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fatty acid regulation including PPARs (Schoonjans et al., 1996)33$5Į LV
highly expressed in the nucleus of hepatocytes, where it regulates a set of 
enzymes that are crucial for fatty acid transport and oxidation (Nguyen et 
al., 2008).  
 
Lipogenesis is tightly controlled by hormonal and nutritional conditions. 
Briefly, high carbohydrate diets induce, whereas fasting or fat feeding 
inhibit lipogenesis (Nguyen et al., 2008). It is especially dependent on 
concentration and tissue sensitivity to insulin (Nguyen et al., 2008). Fatty 
acids synthesised in the liver are exported through lipoprotein production, 
and thus provide an energy source and structural components for 
membrane building (Nguyen et al., 2008). There is a close relationship 
between the rate of fatty acid synthesis and the activity of the enzyme 
FAS. FAS is expressed in both liver and adipose tissue. In humans, the 
major site of fatty acid synthesis is in the liver (Patel et al., 1975), 
whereas in pigs it is in the adipose tissue (O'Hea and Leveille, 1969). It is 
regulated by hormones, nutritional status and the intracellular fatty acid 
concentration. For example, insulin activates FAS and glucagon inhibits it 
(Nguyen et al., 2008).  
 
Fatty acids may be oxidised in the liver, either in the mitochondria or the 
peroxisomes. Two main factors regulating the degree to which fatty acids 
are oxidised in the liver are their supply to the liver, via lipolysis, and the 
partitioning between oxidation and microsomal esterification (Nguyen et 
al., 2008))DWW\DFLGR[LGDWLRQRFFXUV WKURXJKWKHǃ-oxidation pathways, 
resulting in the formation of acetyl-CoA. The acetyl-CoA can then be 
oxidised completely in the citric acid cycle, in order to produce energy. 
3HUR[LVRPDO ǃ-oxidation is responsible for the metabolism of very long 
FKDLQ IDWW\ DFLGV ZKHUHDV PLWRFKRQGULDO ǃ-oxidation oxidises short, 
medium and long chain fatty acids (Nguyen et al., 2008). When 
carbohydrates are scarce the liver has the ability to produce ketone bodies 
from the acetyl-CoA formed during ǃ-oxidation through ketogenesis 
(Nguyen et al., 2008). These are then transported to other tissues in the 
body so that they can be reconverted to acetyl-CoA to produce energy via 
the citric acid cycle  (Nguyen et al., 2008). An accumulation of ketone 
bodies in the blood is known as ketosis. When these reach very high levels 
they will lower the pH of the blood to dangerously acidic levels, this is 
called ketoacidosis.  
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The liver is able to secrete lipids by transforming them to very low-density 
lipoproteins (VLDL). Four sources of fatty acids are used for lipoprotein 
synthesis, these are fatty acids synthesised in the liver through 
lipogenesis, cytoplasmic triglyceride stores, fatty acids derived from 
lipoproteins taken up by the liver, and free fatty acids in the plasma 
(Julius, 2003). Lipid components that are synthesised in the smooth 
endoplasmic reticulum are added, by the microsomal triacylglycerol 
transfer protein, to apoprotein B (White et al., 1998). After being carried to 
the Golgi apparatus in transport vesicles, the apoproteins are glycosylated. 
Secretory vesicles bud off the Golgi membrane, migrate to the sinusoidal 
membrane of the hepatocyte, then fuse with the membrane and release 
VLDL into the blood. It has been suggested that the rate of secretion of 
VLDL is proportional to the rate of fatty acid synthesis (Nguyen et al., 
2008). In addition, VLDL formation is thought to be stimulated by an 
increase in plasma NEFA concentration (Julius, 2003). This situation would 
be expected to be exacerbated in an insulin-resistant state, which also 
promotes increased stability of nascent apoprotein B and enhances the 
gene expression of microsomal triacylglycerol transfer protein (Taghibiglou 
et al., 2000).  
 
The accumulation of lipid droplets in hepatocytes results in hepatic 
steatosis. This may develop as a consequence of multiple dysfunctions 
such DVDOWHUDWLRQVLQ33$5ĮVHQVLQJDQGǃ-oxidation, VLDL secretion, and 
pathways involved in the synthesis of fatty acids (Nguyen et al., 2008). In 
addition, an increase in the circulating pool of non-esterified fatty acids 
may also be a major determinant in the pathogenesis of fatty liver disease 
(Nguyen et al., 2008). 
   
1.7.2.3 Protein metabolism 
Protein metabolism in the liver is just as important as glucose and lipid 
metabolism. Proteins make up the structural tissue for muscles and 
tendons, transport oxygen or haemoglobin in the blood, catalyse all 
biochemical reactions as enzymes, and regulate reactions as hormones 
(Ophardt, 2003a). The body must be able to synthesise proteins, amino 
acids, and other non-protein nitrogen containing molecules for growth, 
replacement and repair.  The liver plays an important role in protein 
synthesis (Tarver, 1963), with the exception of immunoglobulins, nearly all 
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of the plasma proteins are made in the liver (Martin and Neuberger, 1957, 
Beath, 2003). Albumin, the major plasma protein, is synthesised almost 
exclusively by the liver (Tarver, 1963, Bowen, 1995). In addition, excess 
protein can be used to supply energy or build reserves of glucose, 
glycogen, or lipids. 
 
After digestion, proteins and amino acids are transported to the liver, via 
the portal vein. They are rapidly taken up by the sinusoidal hepatocytes 
where they can be catabolised by deanimation or transamination  (Beath, 
2003). Deamination is the process whereby amino acids are converted to 
their corresponding keto acids by the removal of the amine functional 
group and replacement with the ketone group. The ammonia produced 
during this process is toxic and must be removed from the body by 
conversion to urea in the liver (Tarver, 1963); this is excreted via the 
urine. Transamination refers to the transfer of an amine group from an 
amino acid to a ketone group of another acid, using enzymes known as 
transaminases. These reactions are used for the production of non-
essential amino acids in the body (Ophardt, 2003b). Once these keto acids 
have been formed by either deamination or transamination they can be 
used for several purposes. The most obvious purpose is that they complete 
metabolism to form carbon dioxide and water in the citric acid cycle 
(Tarver, 1963). However, if there are excess proteins in the diet then these 
keto acids can be used to synthesise glucose or lipids through 
gluconeogenesis or lipogenesis, depending on the type of amino acid 
(Tarver, 1963, Bowen, 1995).  
 
1.8 Conclusions and future perspectives 
Overall, the current research in this area emphasises the importance of 
maternal nutrition on the development of the embryo, placenta and fetus. 
Importantly, the consequences of sub-optimal nutrition through alterations 
in the macronutrient content of the maternal diet will not simply be 
reflected in altered neonatal body composition and increased mortality, but 
are likely to continue into adulthood and confer greater risk of metabolic 
disease. The mechanisms behind this nutritional programming are 
beginning to be elucidated, with particular focus on GC action and insulin 
sensitivity. The liver is of key importance in these studies due to its 
primary role in metabolism and maintaining whole body energy balance. 
Despite the similarities between pigs and humans in terms of digestive 
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physiology, rats and sheep are still the animals of choice for these studies. 
In addition, the manipulation of the macronutrient content in these studies, 
be it through protein restriction or fat supplementation, is often very 
severe, with experimental diets which are very different to what the animal 
would normally receive.  
 
1.9 Aims and hypothesis 
The aim of this study was to provide a novel insight into the effects of 
moderate changes in the macronutrient ratio of the maternal diet fed to 
pigs, whilst still maintaining energy content, on offspring development and 
liver metabolism until adolescence. In addition, the effect of offspring birth 
weight on liver metabolism will be examined. As well as providing insights 
into potential mechanisms for nutritional programming in humans, this 
study will also have implications for the pig industry where optimum 
maternal nutrition to improve offspring viability and growth are of key 
importance.  
 
This study had two main hypotheses; the first was that increasing the fat 
content of the maternal diet would reduce litter size and increase the risk 
of perturbations in liver metabolism in the offspring, possibly due to 
alterations in insulin sensitivity. It was hypothesised that low-birth weight 
offspring will be at increased risk. The second hypothesis was that protein 
supplementation of the diet would have beneficial effects on offspring 
survival and development.  
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   Chapter 2 - Materials and methods 
 
This chapter describes the materials and methods used throughout the 
study, with a brief description of underlying theory for more novel 
methods. All methods have been validated and supporting data (where 
appropriate) are also included. 
  
All animal procedures, data and sample collection, and milk composition 
analysis were carried out by staff at Schothorst Feed Research in the 
Netherlands. Insulin enzyme-linked-immunosorbent assays (ELISA) on the 
piglet plasma samples were carried out by Dr Hernan P. Fainberg and Miss 
Mehreen Azhar carried out the glycogen extraction and analysis in the 
liver. 
 
2.1 Study protocols 
All animal procedures, described in this thesis, were approved by the 
Ethics Committee for Animal Experiments of the Animal Sciences Group of 
Wageningen Research Centre, and conducted at Schothorst Feed Research 
in the Netherlands. All laboratory procedures were carried out at The 
University of Nottingham under the United Kingdom Control of Substances 
Hazardous to Health (COSHH: SI NO 1657, 1988) code of laboratory 
practice.  
 
Unless otherwise stated, all chemicals and reagents were obtained from 
Sigma-Aldrich Company (Gillingham, UK) and equipment was obtained 
from Scientific Laboratory Supplies (SLS). Details of all suppliers can be 
found in the Appendix. Unless otherwise stated all aqueous solutions were 
made up in distilled water (dH2O) 
 
2.2 Animal study 
Yorkshire x Landrace sows were used in this study. Sows of parity 2 to 6 
were selected and equally distributed amongst the 3 treatments, with a 
mean parity of 3.8 (SEM 0.24). Each week one sow from each treatment 
was artificially inseminated with pooled semen from multiple sires, as is 
normal practice in the pig industry. Pregnancy was confirmed when sows 
did not return to oestrus within 24 days after insemination. If sows failed 
to become pregnant on the first attempt they were removed from the trial 
and another sow was mated for that treatment. This process continued 
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weekly until there were 8 sows per treatment. Throughout gestation all 
sows were maintained in gestation crates. Sows were observed daily 
during lactation and gestation for abnormalities and any clinical signs of 
sickness. Medical treatments were applied after consultation with a 
veterinarian, and registered in an animal log book. 
 
The experimental treatments started at the day of breeding when sows 
(n=24) were randomly allocated to one of three isocaloric gestational diets 
differing in starch, fat and protein content (Table 2.1; see appendix C for 
full dietary composition). Sows were fed according to an increasing feeding 
scheme in gestation, 25.1 MJ/day from mating (day 0) until day 70 and 
32.6 MJ/day from day 70 to 110. Due to the higher energy content of the 
increased fat diet, the daily feed allowance was reduced in this group 
throughout gestation to insure equal energy intake (Table 2.1). Sows in 
parity 2 received 95 % of the feeding scheme. Diets were prepared in a 
factory for research diets according to the National Research Council (NRC) 
energy and nutrient recommendations for gestating and lactating sows. 
The control diet had a high starch content, as is normal practice in the 
commercial pig industry.  Starch was included from cereals or tapioca. 
Palm oil was fed to increase the fat content; this has an equal ratio of 
saturated to unsaturated fatty acids (Chapter 1; Section 1.6.1.3). In 
addition, the fat supplemented diet had a reduced starch content, to 
maintain equal energy intake. Increased protein content was derived from 
the addition of lupins, a type of legume, and sunflower seed meal to the 
diet. These were selected due to their high arginine and glutamine amino 
acid content. All diets were analysed for proximate components prior to 
feeding and met adequate essential amino acid, fatty acid, vitamin and 
mineral requirements. 
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Table 2.1 Composition and quantity of the experimental diets with alterations in macronutrient ratio  
 
 Feed quantity during gestation 
(Kg/day) 
Diet composition  
(MJ/Kg) 
Gestational diet Code Day 0-40 Day 40-70 Day 70-110 Starch Fat Protein 
Control  
(n=8) 
C 2.89 2.89 3.75 5.37 0.93 2.09 
Fat supplemented 
(n=8) 
FS 2.51 2.51 3.26 2.74 3.29 2.07 
Protein supplemented 
(n=8) 
PS 2.89 2.89 3.75 5.39 1.37 2.77 
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All treatment diets were fed from the day of mating (day 0) until day 110 
of gestation. All sows received the same diet for lactating sows (Table 2.3 
see appendix C for full dietary composition) from day 110 of gestation and 
throughout lactation. The feeding level was reduced before farrowing and 
gradually increased post farrowing as is normal practice in the pig industry 
(Table 2.3). Feed intake of each sow was recorded throughout pregnancy 
and lactation. 
 
Table 2.2 Feed allowance of sows from day 110 of gestation until the end of 
lactation 
Day Feed allowance 
(Kg/day) 
111-113 3.2 
114-115 2.5 
Farrowing 2.0 
1 2.5 
2 3.0 
3 3.5 
4 4.0 
5 4.5 
6 5.0 
7 5.5 
8 5.5 
9-10 6.0 
11-28 Ad libitum 
 
One week before the expected farrowing date, sows were moved to 
farrowing crates.  All sows farrowed naturally and piglets were allowed to 
suckle. If litter size exceeded 13 live born piglets, the additional piglets 
were removed before day 3 post-farrowing because of the maximum 
number of functional teats. Body weight of piglets at weaning (28 days), 
63 days and 6 months was recorded.  
 
Standard creep feed was supplied to the piglets from two weeks of age 
(Table 2.3; see appendix D for nutrient composition). At weaning (mean 
lactation length = 28 days), piglets were group housed in pens with pigs of 
similar body weights, and received a commercial post-weaning diet, from 3 
weeks post-weaning (Table 2.3; see appendix D for nutrient composition). 
At 5-6 weeks post-weaning (approximately 25 Kg) piglets were weighed 
and placed in one pen with piglets of mixed sex and equal bodyweights, in 
a barn for growing-finishing pigs. These pigs received a grower diet (Table 
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2.3; see appendix D for nutrient composition) and subsequently a 
commercial diet for finishing pigs until they reached 6 months of age 
(around 110 Kg is commercial slaughter weight; Table 2.3; see appendix D 
for nutrient composition). 
 
At 6 months of age, in pigs that were not selected for tissue sampling 
(Section 2.3), back fat thickness was measured ultrasonically using the P2 
method (back fat measured at 5cm from the midline over the last rib), with 
a Lean-Meater ® (Renco Corp. Minnesota, U.S.A.). 
 
Table 2.3 Basic composition of sow and piglet diets (MJ/Kg) 
 Diet composition (MJ/Kg) 
 Sow Piglet 
 Lactation Creep feed Post-weaning Grower diet Finisher diet 
Starch  5.42 5.65 6.12 6.44 6.39 
Fat  2.33 2.78 2.20 1.82 1.69 
Protein  2.74 2.99 2.98 2.89 2.72 
 
2.3 Collection of plasma and tissue samples 
2.3.1 Collection of maternal plasma  
Blood samples were taken from sows in the morning before feeding, 4 days 
prior to mating, and on days 40, 70 and 108 of gestation. Samples were 
taken via a catheter, placed in the ear one day prior to sampling; this 
avoids excess stress to the sow at the time of sampling. Before a sample 
was taken, the catheter was flushed with saline to remove any blockages 
and an 8 ml sample was collected. The EDTA (ethylenediaminetetraacetic 
acid) tubes containing the blood samples were centrifuged at 1800 g in a 
bench top centrifuge for 15 minutes at 4 °C. Following centrifugation the 
plasma was removed, frozen in eppendorf tubes and stored at -20 °C for 
subsequent analysis. 
 
2.3.2 Collection of piglet samples 
A low and median-birth weight piglet in each litter were selected for tissue 
and plasma sampling either at 1 week ± 2 days or 6 months of age. The 
piglet with the lowest birth weight of each litter was always selected for 
sampling at 1 week of age, and this ZDVLQGHSHQGHQWRIWKHDQLPDO¶V sex. 
The next step was to select a median-birth weight piglet from the litter, of 
which there were usually several animals around the same weight. At this 
stage, if possible, piglets were matched for sex with the low-birth weight 
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piglet which had already been selected. At this time, piglets were pre-
selected for sampling at 6 months of age. For this process, the piglet with 
the next lowest birth weight was selected, and again a median-birth weight 
piglet was chosen as before. Males selected for sampling at 6 months of 
age were not castrated. In the EU (not UK) castration is usual practice in 
the pigs to help reduce fighting DQGWRHOLPLQDWHµERDU¶RGRXr which might 
taint the taste of the meat. Offspring selected for sampling at 1 week of 
age were not fasted as they were still suckling from their mothers. 
However, offspring at 6 months of age were fasted for 12 hours prior to 
sampling.  
 
Piglets selected for sampling were sedated with a ketamin-xylazine 
combination (Ketamin 10%, Alfasan International BV, Woerden, The 
Netherlands) injected intramuscularly. They were then weighed and a 
blood sample was taken intracardially prior to euthanasia with T-61 dose 
(Intervet, Boxmeer, The Netherlands). The Ethylenediaminetetraacetic acid 
(EDTA) tubes containing the blood samples were centrifuged at 1800 g in a 
bench top centrifuge for 15 minutes at 4 °C. Following centrifugation the 
plasma was removed, frozen in eppendorfs and stored at -20 °C for 
subsequent analysis. The liver, kidneys, pancreas, heart, spleen, brain, 
stomach, lungs, adrenals, gonads, thyroid, skeletal muscle (biceps fermoris 
and longissimus dormis) and a sample of subcutaneous adipose tissue 
were then removed from these animals and weighed. Organs were snap-
frozen in liquid nitrogen prior to storage at -80°C for further analysis.  
 
2.4 Analysis of plasma samples 
All plasma samples were deforested slowly on ice and auto-analysed 
(Randox RX Imola, Randox Laboratories Ltd. Co Antrim, UK) for glucose, 
triglycerides (TAG), non-esterified fatty acids (NEFA) and cholesterol using 
quantitative enzymatic colorimetric assays supplied in kits (Randox 
Laboratories Ltd. Co Antrim, UK). To limit freeze-thaw cycles of the 
plasma, all assays for each sample were carried out at the same time. In 
addition, samples were analysed for Insulin using a porcine specific ELISA 
(Mercodia Porcine Insulin ELISA, Mercodia AB, Uppsala, Sweden). 
 
Repeats were carried out for each assay in order to determine co-efficient 
of variance. To measure inter-assay variation, one sample was chosen and 
repeated each time the assay was carried out. In addition, intra-assay 
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variation was measured by running the same sample several times in the 
same assay.     
 
2.4.1 Glucose 
Glucose concentrations were determined using the enzyme glucose oxidase 
(GOD) which catalyses the transformation of glucose and water in the 
presence of oxygen, to gluconic acid and hydrogen peroxide. The hydrogen 
peroxide formed reacts with 4-aminoantipyrine and p-hydroxybenzene 
sulphonate, which is catalysed by peroxidise, to form a red-violet 
quinoeimine dye as an indicator with maximal absorbance at 500 nm. The 
intensity of the dye is directly proportional to the glucose concentration in 
the sample. The inter-assay co-efficient of variance (CV) for glucose was 
1.6 %, and the intra-assay CV was 1.0 %. 
 
2.4.2 Non-esterified fatty acids (NEFA) 
Non-esterified fatty acid (NEFA) concentrations were determined using the 
enzyme acyl-CoA synthetase, which when added to plasma allows NEFA to 
form thiol esters of coenzyme A (CoA; known as acyl-CoA) in the presence 
of adenosine triphosphate (ATP), magnesium cations and CoA. Acyl-CoA is 
oxidised by acyl±CoA oxidase to produce hydrogen peroxide. Peroxidase 
enzymes then catalyse the oxidative condensation of 3-methylN-
(hydroxyethylanaline) (MEHA) with 4-aminoantipyrine in the presence of 
hydrogen peroxide to from a purple coloured adduct with a maximal 
absorbance at 550 nm. The inter-assay CV for NEFA was 4.9 %, and the 
intra-assay CV was 0.4 %. 
  
2.4.3 Triglycerides (TAG) 
Triglyceride (TAG) concentrations were determined after enzymatic 
hydroylisis with lipases which break down the triglycerides to glycerol and 
fatty acids. Glycerol kinase (GK) then catalyses the transfer of a phosphate 
from ATP to glycerol. The resulting glycerol-3-phosphate is oxidised by 
glycerol phosphate oxidase (GPO) to dihydroxyacetone phosphate and 
hydrogen peroxide. Peroxidise then catalyses the reaction of hydrogen 
peroxide with 4-aminophenazone and chlorophenol producing 
quinoneimine dye with a maximal absorbance at 540 nm. The inter-assay 
CV for TAG was 2.8 %, and the intra-assay CV was 1.4 %. 
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2.4.4 Cholesterol 
Cholesterol concentrations were determined after enzymatic hydrolysis to 
produce cholestene-3-one and hydrogen peroxide. The indicator 
quinoneimine is formed from hydrogen peroxide 4-aminoantipyrine in the 
presence of phenol and peroxidise. The resulting quinoneimine dye 
produced is directly proportional to the cholesterol concentration when 
measured at 600 nm. The inter-assay CV for cholesterol was 2.4 %, and 
the intra-assay CV was 1.0 %. 
 
2.4.5 Insulin 
Plasma insulin concentrations were determined in the sows at 108 days of 
age and piglets at 6 months of age, using a commercially available ELISA 
kit (Mercodia Porcine Insulin ELISA, Mercodia AB, Uppsala, Sweden). 
Analysis of the 6 month samples was kindly carried out by Dr Hernan P. 
Fainberg due to time constraints.  
 
This technique works by immobilising two monocolonal antibodies, directed 
against separate antigenic determinants of the insulin molecule, on a 96-
well plate. During incubation, the insulin in the plasma sample binds with 
the peroxidise-conjugated anti-insulin antibodies. After washing with a mild 
detergent solution to remove any unbound enzyme labelled antibody, the 
bound peroxidise-FRQMXJDWH LV GHWHFWHG E\ D UHDFWLRQ ZLWK ¶-¶-
tetramethylbenzidine (TMB). The reaction is stopped by the addition of 
acid, giving a colorimetric endpoint that can be read 
spectrophotometrically. Using known standards, a binding curve can be 
generated, which allows the unknown concentrations of insulin in the 
plasma to be determined. 
 
2.4.5.1 Insulin enzyme-linked-immunosorbent assay (ELISA) 
procedure 
In all plates, a standard curve (0-1.5 µg/L) was used to determine the 
insulin concentrations of the samples. 25 µl of the correct standard or 
sample was carefully pipetted into the appropriate wells of an antibody 
bound 96-well plate (Mercodia Porcine Insulin ELISA, Mercodia AB) and 
100 µl of enzyme conjugate (Mercodia Porcine Insulin ELISA, Mercodia AB) 
solution added. All samples were run in duplicate in order to establish 
intra-assay variability. A CV of less than 5 % was considered acceptable 
and samples were repeated if the CV was higher than this (see section 
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2.6). Plates were incubated at room temperature whilst being agitated for 
2 hours, and then washed 6 times with 700 µl of wash buffer (Mercodia 
Porcine Insulin ELISA, Mercodia AB) per well. After the final wash plates 
were inverted and tapped firmly against absorbent paper to ensure all 
buffer was removed. 200 µl of substrate TMB (Mercodia Porcine Insulin 
ELISA, Mercodia AB) was then added to each well and plates incubated for 
15 minutes at room temperature. Following this, 50 µl of Stop Solution 
(Mercodia Porcine Insulin ELISA, Mercodia AB) was added to each well and 
the plate was agitated for approximately 5 seconds to ensure mixing. 
Absorbance was then measured at 450 nm using the automated plate 
reader (µQuant, BIO-TEK Instruments Inc. Vermont, USA). Insulin 
concentrations were determined following linear regression analysis of the 
standard curve.  
 
2.5 Analysis of piglet tissue samples 
The preparation and sorting of tissue samples prior to analysis was carried 
out on dry ice so no significant thawing of the samples occurred. For each 
analysis, the required amount of frozen tissue was cut from the sample 
and the remainder returned to the freezer.  
 
2.5.1 Lipid extraction and triglyceride (TAG) assay 
Liver lipid content was assessed using a modified version of the Folch 
assay (Folch et al., 1957) followed by colorimetric analysis for TAG content 
using a commercially available kit (Randox Laboratories Ltd.). The 
extraction procedure exploits the interaction between chloroform-
methanol-water and cellular lipids for the separation of the homogenised 
tissue into two phases in which the lower phase is the total pure lipid 
extract (Folch et al., 1957). After homogenisation and gravity filtration, 
due to the polarity and density of the suspension solution and the lipids, 
the cellular debris can be separated by adding water (Folch et al., 1957). 
The chloroform-methanol solution can be removed by applying nitrogen 
steam. TAG concentrations of the extracted lipid samples were determined 
after enzymatic hydrolysis with lipases. The indicator is a quinoneimine 
formed from hydrogen-peroxide, 4-aminophenazone and 4-chlorophenol 
under the catalytic influence of peroxidise (Section 2.4.3).  
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2.5.1.1 Lipid extraction procedure 
Samples (0.5 g) were sectioned from liver and muscle tissue and thawed in 
2 ml of cold chloroform:methanol (2:1). The tissues were then completely 
disrupted using a Dispomix® (Thistle Scientific Ltd. Glasgow, UK) closed 
system homogeniser. The homogenate was agitated for 15-20 minutes at 
room temperature then filtered to recover the liquid phase. The filter paper 
was washed further with 8ml solvent, to a final volume 20 times the tissue 
sample. The solvent was then washed with 0.2 volumes of H2O and 
vortexed for a few seconds. The resulting mixture was centrifuged at 1160 
g for 10 minutes at room temperature to separate the homogenate into 
two phases. The upper phase was discarded and the lower phase which is 
total pure lipid extract was centrifuged for a further 10 minutes and any 
remaining impurities removed. Samples were dried under nitrogen steam 
and then re-dissolved in a mixture of tert-butanol: triton X-100 (3:2).  
 
2.5.1.2 Triglyceride (TAG) assay procedure 
This assay was carried out in sterile 96-well plates (ABgene Ltd. UK, 
Epsom, UK). In all plates, a standard curve (0-390 mg/dL) was used to 
determine the TAG concentrations of the samples. 2 µl of the correct 
concentration of standard or lipid of the unknown samples was carefully 
pipetted into each well of the plate and 200 µl of TAG reagent (Randox 
Laboratories Ltd.) added, ensuring no bubbles were formed. All samples 
were run in triplicate in order to establish intra-assay variability. A CV of 
less than 5 % was considered acceptable and samples were repeated if the 
CV was higher than this (Section 2.6). Due to the large sample number, 
inter-assay variability was established by running one lipid sample on all 
plates (CV = 8.8 %). Plates were incubated at 37 ºC whilst being agitated 
for 5 minutes. Absorbance was then measured at 500 nm using the 
automated plate reader. TAG concentrations were determined following 
linear regression analysis of the standard curve. TAG concentrations were 
expressed as a ratio of TAG found in micrograms and weight in grams of 
the sample previously dissected (mg/g).  
 
2.5.2 Glycogen extraction and assay 
Liver glycogen was extracted using a modified version of the method first 
used to extract glycogen from muscle cells (Dalrymple and Hamm, 1972). 
This work was carried out by Miss Mehreen Azhar as part of her BmedSci 
(hons) project.  
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Neutralized Perchloric acid (PCA, Thermo Fisher Scientific Ltd. 
Leicestershire, UK) homogenates of liver were mixed with the enzyme 
amyloglucosidase which extracts the glycogen and reduces it to glucose. A 
glucose enzymatic colorimetric assay was then carried out to determine 
glucose content and by using reduced glycogen standards this can easily 
be converted to glycogen concentration. In order to eliminate any free 
glucose in the tissues, each sample is run with a control which is not 
treated with the enzyme; this can then be taken into account when 
calculating the glycogen content.  
 
2.5.2.1 Glycogen extraction procedure 
Samples (0.5 g) were sectioned from liver and thawed in 2 ml of PCA (8 % 
(v/v)). The tissues were then completely disrupted using a Dispomix® 
closed system homogeniser. After addition of a further 3 ml of PCA (8 % 
(v/v)), the tubes were vortexed briefly and spun at 3220 g for 1 minute at 
4 °C. 1 ml of the supernatant was removed to a fresh 1.5 ml eppendorf 
and neutralised (pH 7) with 100 µl of saturated sodium bicarbonate 
solution. Sufficient quantities of sodium acetate (0.2 M) were then added 
to the neutral supernatant to reduce the pH to 4.8, the optimal pH for 
amyloglucosidase, and the volume made up to 400 µl with H2O. 200 µl of 
the supernatant was transferred to a fresh 1.5 ml eppendorf so each 
sample had two tubes. To one of these sets of tubes 5 µl of 
amyloglucosidase (80 U/ml) was added and gently tapped to mix. The 
other set of tubes acted as the free glucose controls and so 5 µl of H2O was 
added. All samples were incubated at 37 °C for 30 minutes whilst agitating 
at low speed, thus allowing for optimal reduction of glycogen to free 
glucose, and then boiled at 100 ºC for 5 minutes to stop the reaction. 
Samples were then centrifuged at 13250 g for 10 minutes at 4 °C and the 
supernatant collected.  
 
2.5.2.2 Glucose assay procedure 
This assay was carried out in sterile 96-well plates. In all plates, a standard 
curve was used to determine the glucose concentrations of the samples. 
Glycogen standards (0±200 µg/µl) were prepared using bovine liver 
glycogen in neutralised PCA solution (8 % PCA (v/v) neutralised with 
saturated sodium bicarbonate). All standards were treated with 
aminoglucosidase to reduce them to glucose as shown above.  
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2 µl of the correct concentration of standard or sample was carefully 
pipetted into each well of the plate and 200 µl of glucose reagent (Randox 
Laboratories Ltd.) added, ensuring no bubbles were formed. All samples 
were run in duplicate in order to establish intra-assay variability. A CV of 
less than 5 % was considered acceptable and samples were repeated if the 
CV was higher than this (Section 2.6). Due to the large sample number 
inter-assay variability was established by running one sample on all plates 
(CV<10 %). Plates were incubated at 37 ºC whilst being agitated for 10 
minutes. Absorbance was then measured at 500 nm using the automated 
plate reader. Glucose concentrations were determined following linear 
regression analysis of the standard curve. The free glucose concentration 
was then subtracted from the total glucose reading and glycogen 
concentrations were attained using the standards. Results were expressed 
as a ratio of glycogen found in micrograms and weight in grams of the 
sample previously dissected (mg/g).  
 
2.5.3  RNA extraction 
Total RNA was extracted from liver tissue using Tri Reagent (Sigma-
Aldrich), a modified version of the single step acidified phenol-chloroform 
homogenisation/precipitation method (Chomczynski, 1987). Tri Reagent 
contains guanidine thiocyanate and phenol, which dissolves RNA during 
tissue homogenisation. The addition of chloroform separates the 
homogenate into three phases. RNA can then be precipitated from the 
aqueous phase containing the RNA, which can be further precipitated.  
 
In order to ensure any DNA that may be contaminating the RNA is 
removed, the RNA extract was treated with DNase before determination of 
the RNA integrity using spectrophotometric absorbance (Nanodrop® ND-
1000 spectrophotometer, Labtech International Ltd. East Sussex, UK) to 
fully confirm quantity and quality. The absorbance at 260 nm relative to 
RNA free water alone was measured. In addition, the absorbance of each 
sample at 280 nm was calculated. This allowed the calculation of the ratio 
of optical density of the samples at 260:280 nm. Spectrophotometric 
absorbencies at 260 nm reflect nucleic acids, whereas that at 280 nm 
reflects protHLQ FRQWDPLQDQWV $ UDWLR  ZDs regarded as satisfactory 
(Wilkinson, 1995). RNA concentrations were automatically calculated using 
the absorbance at 260 nm using the software (Nano D2000, Labtech 
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International Ltd.) with the spectrophotometer, where one unit of optical 
density reflects 40 µg RNA/ml. 
 
  RNA concentration of the stock extraction (µg/µl): 
   = (Optical density at 260nm x 40µg/ml) x (ml of sample) 
     Original stock volume added (µl) 
 
Due to the high glycogen content of the liver, which makes RNA extracts 
yellow in colour, glycogen had to be removed from the samples prior to 
spectrophometric analysis. This procedure was carried out using addition of 
sodium acetate. 
 
In order to minimise the risks of contamination and degradation of RNA, 
the environment and reagents had to be ribonuclease-free. Several 
measures were taken to achieve and maintain this, including; the use of 
RNA free water, the treatment of tips and eppendorff tubes whilst wearing 
gloves to protect samples from RNases in human skin, the use of the 
laminar flow cabinet to set up reactions, and autoclaving all solutions and 
equipment before use. Moreover, all samples are maintained on ice 
throughout and aliquots of RNA containing solutions are prepared at the 
time of extraction to minimise the need for repeated freezing and thawing, 
which is known to lead to RNA degradation (Wilson and Walker, 2001).  
 
2.5.3.1 RNA extraction procedure 
RNA preparation 
Samples (between 0.05 and 0.1 g) were sectioned from liver tissue, and 
thawed in 1 ml Tri-reagent (Sigma-Aldrich). The tissues were then 
completely disrupted using a Dispomix® closed system homogeniser.  
 
Once homogenised, 200 µl of chloroform was added, vortexed and then 
incubated at room temperature for 15 minutes. After incubation, the 
samples were centrifuged in a microcentrifuge at 11300 g for 15 minutes 
at 4 °C. Once centrifuged, the top aqueous phase was then carefully 
transferred to fresh 1.5 ml sterile eppendorf tubes, taking care not to 
disturb the interface. 500 µl isoproponal was added and the tubes were 
allowed to stand for 10 minutes at room temperature to precipitate the 
RNA.  
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Following this, the samples were centrifuged at 11300 g for 10 minutes at 
4 °C. The supernatant was decanted and the RNA precipitate was washed 
in 1 ml of ice cold 70 % (v/v) ethanol and centrifuged at 11300 g for 5 
minutes at 4 °C. The ethanol supernatant was decanted and the RNA 
pellets allowed to air dry before reconstitution with 250 µl sterile RNA free 
water and freezing at -80 °C to facilitate re-suspension. 
 
Glycogen removal 
To each 250 µl RNA sample, 750 µl of 4 M sodium acetate was added, 
vortexed, and left at 20 °C overnight. The next day the samples were 
centrifuged at 7840 g for 20 minutes at 4 °C, this allows reformation of the 
RNA precipitate. The supernatant was decanted and the precipitate washed 
with 1 ml of 75 % (v/v) ethanol. Following this, the samples were 
centrifuged at 7840 g for 20 minutes at 4 °C. The ethanol supernatant was 
decanted and the RNA pellets allowed to air dry before reconstitution with 
20 µl RNA free water and freezing at -80 °C to facilitate re-suspension. 
 
DNase treatment of RNA 
Working on ice, 1 µl of DNase buffer and 1 µl DNase (1 U/µl) were 
aliquoted into each tube followed by 8 µl of the RNA sample. The samples 
were then vortexed and allowed to incubate for 15 minutes at room 
temperature to allow the DNase to remove any DNA that may be 
contaminating the RNA. After incubation, 1 µl of DNase Stop solution was 
added to each tube, vortexed and transferred to the PCR machine (Techne 
Thermal Cycler, Bibby Scientific Ltd. Staffordshire, UK) and heated at 70 
°C for 10 minutes to denature both the DNase 1 and the RNA. The samples 
were then placed on ice. 
 
Spectrophotometric analysis of RNA 
1 µl aliquots of each sample were used and spectrophotometric absorbance 
measured using a Nanodrop® spectrophotometer. 
 
2.5.4 Reverse transcriptase polymerase chain reaction (RT-PCR)  
Reverse transcriptase polymerase chain reaction (RT-PCR) is a molecular 
biology technique that allows generation of complimentary DNAs (cDNAs) 
from messenger RNA (mRNA) for cloning using the reverse transcription 
enzyme Superscript II (Invitrogen Ltd. Paisley, UK); the cDNA can then be 
amplified by PCR (Polymerase Chain Reaction).  
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2.5.4.1 Reverse transcriptase polymerase chain reaction (RT-
PCR) procedure  
0.2 ml sterile eppendorf tubes were labelled with the individual sample ID. 
Working on ice, RNA samples were prepared to obtain a 3 µg of RNA in a 3 
µl volume of RNA free water using the RNA concentrations obtained from 
the spectrophotometric absorbance at 260 nm (Section 2.5.3). Two 
negative controls were DOVR LQFOXGHG DW WKLV SRLQW WKH µQR 51$¶ DQG µQR
VXSHUVFULSW¶ FRQWURO  O RI 57 UHYHUVH WUDQVFULSWDVH PDVWHU PL[
(Invitrogen Ltd.) was aliquoted into each tube, vortexed and centrifuged 
briefly at 1250 g. This RT master mix consisted of 1 µl random hexamers 
primers (Roche Co. Basel, Switzerland), 1 µl deoxyribonucleotide 
triphosphate (dNTP; final concentration 10 nmpol/l) and 7.5 µl RNase free 
water. The tubes were then transferred to the PCR machine and heated to 
65 °C for 10 minutes. 4 µl 5 x first strand buffer (Invitrogen Ltd.) and 2 µl 
dithiothreitol (DTT; 0.1M) were then added on ice. Samples were incubated 
for 32 minutes at room temperature before addition of 0.75 µl of 
Superscript II (200 U/µl) and 0.75 µl RNA free water. Reverse transcription 
was allowed to proceed for 45 minutes at 42 °C, then for 15 minutes at 70 
°C. The reaction was then stopped and cooled to 8 °C.  
 
2.5.5 Polymerase chain reaction (PCR)  
PCR is a basic technique that results in the selective amplification of a 
chosen region of a DNA molecule (Bustin, 2004). Any region of the DNA 
molecule can be chosen, provided the sequences at the borders of the 
selected regions are known. The vast diversity of PCR methodology makes 
it a powerful tool to amplify small amounts of DNA or mRNA for a variety 
of analysis (Bustin, 2004). Since many cellular decisions concerning 
survival, growth and differentiation are reflected in altered patterns of 
gene expression, the ability to quantitate transcription levels of specific 
genes is essential to any research into gene function (Bustin, 2004).  
 
PCR involves two primers (single-stranded DNAs) which are complimentary 
to opposite strands of the double stranded DNA sequence to be amplified 
(Bustin, 2004). It therefore presupposes knowledge of the genome 
sequence. The use of thermostable Taq Polymerase enzyme allows the 
double stranded DNA to be separated and subsequently permits the 
primers to anneal to their respective sequences with minimal loss of 
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enzymatic activity (Saiki et al., 1988). During this reaction, the polymerase 
enzyme synthesises the new DNA strand by adding nucleotides after 
binding the primers. The basic process of PCR is carried out over several 
cycles of denaturation, hybridisation and synthesis resulting in the 
eventual synthesis of several hundred million copies of the desired DNA 
fragment (Wilkinson, 1995, Wilson and Walker, 2001).  
 
The products of each PCR reaction were tested using agarose gel 
electrophoresis in order to assess the size and abundance of the PCR 
product, and to check for DNA contamination. One clear band should be 
visible for each PCR reaction, more than one band or smearing on the gel 
indicates DNA contamination. DNA molecules carry a negative charge, 
which enables their separation in an electric field, with the smaller 
molecules moving faster and migrating farther than the larger ones in the 
direction of the cathode. The gel contains ethidium bromide which 
fluoresces under ultra violet (UV) light when intercalated in DNA.  The DNA 
can then be visualised using a UV transilluminator CCD camera (Fujifilm 
luminescent image analyser LAS-1000 V1.01, Fuji Photo Film Co. Ltd. 
Tokyo, Japan).  
 
The PCR product was then extracted from the gel and purified using the 
QIAquick® gel extraction kit (Qiagen, West Sussex, UK). This combines 
spin-column technology with the selective binding properties of a silica 
membrane which absorbs the DNA in the presence of high concentrations 
of salt, while allowing contaminants to pass through; after further 
purification steps, the purified DNA can then be eluted.  
 
Primer design 
Oligonucleotide primers are sequences of nucleic acids, essential for the 
first step of DNA replication by polymerase reaction. They are required 
because their binding to the genome marks the point where the DNA 
polymerase starts or finishes the imprinting of the new DNA sequence. The 
DNA polymerase starts rHSOLFDWLRQ DW WKH ¶ HQG RI WKH SULPHU DQG WKHQ
copies to the opposite strand.  
 
One of the parameters for optimal polymerase amplification is similar 
melting temperature (Tm) of both primers, to ensure annealing to the DNA 
occurs at the same time. A significant difference between temperatures 
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may result in an incorrect sequence of DNA or failure to extend at all. 
Correct Tm also prevents formation of primer dimmers, where the primers 
anneal to each other during the reaction. Optimal primer length is between 
15-30 bases with a cytosine (C) and guanine (G) content (the number of 
Cs and Gs in the primer as a percentage of the total bases) around 30-80 
% to avoid the formation of loops and mishybridisation of the primers. 
Primer sequences should also be unique to select for a specific region of 
DNA. A common method to check for this is to use an NCBI tool, Primer-
BLAST (http://blast.ncbi.nlm.nih.gov/), which will indicate all possible 
regions that the primer might bind to, and indicate any intron/exon 
boundaries, avoiding any amplification of genomic DNA. Alternatively, 
software such as Beacon Designer can be used to design specific primers.  
 
All primer sequences used were taken from previously published literature 
and then optimised for this study. The oligionucleotides were purchased 
from Sigma-Genosys (Sigma Genosys Ltd. Suffolk, UK) and were re-
suspended with the appropriate volume of RNA free water to a stock 
concentration of 100 µM. Each PCR product was sent for DNA sequencing 
for the validation of the primers using the QMC sequencing service. The 
resulting chromatogram was then analysed using Chromas Ligte computer 
software (http://www.technelyium.com.au) and checked for the correct 
genes using BLAST (http://www.ncbi.nlm.nih.gov/BLAST). Table 2.4 
describes the sequence and annealing temperature of each primer used 
during this project.  
64 
 
Table 2.4 Primer sequences used in this thesis 
Gene Abbreviation Primer sequences  
¶-¶ 
Annealing temp.  
(°C) 
Ascension 
number 
18S ribosomal RNA  18S F: GATGCGGCGGCGTTATTC 
R: CTCCTGGTGGTGCCCTCC 
60 AK2372246 
Ribosomal phosphoprotein RPO F: CAGCAAGTGGGAAGGTGTAATC 
R: CCCATTCTATCATCAACGGGTA 
60 NM_001098598 
Cyclophylin Cyclo F: GCACTGGTGGCAAGTCCAT 
R: AGGACCCGTATGCTTCAGGA 
60 AY008846 
 
Glucocorticoid receptor GR F: GCTGCTGGTCCTGCTGCTC 
R: CCTTCACATTCGGCTGCTCTGG 
60 AF141371 
 
11beta-Hydroxysetroid Dehydrogenase type 1   11-ƨ+6' F: CGCAGAAGCATGGAGGTCAAC 
R: AATAGGGAGCAACAAGTCGAT 
60 NM_214248 
 
11beta-Hydroxysetroid Dehydrogenase type 2 11-ƨ+6' F: ACCGTGTTGGAGTTGGATAGC 
R: CTGGCAGTGTGGACCTTGG 
60 NM_213913 
 
Insulin receptor IR F: AGCCTGCGAGAGCGGATC 
R: AGCCATCAATTCCATCACCAC 
60 AF102858 
 
Peroxisome proliferator-activated receptor alpha   33$5Į F: CGGAGAACCATTCGGCTAAAG 
R: CGAGAGGCACTTGTGGAAACG 
60 NM_001044526 
 
Fatty acid binding protein 1 FABP1 F: CCAAGGTCGTCCAGAATGAG 
R: CTGAACCACTGTCTTGACCTT 
60 AY960623 
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2.5.5.1 Polymerase chain reaction (PCR) procedure  
As previously described, the PCR reaction was performed working on ice, 
wearing gloves and using filter tips. The reaction was performed in a final 
volume of 20 µl using 1 µl of cDNA, 10 µl of PCR master mix (ABgene 
Ltd.), 1 µl of forward and 1 µl reverse primer, at a final concentration of 
100 µmol/l in 7 µl of RNA free water.  The tubes were then transferred to 
the PCR machine (Touchgene Gradient, Techne). PCR conditions are 
described in table 2.5. 
 
Table 2.5 Polymerase chain reaction (PCR) standard program 
Step Temperature 
(°C) 
Time 
Initiation 105 4 minutes 
Enzyme activation 95 15 minutes 
 45 cycles  
Denaturing  94 30 seconds 
Annealing  60 30 seconds 
Primer extension  72 60 seconds 
 
Final extension  
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7 minutes 
Hold 8 Indefinitely 
   
2.5.5.2 Gel electrophoresis of DNA 
A gel was made by dissolving agarose (3 % (w/v) agarose pH7) in 1x TAE 
(tris-acetate EDTA) buffer  (2 M Tris([hydroxymethyl] amino-methane, 0.2 
% (w/v) SDS, 1 M glacial acetic acid, 0.5 M Na2 EDTA pH8, made in 
deionsate water to 100ml) and heating. The solution was cooled before 
adding ethidium bromide to a final concentration of 5 µg/ml. The agarose 
was then immediately poured into a horizontal gel tank with the 
appropriate size comb inserted, allowing wells to form. Once the gel had 
set, the comb was removed, and the gel covered with 1x TAE. 
 
20 µl of PCR product was mixed with 5 µl of 5x loading buffer (0.0016 % 
(v/v) saturated bromophenol blue, 0.15 % (w/v) EDTA, 20 % (v/v) 
glycerol) and loaded into separate lanes along with a 1 Kb size marker 
(ABgene Ltd.). Electrophoresis was then performed at constant 120 V for 1 
hour. For the visualisation of DNA, the gel was exposed to a UV 
transilluminator CCD camera. The size of PCR product was then estimated 
by comparison to the DNA marker bands. 
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2.5.5.3 DNA extraction procedure 
After visualisation, the bands were cut out of the gel and transferred into 
sterile 1.5ml eppendorfs. The weight of each gel slice was noted and the 
DNA was extracted using a QIAquick® gel extraction kit, following the 
instructions. In summary, 3x volume of buffer QG (pre-made buffer 
contained within the Qiagen kit (QG not defined)) was added to each tube, 
vortexed and incubated at 50 °C for 10 minutes, vortexing at regular 
intervals. Once the agarose had completely dissolved, 1x volume of 
isopropanol was then added to precipitate the DNA. The samples were then 
transferred into sterile spin columns (contained within the kit), and 
centrifuged at 13,250 g for 1 minute. The resulting flow-through was 
discarded and a further 500 µl of buffer QG was added to the spin columns 
and centrifuged again at 13,250 g for 1 minute to ensure the removal of all 
traces of agarose.  
 
Once centrifuged, the flow-through was again discarded and the samples 
washed in 750 µl of ethanol based buffer PE (pre-made buffer contained 
with the kit; PE not defined). The samples were then centrifuged at 13,250 
g for 1 minute and the resulting-flow through discarded. Finally, the 
columns were transferred into sterile 1.5 ml eppendorfs and 30 µl of RNA 
free water was added directly onto the membranes of each spin column; 
these were left to stand for 1 minute, and then centrifuged at 13,250 g for 
1 minute to elute the DNA. 
 
Once extracted, the DNA concentrations were determined using the 
nanodrop® spectrophotometer (Section 2.5.3.1), and subsequently used 
for making standards to be used on the real-time PCR machine. 
 
2.5.6 Real-time polymerase chain reaction (QPCR) 
Real time PCR (QPCR) uses a signal, normally fluorescence, which 
increases with the increased amount of DNA formed by PCR (Bustin, 
2004). When the signal rises above a set background, it is detected. The 
signal normally rises in a sigmoidal way, until it reaches its plateau (Figure 
2.1). During the linear increase, the signal can be compared with the signal 
from other samples. A standard curve with known DNA concentrations 
(Figure 2.2) is usually run on the same 96-well plate, to compare the 
signal of the samples and to calculate the efficiency of the reaction (Bustin, 
2004). The signal is normally measured at a threshold level called the cycle 
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point (Cp). The cycle number at which the signal crosses the Cp is 
correlated to the initial concentration of DNA in the template (Higuchi et 
al., 1993). The plotting of the Cp values, versus the log of the cDNA 
concentration of the standard curve creates a slope, which reflects the 
amplification efficiency (E). E can be calculated by the formula shown 
below (Equation 2.1) (Pfaffl, 2001) and should be between 95-100 % (1.95 
( 
 
E = 10 [-1/slope] 
Equation 2.1 Calculation of the real-time polymerase chain reaction (QPCR) 
efficiency (E); Slope = gradient of standard curve (Pfaffl, 2001)  
 
 
Figure 2.1 Typical real-time polymerase chain reaction (QPCR) result. Red: 
standard curve; green: unknown samples and blue: negative control 
 
 
 
Figure 2.2 Typical standard curve from real-time polymerase chain reaction 
(QPCR), indicating the appropriate R2, efficiency (E), and slope values 
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DNA binding agents, like SYBR green, bind specifically to double stranded 
DNA; they emit a fluorescent signal once bound. During each cycle of PCR, 
the fluorescent signal increases with the amount of double stranded DNA. 
As with conventional PCR, the specificity of the reaction is determined 
entirely by its primers; however the PCR can be verified by a melting curve 
that allows comparison of the melting temperatures of the specific product 
and any suspected non-specific products (Ririe et al., 1997, Al-Robaiy et 
al., 2001). The reason for this is that different length products and 
products of different sequences will melt at different temperatures and will 
be observed as distinct peaks (Figure 2.3); therefore, a single dissociation 
peak should be present to confirm specificity (Ririe et al., 1997). 
 
 
Figure 2.3 A typical dissociation peak from real-time polymerase chain reaction 
(QPCR); Negative first derivative of the melt curve which measures a cycle to cycle 
decrease in fluorescence as temperature is increased; -dF/dT = negative of the rate 
of change in fluorescence (dF) as a fraction of temperature (dT); Red: standard 
curve; green: unknown samples and blue: negative control 
 
When comparing samples, at least one housekeeping (HK) gene should be 
used to rule out any pipetting errors and to normalise for any variation in 
RNA abundance between samples (Bustin, 2004). HK genes should be 
highly expressed and not altered by the treatment in question (Bustin, 
2004). For all gene expression data analysed in this study, three HK genes 
18S ribosomal RNA (18S), Ribosomal phosphoprotein (RPO) and 
cyclophylin (cyclo), were used. All Cp values (both target and HK genes) 
were first transformed to normalised relative expression levels using the 
delta-Cp method (Equation 2.2), where the Cp value of your gene is 
69 
 
related to the control Cp (sample with the highest expression (lowest Cp 
value)). The Microsoft excel program geNorm was then used to calculate 
the gene expression stability measure (M) for a HK gene as the average 
pair wise variation (V) for that gene with all other tested HK genes 
(Vandesompele et al., 2002). Exclusion of the gene with the highest M 
value allows ranking of the genes according to their expression stability. A 
gene expression normalisation factor was then calculated for each tissue 
sample, based on the geometric mean of the two most stable reference 
genes.  
 
Delta-Cp = E ^ (control Cp ± sample Cp) 
Equation 2.2 Calculation of Delta-Cp; E = Efficiency (calculated in Equation 2.1); 
control Cp = Crossing point of the sample with the highest expression (lowest CP 
value) 
 
The relative gene expression of each sample was then calculated using a 
mathematical model for relative quantification developed by (Pfaffl, 2001), 
where the normalised relative expression values for each sample (delta-
Cp) were divided by the normalisation factor of the reference genes for 
that specific sample (Equation 2.3).  
Delta-CP
Normalisation factor of 
reference genes
Relative gene expression =
 
Equation 2.3 Calculation of relative gene in a real-time polymerase chain reaction 
(PCR); Delta-CP calculated from Equation 2.2; Normalisation factor of reference 
genes = geometric mean of the two most stable reference genes  
 
2.5.6.1 Real-time polymerase chain reaction (QPCR) 
procedure 
In all runs, a standard curve was used to enable the efficiency of the 
reaction to be calculated. For each gene, DNA that made up the standard 
curve was obtained from DNA extracted from the agarose gels. A serial 
dilution, 1:10 of the DNA is completed, until a set of 9 standards is 
achieved; the lowest standard having a concentration of 1 x 10-9 ng/µl.  
 
QPCR reactions were carried out in a final volume of 15 µl, which included 
1 µl of both forward and reverse primers, 7.5 µl of SYBR green master mix 
(Qiagen), and 4.5 µl of RNA free water. Fourteen µl of this mix was 
carefully pipetted into each well of a sterile 96-well plate and 1µl of cDNA 
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of the unknown samples or 1 µl of the correct concentration of standards 
was used, ensuring no bubbles were formed. Furthermore, a cDNA 
negative control was also run on each plate to check for any 
contamination; RNA free water was used instead of cDNA for this. All 
samples were run in duplicate in order to establish intra-assay variability. 
A CV of less than 5 % was considered acceptable and samples were 
repeated if the CV was higher than this (Section 2.6). Due to the large 
sample number inter-assay variability was established by running one 
cDNA sample on all plates for that gene (CV<10 %). 
 
Once the plates were made, they were heat-sealed and placed in the PCR 
machine (Quantica, Techne). PCR conditions are described in Table 2.6.  
 
Table 2.6 Real-time polymerase chain reaction (QPCR) standard program 
Step Temperature °C Time 
Denaturing 95 15 minutes 
 45 cycles  
Denaturing  94 30 seconds 
Annealing  60 30 seconds 
Extension  72 60 seconds 
   
Melt curve Ramp from 75-95 15 minutes 
   
Hold 8 Indefinitely 
 
The data collected from the QPCR reaction was exported to an Excel 
datasheet and the relative gene expression for each sample calculated. 
 
2.6 Statistical analysis 
To assist in the study design and to limit the sample sizes that would be 
required in each group and not erroneously accept or reject the null 
hypothesis, a power calculation was performed. Sample size was calculated 
to assess the effect of measured variables obtained from a dietary 
intervention or group at 80 % power. The sensitivity of the power 
calculation is a function of the group sizes, statistical controls and reliability 
of the measures. Therefore, by increasing the sample size it is possible to 
increase the statistical power. In the research literature, it is generally 
accepted that a power of 80 % is adequate. After performing power 
calculations using Samplepower TM (SPSS Inc. IL, USA), it was decided 
that 8 animals in each group would be sufficient. This is based on data 
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from a prior study investigating metabolic gene expression in adipose 
tissue from small and normal piglets. A difference of at least 34 % was 
observed (25±4; 16.5±5 gene as a % of 18S), groups of 8 will have 96.4 
% statistical power to yield a statistically significant result (P<0.05).  
 
Previous to any statistical analysis, all the values collected in each assay 
were transferred to an excel datasheet. The CV of all the duplicate values 
were analysed and a CV < 5 % confirmed low variation between duplicates 
and the reproducibility of the assay. The data points that fulfil this 
requirement were used for the analysis.  
 
All data were analysed using the SPSS for windows package, version 18.0. 
The distribution of the data collected in each assay was the main factor for 
the chosen statistical test to perform. Data were tested for normal 
distribution using the Kologorov-6PLUQRY WHVW DQG D 3   FRQILUPHG
normality. Depending on the significance of this analysis, parametric or 
non-parametric tests were utilised for the analysis of the data. For 
consistency, the data in these studies are presented as mean and standard 
error (SEM).  
 
Throughout this study, in order to examine the effect of increased fat or 
protein during gestation, the means of the fat supplemented (FS) or 
protein supplemented (PS) groups were compared with the control (C), but 
not with each other. In addition, differences between small and median-
birth weight offspring were investigated by comparing the small and 
median-birth weight animals selected for each dietary group. Thus, 
depending on their type of distribution based on the significance of the 
Kologorov-Smirnov test, either an independent parametric (T-test) or non-
parametric test (Mann Whitney U) was assigned to compare each group 
with the control. When an independent T-test was applied, it was followed 
E\D /HYHQ¶V WHVW WR HYDOXDWHHTXDO YDULDQFHV ,I WKH WHVW UHVXOWZDV3
0.05, equal variance between the groups could be assumed. More specific 
tests are detailed in the relevant results chapters and further explanation 
is given when relevant.  
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Chapter 3 - Impact of maternal nutrition on neonatal mortality  
 
3.1 Introduction 
The piglet has a higher rate of neonatal mortality than many other animals 
(Table 3.1). Most of these occur in the very early postnatal period, with 50 
percent of all pre-weaning deaths taking place within the first 3 days after 
parturition, and 90 percent within the first week of life (Varley, 1995). 
Multiparous species such as the pig have evolved to allow for relatively 
high losses as a natural selection mechanism (Varley, 1995). Cattle, sheep 
and humans produce fewer offspring and therefore display increased 
maternal investment to individual offspring, thus resulting in lower 
mortality rates (Varley, 1995). In addition, there is also the availability of 
advanced, medical technology to promote high survival rates in many 
human populations. However, in animal production, this is much more 
difficult and not considered to be cost-effective.  
 
Table 3.1 Neonatal mortality for different species (Varley, 1995) 
 Neonatal mortality (%) 
Species Average Range 
Pig 13 5-20 
Human 2 1.5-7 
Cattle 4 0-10 
Sheep 5 3-8 
 
3.1.1 Maternal nutrition and neonatal mortality  
Optimal feeding during pregnancy is important because it determines the 
size and viability of piglets at birth (Pluske et al., 1995). It also has a key 
role in determining the subsequent milk production potential during 
lactation (Pluske et al., 1995)ZKLFKZLOOLQWXUQGHWHUPLQHWKHRIIVSULQJ¶V
growth. Piglets are born with very low energy reserves (Chapter 1; Section 
1.5.1.2) and in the absence of immediate and adequate nutrition, 
hypoglycaemia will occur (Varley, 1995). The availability of body reserves 
and the ability of the piglet to utilise these, determines the extent to which 
it avoids hypoglycaemia and hypothermia and hence survival. Therefore, 
emphasis has been placed on increasing the piglets limited neonatal 
energy stores to enhance birth weight and/or survival by manipulating sow 
nutrition during gestation.  
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In gilts, increasing the feed intake during gestation will increase average 
piglet birth weight, with a maximum birth weight achieved by feeding 
around 1.9 Kg/day (Figure 3.1) (Baker et al., 1969), although in this 
study, the level of feed intake had no effect on litter size or piglet mortality 
(Baker et al., 1969). Similar results have been observed in sows, although 
a maximum birth weight is not achieved until food intake is greater than 
observed with gilts (Pond, 1973).  
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Figure 3.1 Relationship between daily food intake of gilts during pregnancy and 
piglet birth weight (Baker et al., 1969) 
 
3.1.1.1 Fat supplementation 
The effects of a high-fat intake during pregnancy on maternal glucose 
tolerance and offspring birth weight and mortality in rat nutritional 
programming studies have already been described in Chapter 1 of this 
thesis. Briefly, consumption of a high-fat diet during pregnancy increases 
the risk of insulin resistance in the mothers which may be linked to a 
reduction in litter size and an increase in offspring mortality (French et al., 
1952, Guo and Jen, 1995, Khan et al., 2003, Taylor et al., 2003, Taylor et 
al., 2005). Despite gestational fat supplementation being detrimental in rat 
programming studies, it is widely used in the commercial pig industry to 
reduce offspring mortality, although the levels of fat used are much lower.  
  
As previously mentioned (Chapter 1; Section 1.5.1.2), piglets are born 
with a very small amount of stored lipid that they can use for energy. They 
have large energy stores in the form of glycogen but much of this is 
depleted during the first 2 days after birth (Chapter 1; Section 1.7.2.1) 
(Okai et al., 1978). It has been previously suggested that maternal fat 
supplementation, may improve the pre-weaning survival of piglets by 
improving their energy status (Seerley et al., 1974). However, this has 
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been demonstrated not to be the case, and, supplementing the diet with 
fat during late gestation, whilst maintaining energy content, has no effect 
on maternal plasma glucose concentrations, or piglet birth weight and liver 
glycogen content (Seerley et al., 1974, Boyd et al., 1978, Seerley et al., 
1981, Azain, 1993). There is a slight increase in carcass fat concentration 
slightly after birth (Seerley et al., 1974), but this increase is so small it is 
unlikely to be of practical importance (Pettigrew, 1981).  
 
The most consistent effect of feeding fat during late gestation and/or 
lactation is to increase the milk yield and fat content of both the colostrum 
and the milk (Seerley et al., 1974, Pettigrew, 1981). Such increases may 
account for an improvement in the survival rate of piglets born to sows 
whose diets were supplemented with fat during late gestation and lactation 
(Seerley et al., 1974, Boyd et al., 1978, Pettigrew, 1981, Seerley et al., 
1981, Azain, 1993). This effect was largest within herds where the 
expected survival rate of piglets is low (less than 80 %) (Pettigrew, 1981). 
A greater effect on the survival rate of low-birth weight piglets (less than 1 
Kg) than on their larger litter mates has been seen in most studies 
(Seerley et al., 1974, Pettigrew, 1981, Seerley et al., 1981, Azain, 1993). 
However, these results need to be interpreted with caution as not all 
studies produced positive results on piglet survival, and negative responses 
to fat supplementation are often not published (Pettigrew, 1981).  
75 
 
Table 3.2 Summary of effects of maternal fat supplementation in pigs, during late gestation and lactation on offspring survival rate  
Source Seerley et al. (1974) Seerley et al. (1981) Boyd et al. (1978) Azain et al. (1993) 
Diet  Gestation day 109 ±  
parturition 
C: 40 % corn starch 
FS: 40 % corn oil 
Gestation day 109 -  
end of lactation 
C: 5.3 % fat 
FS (corn oil): 12.4 % fat  
FS (lard): 13.7 % fat 
 
Gestation day 109 ±  
day 14 lactation 
C: 15 % corn starch 
FS: 15 % corn oil 
Gestation day 109 - 
day 7 lactation 
C: 2 % soy bean oil 
FS (MCT): 2 % soy bean oil + 10 % MCT  
FS (LCT): 12 % LCT (soy bean oil) 
 
Calorie intake No difference Ĺ 
 
No difference No difference 
Maternal glucose No difference  n/a 
 
No difference No difference 
Birth weight No difference No difference 
 
No difference No difference 
% Milk lipid Ĺ 
 
No difference 
 
n/a No difference 
Liver glycogen No difference No difference 
 
No difference n/a 
% Total lipid Ĺ 
 
No difference 
 
No difference n/a 
Piglet  glucose Ĺ 
 
n/a 
 
n/a Ĺ 
Survival rate Ĺ 
 
Ĺ 
 
Ĺ 
 
Ĺ 
C = Control; FS = Fat supplemented; ј = Increased in fat-supplemented groups; MCT = Medium-chain triglycerides; LCT = Long-chain triglycerides  
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3.1.1.2 Amino acid supplementation 
At present, there is limited and conflicting evidence demonstrating the 
effects of protein supplementation during pregnancy on offspring outcome 
(Chapter 1; Section 1.4.1), with most work instead, focussing on the 
effects of high-protein diets during childhood or on obesity in adults 
(Chapter 1; Sections 1.4.2-1.4.3). Recent studies have begun to focus on 
the role of specific amino acids, during pregnancy, and thus investigate the 
consequences of supplementing in order to provide beneficial outcomes for 
the offspring.  
 
Amino acids are not only the building blocks of proteins in cells, but are 
also precursors for the syntheses of nitrogenous substances, polyamines, 
creatine, dopamine and catecholamines, essential for whole-body energy 
homeostasis (Wu, 2009, Wu et al., 2010). One key amino acid thought to 
be crucial in placental and fetal development is arginine, probably due to 
its role as an essential precursor for nitric oxide (NO) and polyamine 
production (Figure 3.2) (Wu and Morris, 1998, Wu et al., 2004, Wu, 2009).  
Glutamine is a precursor for arginine synthesis, and is also important in its 
own right for polyamine production (Wu and Morris, 1998). NO and 
polyamines are essential for angiogenesis, embryogenesis, placental 
trophoblast growth, regulating placental-fetal blood flow, and thus, the 
transfer of nutrients and oxygen from the mother to the fetus (Roselli et 
al., 1998, Bird et al., 2003, Wu et al., 2010). Consequently, NO and 
polyamine synthesis have a key role in fetal growth and perinatal survival 
(Wu et al., 2006). This is demonstrated by knocking out the NO synthase 
(NAS) gene, which results in inhibition of NO synthesis in pregnant mice 
and causes intrauterine growth retardation (IUGR) (Hefler et al., 2001). A 
large abundance of arginine has been discovered in porcine allantoic fluid 
during early gestation (Wu et al., 1996), further supporting the important 
role of arginine in fetal growth and development.  
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Figure 3.2 Metabolic fates of arginine in mammalian cells (Wu and Morris, 1998) 
 
It is normal commercial practice in the swine industry, to restrict feed 
intake of sows during pregnancy, to prevent excessive weight gain (Ewan, 
1991). Therefore, in some cases animals do not receive sufficient amino 
acids to support optimal embryonic and fetal survival throughout gestation 
(Kim et al., 2007). Because of extensive catabolism of arginine by arginase 
in the small intestine, only a percentage of dietary arginine will enter the 
portal circulation of the pregnant animal (Bergan and Wu, 2009). 
Therefore, it was hypothesised that dietary supplementation with arginine 
would improve reproductive performance. Several lines of experimental 
evidence support this hypothesis. Firstly, a recent study with pregnant 
sows demonstrated that dietary supplementation with 1 percent arginine 
from 30 days of gestation until term decreased the number of stillborn 
piglets (Mateo et al., 2007). Similarly in rats, supplementing the maternal 
diet with 1.3 percent arginine, either throughout the whole of pregnancy or 
during days 1 to 7 of gestation, increased the litter size and number of 
live-born pups, with no effect on birth weight (Zeng et al., 2008). 
Conversely, dietary supplementation with 0.8 percent arginine from the 
beginning of pregnancy has been shown to produce detrimental effects by 
reducing embryonic survival rate  and thus litter size in pregnant sows on 
day 25 of gestation (Li et al., 2010).  
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3.1.2 Aims and hypothesis 
In summary, fat supplementation, during late gestation and lactation, has 
been used in the commercial pig industry in an attempt to reduce the high 
rates of piglet mortality for many years. This is the first study to 
investigate the effects of fat supplementation in sows, throughout most of 
gestation (until day 110), on maternal weight gain, glucose tolerance at 
term and piglet mortality. It is hypothesised that there will be an increase 
in maternal body weight and back fat throughout gestation, although this 
will not be different with fat supplementation due to the isocaloric nature of 
the diets. Glucose tolerance will be reduced near to term in the fat 
supplemented animals, which may result in an increase in postnatal 
mortality, particularly in the first few days after birth. 
 
In contrast to the studies investigating the effects of fat supplementation 
on offspring mortality, the effects of protein supplementation are relatively 
unknown. However, recent studies have demonstrated the beneficial 
effects of arginine supplementation in reducing mortality and increasing 
offspring birth weight. The second aim of this chapter is to examine the 
effects of supplementing the sow diet with a protein source that is high in 
arginine and glutamine, on offspring mortality and birth weight. It is 
hypothesised that this will result in a slight increase in offspring birth 
weight and thus a reduction in neonatal mortality.  
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3.2 Methods 
A full description of the study design and plasma sampling and analysis 
methods are described in Chapter 2.   
 
3.2.1 Measurement of maternal body weight and back fat 
The body weight and back fat measurements of all sows were recorded 4 
days prior to mating (-4) and on days 40, 70 and 108 of gestation. Back 
fat was recorded ultrasonically using the P2 method (back fat measured at 
5cm from the midline over the last rib), with a Lean-Meater ® (Renco 
Corp. MA, U.S.A.). 
 
3.2.2 Analysis of maternal plasma 
Plasma was sampled on days -4, 40, 70 and 108 days of gestation and 
auto-analysed for glucose, non-esterified fatty acids (NEFA), triglycerides 
(TAG), cholesterol as described in Chapter 2, Sections 2.3-2.4. In addition, 
fasting plasma insulin concentrations were determined at 108 days of 
gestation as previously described (Chapter 2; Section 2.4.5).  
 
3.2.2.1 Glucose tolerance test (GTT) 
Sows fed the control and fat supplemented diets were tested for glucose 
tolerance on day 108, towards the end of gestation. Protein supplemented 
sows were not tested for glucose tolerance due to commercial constraints. 
As with the blood sampling, one day prior to sampling, a catheter was 
placed in the sow¶Vear. The first blood samples were taken every minute, 
for 4 minutes prior to glucose administration; the catheter was flushed 
with saline between sampling. Blood from each time point was tested for 
glucose using indicator stick (Precision Xtra Plus, Abbott Laboratories, IL, 
USA) and an automated glucose reader (Precision Xceed, Abbott 
Laboratories). Glucose solution (Dextrose monohydrate, 495.4 g/L; AVEBE, 
Veendam, The Netherlands) was then infused intravenously over a 5 
minute period. The catheter was flushed with saline and 15 blood samples 
were then taken over a period of an hour. Glucose concentrations were 
measured as before, in order to determine the rate of glucose clearance of 
the sows.  
 
3.2.3 Measurements at birth 
The gestation length, total number of live and still born piglets, and birth 
weight were recorded. In addition, any piglet deaths during the lactation 
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period were recorded and the reason for death noted as one of 5 
categories which were low-viability, trauma, scours (diarrhoea), deformity, 
or other (unknown diagnosis).  
 
3.2.4 Milk sampling and composition analysis 
Milk composition analysis was carried out by employees from Schothorst 
Feed Research. In all sows, milk was sampled, after milk let down via an 
intravenous oxytocine injection (10 I.U./mL; Eurovet Animal Health, 
Bladel, The Netherlands) into the ear on day 2 and 24 of lactation. The fat, 
protein and lactose concentrations were determined in the fresh milk by 
infared analysis, using a Fourier Transform InfaRed (FTIR) interferometer 
(MilkoScanTM, Foss Electric, Hillerød, Denmark). This works by sending out 
light of the specific wavelength to be detected, which differs for fat, 
protein, and lactose, and measuring the absorbance at this wavelength.  
 
3.2.5 Statistical analysis 
Details of all statistical test performed are described in Chapter 2, Section 
2.6.   
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3.3 Results 
3.3.1 Maternal growth  
All sows consumed most of the food offered to them throughout gestation 
(Table 3.3). This meant that as the diets were isocaloric, (except FS diet 
which was slightly higher in energy, counteracted by a reduced feed 
allowance) energy intake was similar between groups throughout 
gestation.  
 
Table 3.3 Average daily feed intake of sows throughout gestation  
Gestational day C 
(Kg/day) 
FS 
(Kg/day) 
PS 
(Kg/day) 
0-40 2.82±0.02 2.47±0.02 2.81±0.02 
40-70 2.86±0.02 2.47±0.02 2.85±0.02 
70-110 3.71±0.02 3.16±0.07 3.70±0.03 
Values are means ± SEM for control (C; n=8), fat supplemented (FS; n=8), and protein 
supplemented (PS; n=8) sows 
 
Prior to mating and the beginning of this study, there was no difference in 
body weight or back fat thickness between the sows (Table 3.4). As 
expected, both maternal body weight and back fat increased throughout 
gestation (Table 3.4), with a total increase in body weight of around 72-79 
Kg and an increase in back fat of 3-4 mm (Table 3.4). Fat or protein 
supplementation did not affect mean body weight or back fat throughout 
gestation at any time point (Table 3.4). The increase in body weight was 
largest during the final part of gestation (day 70-80) when compared with 
early gestation (prior to mating-day 40), this is shown by a higher 
fractional growth rate during this time (Table 3.4).  In contrast, the 
increase in back fat followed an opposite pattern, with the largest increases 
being seen in early gestation (Table 3.4). However, this is not the case in 
the protein supplemented group, where a similar increase in back fat was 
seen during both early and late gestation resulting in a significant increase 
in the growth rate of the back fat of sows during late gestation when 
compared to the control animals (Table 3.4).  
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Table 3.4 Body weights, back fat and growth rates throughout gestation  
 C FS PS 
Prior to mating:    
   Body weight (Kg) 215.50±13.42 209.88±9.25 204.00±9.69 
   Back fat (mm) 13.88±0.86 13.81±0.59 12.94±1.05 
Day 40 of gestation:    
   Body weight (Kg) 236.63±11.76 232.63±9.61 224.63±9.32 
   Back fat (mm) 15.63±1.01 15.50±0.63 14.38±0.91 
Day 70 of gestation:    
   Body weight (Kg) 257.75±10.82 254.63±8.60 251.75±9.22 
   Back fat (mm) 16.44±1.26 16±0.56 15.81±1.04 
Day 108 of gestation:    
   Body weight (Kg) 287.75±10.47 281.88±8.70 282.88±9.03 
   Back fat (mm) 17.31±1.27 16.69±0.46 17.31±1.09 
Fractional growth rate (prior to mating-108 days):    
   Body weight (Kg/day/Kg) 3.3x10-3±5x10-4 3.3x10-3±4x10-4 3.7x10-3±4x10-4 
   Back fat (mm/day/mm) 2.3x10-3±2x10-4 2.0x10-3±3x10-4 3.4x10-3±7x10-4 
Fractional growth rate (prior to mating-40 days):    
   Body weight (Kg/day/Kg) 2.7x10-3±6x10-4 2.8x10-3±3x10-4 2.6x10-3±4x10-4 
   Back fat (mm/day/mm) 3.1x10-3±5x10-4 3.1x10-3±2x10-4 3.1x10-3±2x10-4 
Fractional growth rate (70-108 days):    
   Body weight (Kg/day/Kg) 3.8x10-3±4x10-4 3.5x10-3±4x10-4 4.2x10-3±6x10-4 
   Back fat (mm/day/mm) 1.7x10-3±3x10-4 1.4x10-3±7x10-4 3.1x10-3±5x10-4* 
Values are means ± SEM taken 4 days prior to mating and on days 40, 70 and 108 of gestation for control (C; n=8), fat supplemented (FS; n=8), and protein 
supplemented (PS; n=8) sows; Statistical differences between PS and the control are denoted by * P<0.05 (Mann-Whitney) 
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3.3.2 Fasted plasma metabolite concentrations 
In some groups, the number of sows does not equal 8 (Table 3.5). This 
was GXHWRWKHFDWKHWHULQWKHVRZ¶V ear not working properly. Either there 
were problems with initial insertion, or withdrawing blood due to a 
blockage.  
 
Fasted plasma glucose and TAG concentrations remained constant 
throughout gestation (Table 3.5). A similar pattern was seen with plasma 
total cholesterol; however there was a decrease in concentration towards 
term at 108 days of gestation (Table 3.5). There was a sharp decrease in 
plasma NEFA during the first 40 days of gestation (Table 3.5). 
Concentrations then levelled out and remained constant throughout 
gestation (Table 3.5).  
 
Supplementing the maternal diet with fat had no effect on the fasting 
plasma concentrations of glucose, TAG or NEFA throughout gestation 
(Table 3.5). Total cholesterol plasma concentrations were raised 
throughout gestation in the fat supplemented group (Table 3.5). However, 
levels were consistently higher before mating took place on day 0, so this 
is probably not a dietary effect.   
 
Protein supplementation had no effect on glucose, TAG or cholesterol 
concentrations throughout gestation (Table 3.5). There was a reduction in 
NEFA concentration at 108 days of gestation in the protein supplemented 
group (Table 3.5).  
 
Dietary supplementation with either fat or protein had no effect on 
maternal fasting plasma insulin concentrations (µg/ml) at 108 days of 
gestation (C: 0.46±0.01; FS: 0.48±0.01; PS: 0.48±0.18).  
 
84 
 
Table 3.5 Fasted plasma concentrations of glucose, triglycerides (TAG), non-esterified fatty acids (NEFA) and cholesterol during gestation  
Gestational day Gestational diet Glucose  
(mM) 
TAG 
(mM) 
NEFA 
(mM) 
Cholesterol 
(mM) 
-4 C (n=5) 3.88±0.57 1.48±0.30 1.12±0.47 2.10±0.12 
FS (n=8) 3.58±0.51 1.57±0.20 1.46±0.36  2.46±0.07* 
 PS (n=7) 3.80±0.32 1.63±0.33 1.24±0.21 2.49±0.19 
40 C (n=8) 3.93±0.12 1.27±0.09 0.27±0.05 2.15±0.09 
FS (n=8) 4.11±0.08 1.52±0.32 0.27±0.02  2.61±0.14* 
 PS (n=8) 3.90±0.21 1.30±0.08 0.21±0.02 2.10±0.11 
70 C (n=8) 3.90±0.10 1.24±0.05 0.19±0.01 2.03±0.09 
FS (n=8) 3.98±0.10 1.38±0.13   0.28±0.02*  2.44±0.14* 
 PS (n=8) 3.71±0.19 1.34±0.15 0.24±0.02 2.00±0.11 
108 C (n=7) 3.93±0.10 1.38±0.13 0.32±0.06 1.57±0.06 
FS (n=8) 3.70±0.17 1.41±0.15 0.38±0.09  1.94±0.15* 
 PS (n=8) 3.97±0.10 1.34±0.08  0.15±0.04* 1.83±0.11 
Values are means ± SEM taken 4 days prior to mating and on days 40, 70 and 108 of gestation; Data was statistically tested using unpaired T-tests between control (C) 
and fat supplemented (FS) or protein supplemented (PS) groups and differences are: * P<0.05  
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3.3.3 Glucose tolerance tests 
Two sows were unable to be tested for glucose tolerance due to a blockage 
of the catheter in their ear. As previously stated, protein supplemented 
sows were not tested for glucose tolerance. 
 
Following intravenous glucose administration, at 108 days of gestation, the 
glucose area under the curve was greater in those sows receiving the 
supplemented fat diet (Figure 3.3 and 3.4), indicating a slower rate of 
glucose clearance in these animals. The basal glucose concentrations and 
the peak glucose concentrations achieved in both the control and fat 
supplemented groups were not different (Table 3.6).      
-20 0 20 40 60 80
5
10
15
20
Time (mins)
Gl
uc
os
e 
(m
m
ol
/l)
Figure 3.3 Plasma glucose after intravenous glucose tolerance test (See Chapter 
3; Section 3.2.2.1) in control  or fat supplemented  sows at 108 days of 
gestation; Values are means ± SEM 
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Figure 3.4 Area under the curve (AUC) following bolus administration of glucose 
(See Chapter 3; Section 3.2.2.1) to control (C; n=8) or fat supplemented (FS; 
n=6) sows at 108 days of gestation; Values are means ± SEM; Statistical 
differences are denoted by * P<0.05 (T-test) 
 
Table 3.6 Derived values from intravenous glucose tolerance test (See Chapter 3; 
Section 3.2.2.1) at 108 days of gestation 
 C  FS  
Basal glucose, mM 4.14±0.17 5.05±0.99 
Max. Peak, mM 12.48±0.25 14.73±2.62 
Values are means ± SEM for control (C; n=8) and fat supplemented (FS; n=6) fed sows 
 
3.3.4 Milk composition 
7KHVRZ¶VPLONRQGD\RIODFWation contained approximately 8 % fat, 5 % 
lactose and 6 % protein (Table 3.7). Fat or protein supplementation had no 
effect on this composition (Table 3.7). 
 
Table 3.7 Milk composition on day 2 of lactation 
Milk composition (%) C FS PS 
Fat 7.80±0.56 7.87±0.56 7.46±0.71 
Lactose 5.35±0.17 4.85±0.33 5.05±0.15 
Protein 5.55±0.24 6.32±0.51 5.95±0.14 
Values are means ± SEM for control (C; n=8), fat supplemented (FS; n=8), or protein 
supplemented (PS; n=8) sows 
 
3.3.5 Birth weight and postnatal mortality 
Gestation length was unaffected by maternal diet (C: 117.4±0.32; FS: 
116.1±0.67; PS: 115.9±0.77). The average litter size was 15-16 piglets, 
and this was unaffected by fat or protein supplementation during 
pregnancy (Table 3.8). In both the control and protein supplemented 
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groups, there was an equal distribution of males and females amongst 
litters (Table 3.8). However, maternal fat supplementation tended to 
increase the number of male offspring within a litter (Table 3.8).  
 
Maternal fat or protein supplementation had no effect on offspring birth 
weight, with the average birth weight remaining around 1.2 kg (Table 3.8). 
Birth weight distribution is usually normally distributed, and this can be 
seen from the data and was unaffected by fat or protein supplementation 
(Figure 3.5). Female offspring tended to be lighter than the male offspring 
in the control and fat supplemented group, with a higher percentage of 
very low-birth weight (<800g) female offspring (Table 3.8; Figure 3.5). 
However, this is not seen in the protein supplemented group, where birth 
weight was similar between gender (Table 3.8; Figure 3.5). 
 
Table 3.8 Litter size, offspring birth weight and sex ratio  
 C FS PS 
Litter size 14.88±0.78 16.38±0.75 16.00±1.07 
   Males 7.00±0.59  9.00±0.65** 8.50±0.92 
   Females 7.88±0.85 7.38±0.68 7.50±0.78 
Mean birth weight (Kg) 1.22±0.04 1.25±0.07 1.21±0.06 
   Males 1.26±0.07 1.30±0.08 1.22±0.08 
   Females  1.16±0.03* 1.20±0.06 1.21±0.04 
Values are means ± SEM for control (C; n=8), fat supplemented (FS; n=8), or protein 
supplemented (PS; n=8) gestational groups; Statistical differences between males and 
females are denoted by * P<0.05 (T-Test); Statistical differences between FS and the control 
are denoted by ** P<0.05 (T-Test) 
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Figure 3.5 Relationships between the percentage of piglets born in each weight category (  ) and percentage of male (  ) and female (  ) piglets in 
that specific weight category for control (a), fat supplemented (b), or protein supplemented (c) gestational groups; Values are means ± SEM     
a) b) c) 
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The average number of stillborn piglets per litter was 8-10 %, with the 
average piglet mortality from birth until weaning (day 28) around 4 % for 
the control group (Table 3.9). Despite maternal diet having no effect on 
the number of stillborn piglets per litter (Table 3.9), the number of piglets 
who died after birth was significantly increased with both fat and protein 
supplementation (Table 3.9). 92 % of these deaths occurred within the 
first 24 hours after birth in the fat supplemented group and 80 % in the 
protein supplemented group. These piglets tended to be those with the 
lowest birth weight of the litter (Figure 3.3). Male piglets tended to account 
for a higher percentage of the postnatal mortality in all groups (Table 3.9). 
The primary cause of piglet mortality was trauma caused by entrapment by 
the sow, although the reasons for this entrapment are not known (Table 
3.9). One litter in the fat supplemented group had a high percentage of 
piglet deaths from a muscle deformity known as spraddled legs (Table 
3.8).   
 
Table 3.9 Stillbirths and postnatal mortality until 28 days of age 
 C FS PS 
Stillbirths (% of litter) 9.45±2.28 7.91±2.78 10.05±2.83 
   Males  5.32±2.30 3.49±1.94 7.48±2.92 
   Females 4.13±1.23 4.42±1.74 3.30±1.28 
Postnatal mortality (0-28 days) (% of litter) 3.95±1.66 17.51±6.00* 11.68±2.93* 
   Males 3.05±1.66 10.31±4.30 6.12±2.82 
   Females 0.89±0.89 7.19±3.43  5.55±1.36 
Reasons for mortality (% of litter):    
   Trauma 3.11±1.67 8.84±3.0 5.78±3.50 
   Low viability 0.83±0.83 4.85±2.55 3.40±1.68 
   Deformity ± Spraddled legs n/a 3.13±3.13 1.88±1.24 
   Scours n/a n/a 0.63±0.63 
   Unknown n/a 0.69±0.69 n/a 
Values are means ± SEM for control (C; n=8), fat supplemented (FS; n=8) or protein 
supplemented (PS; n=8) gestational groups; Statistical differences between FS or PS and the 
control are denoted by * P<0.05 (Mann-Whitney) 
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Figure 3.6 Relationships between the percentage of piglets born in each weight category (  ) and percentage stillbirths (  ) and pre-weaning 
mortality (    ) for that specific weight category for control (a), fat supplemented (b), or protein supplemented (c) gestational groups; Values are 
means ± SEM     
a) b) c) 
91 
 
3.4 Discussion 
3.4.1 Fat supplementation 
Maternal fat supplementation has contrasting effects in both rat and pig 
studies, with differing results even within species. In the rat model, fat 
supplementation throughout pregnancy has been shown, in some cases, to 
reduce the number of successful pregnancies and/or offspring birth weight 
(French et al., 1952, Khan et al., 2003, Taylor et al., 2003), whilst other 
studies have reported no effects until the offspring have been followed up 
in later life (Guo and Jen, 1995, Taylor et al., 2005). In contrast to this, fat 
supplementation to pigs during the last few days of gestation and lactation 
is thought to improve neonatal survival, possibly by an increase in lipid or 
glycogen stores at birth, or through an increase in milk yield or fat content 
of the milk (Seerley et al., 1974, Boyd et al., 1978, Pettigrew, 1981, 
Seerley et al., 1981, Azain, 1993). There are many reasons why such large 
differences between rat and pig studies may have been observed; these 
include the timing of supplementation, the source and quantity of the fat, 
and the energy intake of the animals.  
 
The sole purpose of the previous investigations in pigs was to improve 
neonatal survival and so, in contrast to this study and past rodent studies, 
fat was only supplemented in the final week of gestation, as opposed to 
most of the gestational period, and a normal diet was fed to all animals the 
rest of the time. In this investigation, the control diet fed to the pigs 
contained 2.5 percent fat (w/w), with the fat supplemented diet containing 
9 percent fat (w/w). These are similar to the levels seen in the previous pig 
supplementation investigations (Seerley et al., 1974, Boyd et al., 1978, 
Pettigrew, 1981, Seerley et al., 1981, , Azain, 1993). In contrast, a typical 
rodent diet for fat supplementation investigations would contain around 
20-25 percent fat (w/w), usually in the form of animal fat (Taylor et al., 
2003). Outcomes from this would be measured against animals fed a 
control diet containing just 5 percent fat (w/w), usually from a vegetable 
source. This is probably because the rat is being used as a model for 
nutritional programming, therefore, the level of fat that is fed is often 
much higher than in the pig in order to mimic human fat consumption. 
 
In addition, in this study, and most previous investigations into fat 
supplementation in pigs (Seerley et al., 1974, Boyd et al., 1978, Pettigrew, 
1981, Seerley et al., 1981, Azain, 1993,), all diets were isocaloric, so 
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energy intake was identical between groups throughout gestation. In order 
to do this, starch content had to be reduced by almost half, from 31.6 
(w/w) percent in the control diet, to 16.1 percent (w/w) in the fat 
supplemented group. However, protein content remained constant at 12 
percent (w/w), this is within recommended protein quantity guidelines for 
pigs (Burrin, 2001). In addition, the source of protein was the same 
between diets, ensuring that the amino acid composition remained 
constant. However, in rodent studies (Khan et al., 2003, Taylor et al., 
2003), despite the diet compositions being similar between groups, with 
just an increase in fat content, there is often a reduction in food intake by 
the rats, due to the higher energy content and often reduced palatability of 
these diets. This in turn will reduce the carbohydrate, and perhaps more 
importantly, the protein intake of these animals, perhaps explaining the 
reduction in successful pregnancies, litter size and birth weight.   
 
3.4.1.1 Maternal glucose tolerance  
To meet the increasing demand for glucose by the fetuses, due to higher 
energy needs, insulin sensitivity and glucose tolerance decreases towards 
the end of gestation (Frienkel, 1980, Leturque et al., 1980, Pere and 
Dourmad, 2000, Pere and Etienne, 2007). This effect has been shown to 
be exaggerated in animal experiments using rats and pigs investigating the 
outcomes of feeding additional fat during gestation (Guo and Jen, 1995, 
Taylor et al., 2003, van der Peet-Schwering et al., 2004). For example in 
one pig study, which fed additional fat (fat-supplemented: 9.6 % fat; 
control: 5.2 % fat), to pigs from day 85 of gestation, there is a reduction 
in glucose tolerance at 108 days of gestation, shown by an increase in the 
area under the curve, with no effect on basal glucose or maximum peak 
glucose concentrations (van der Peet-Schwering et al., 2004). Due to the 
higher energy intake of sows fed the fat supplemented diet, these animals 
gained more weight and had a larger increase in back fat thickness, during 
the period of nutritional intervention than the control animals (van der 
Peet-Schwering et al., 2004). Similarly, rat studies have shown that 
consumption of a high-fat diet (high-fat: 25 % fat; control: 5 % fat) 
throughout pregnancy, causes an increase in maternal basal insulin 
concentrations on day 20 of gestation, suggesting hyperinsulinemia in 
these mothers (Taylor et al., 2003).  This occurred despite no differences 
in weight gain between these animals (Taylor et al., 2003).  
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The rate at which glucose is used by maternal tissues decreases during 
gestation and this allows for improved placental transfer of glucose (Pere 
and Dourmad, 2000) that could result in fetal hyperinsulinemia (van der 
Peet-Schwering et al., 2004). This in turn can cause extreme 
hypoglycaemia immediately after birth, thus resulting in postnatal death 
(van der Peet-Schwering et al., 2004) as demonstrated in both human and 
pig studies where increased birth weight and postnatal mortality was seen 
in mothers who were less glucose tolerant (Kemp et al., 1996, Schmidt et 
al., 2001). It would be logical to therefore conclude that supplementing the 
maternal diet with fat during gestation may reduce maternal glucose 
tolerance and increase postnatal mortality.  
 
In agreement with previous findings (van der Peet-Schwering et al., 2004), 
this study has demonstrated a reduction in glucose tolerance at term, 
when sows were fat supplemented from mating until day 110 of gestation. 
However, the area under the curve and maximum peak after glucose 
administration is very different between studies. This is probably because 
previous investigations by van der Peet-Schwering et al. (2004) used 
pelleted glucose (3 g/Kg BW.75) and fed this to animals before glucose 
testing thus producing much lower average maximum glucose peak and 
area under the curve concentrations than observed in this study where 
glucose solution (123.85 g/L BW) was injected intravenously. In addition, 
basal glucose concentrations were much lower (average 2.5 mmol/L; (van 
der Peet-Schwering et al., 2004) in comparison to the normal 
concentrations (4-5 mmol/L) seen in this and other investigations in pigs 
(Pere and Dourmad, 2000, Pere and Etienne, 2007), and this could also 
account for differences seen in area under the curve. The reasons for such 
pronounced differences are unclear as pig breed, body weight, back fat, 
and timing of plasma sampling are all comparable between studies. The 
only notable difference is in sampling technique, were that in our study 
blood was sampled from a vein in the ear, and in the study by van der 
Peet-Schwering et al. (2004) it was taken from an incision in the tail. The 
changes in glucose tolerance observed in this study occurred despite fat 
supplementation having no effect on maternal body weight, back fat, or 
plasma glucose, NEFA, TAG and cholesterol concentrations, throughout 
gestation, probably due to identical energy intake between the gestational 
groups. In addition, in contrast to previous investigations in rats (Taylor et 
al., 2003), basal insulin concentrations were not affected by maternal fat 
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supplementation. Unfortunately, it was not possible to determine insulin 
sensitivity in these mothers, by examining the insulin area under the curve 
following glucose administration, because blood samples taken and tested 
for glucose were not stored for further analysis.  
 
3.4.1.2 Piglet mortality 
Fat supplementation increased piglet mortality by around 14 percent, 
despite having no effects on gestation length, litter size or birth weight. 
Most of these deaths occurred within the first day of life, thus further 
supporting the hypothesis of hypoglycaemia at birth due to reduced 
maternal glucose tolerance. This is in contrast to previous studies which 
have indicated a protective effect of fat supplementation during pregnancy 
on postnatal survival, although these studies also see no differences in 
piglet birth weight (Seerley et al., 1974, Boyd et al., 1978, Pettigrew, 
1981, Seerley et al., 1981, Azain, 1993,). In addition, van der peet-
Schwering at al. (2004) demonstrated no effects of fat supplementation on 
postnatal mortality, despite these mothers showing reduced glucose 
tolerance and producing a higher number of stillborn offspring. The 
contrasting results in postnatal mortality between studies may perhaps be 
due to the much longer length of fat supplementation in this study, thus 
causing greater detrimental results.  
 
The two major reasons for piglet mortality between 0 and 3 days of age 
are low viability and trauma (Vaillancourt et al., 1990). Low viability is 
classified according to PigCHAMPTM standardised pre-weaning mortality 
form, as weakness from very low-birth weight and/or starvation. Trauma is 
classified as being laid on, savaged or injured by the mother. Scours and 
infection are the major cause of death in piglets older than 7 days of age 
(Vaillancourt et al., 1990). The outcomes of this study agree with this; with 
50 percent of deaths in offspring of fat supplemented mothers, caused by 
trauma, and 28 percent caused by low viability and the failure to suckle, 
perhaps due to hypoglycaemia at birth.  
 
Studies investigating the cause of death in neonatal piglets need to be 
interpreted with caution. One reason for this is that subjective appraisal is 
involved in determining the cause of death. For example in one study, pig 
producers from 11 herds submitted 155 piglets thought to be stillborn 
(Vaillancourt et al., 1990). With further examination, 13 of these piglets 
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were found to have been born alive, and one piglet was mummified. In 
summary, 9 percent of all piglets submitted as stillborn were classified 
incorrectly.  In addition, the recorded cause of death is often only the 
terminal factor, and there may have been one or more other predisposing 
influences leading up to death (Vaillancourt et al., 1990, Varley, 1995). For 
example, it is possible that those deaths associated with trauma, are a 
result of low viability and a failure to suckle resulting in a reduction in 
glucose intake thus reducing piglet cognition and ability to move away 
quickly and, ultimately, being trapped by the sow as she lies down. This is 
IXUWKHUVXSSRUWHGE\(QJOLVKDQG6PLWKZKRXVHGDµFDVHKLVWRU\¶
approach to monitor the factors leading to the death of 236 piglets. They 
discovered that whilst crushing and trampling by the sow were involved in 
35 percent of the deaths, nearly half of these animals had already been 
weakened, usually by malnutrition, before being crushed (English and 
Smith, 1975).  
 
Within a litter, piglets that are light at birth, have a higher risk of mortality 
(Milligan et al., 2002). In agreement with this, in this study, low-birth 
weight piglets (<1 Kg) accounted for the majority of deaths. Smaller 
piglets will have less energy reserves, and probably less ability to suckle 
than the larger piglets (Milligan et al., 2002), and thus it is possible that 
they may be more susceptible to hypoglycaemia than their larger litter 
mates. This is further supported by human cohort studies, which suggest 
that the risk of developing hypoglycaemia after birth is highest in low-birth 
weight babies (Lubchenco and Bard, 1971). In addition, piglet hierarchy 
within the litter is established soon after birth, with the smallest piglets 
tending to be lowest in the hierarchy order and therefore receiving less 
milk than their larger littermates due to competition for the most 
productive teats (Mitchell et al., 2001).  
 
As demonstrated in previous studies (Bereskin et al., 1973), male piglets 
tend to be heavier at birth than female piglets. It would therefore be 
logical to conclude that males would have a survival advantage over 
females. However, this is not the case with this study agreeing with the 
findings of Bereskin et al. (1973) where a higher proportion of piglet 
mortality occurred in males. This could perhaps be because the low-birth 
weight male piglets tended to be the runts of the litter who are not as well 
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adapted to postnatal life, with less energy reserves, than their female litter 
mates who were genetically programmed to be of lower birth weight. 
 
3.4.1.3 Milk composition 
It has been suggested that maternal fat supplementation may affect milk 
composition by increasing the fat content (Pettigrew, 1981). However, milk 
composition of the sows was unaffected by fat supplementation in this 
study. This is probably due to the dietary interventions ceasing at 110 days 
of gestation and all sows being fed the same diet from this period until the 
end of lactation.   
 
3.4.2 Protein supplementation 
Investigations into the effects of protein supplementation in pregnancy are 
limited, and most are linked to the role of key amino acids during 
pregnancy.  It has been previously suggested in pigs and rats, that 
supplementing the maternal diet with arginine, provides beneficial effects 
on reproductive performance by increasing litter size and reducing the 
number of stillborn animals (Mateo et al., 2007, Zeng et al., 2008). This is 
probably due to the role of arginine in nitric oxide and polyamine 
production and therefore its essential role in fetal development (Roselli et 
al., 1998, Wu and Morris, 1998, Bird et al., 2003, Wu et al., 2004).  
 
Whole protein sources of legumes and sunflowerseed meal were added to 
the gestational diets for protein supplementation in this study. These were 
selected as they are rich in arginine and glutamine. The final diet 
composition contained 1.2 percent arginine (control: 0.7 % arginine) and 
3.5 % glutamine (control: 2.2 % glutamine). In addition, concentrations of 
all other amino acids were increased slightly because a whole protein 
source was fed, although it must be noted that minimum essential amino 
acid requirements were met for all gestational diets.  
 
3.4.2.1 Maternal body weight and back fat 
As expected, and demonstrated in other studies (Mateo et al., 2007), 
maternal body weight and back fat thickness increased gradually 
throughout gestation. This increase in maternal body weight is highest 
during the final portion of gestation (day 70-108) and coincides with the 
increase in maternal feed intake and the maximal period of fetal growth 
(Book and Bustad, 1974, Litten-Brown et al., 2010). Protein 
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supplementation had no effect on maternal body weight throughout 
gestation. This is similar to other findings which show no effects of arginine 
supplementation on maternal body weight (Mateo et al., 2007, Zeng et al., 
2008). In contrast to the pattern of a higher rate of maternal body weight 
gain in late gestation, the rate of maternal back fat thickness gain is 
highest during early gestation (mating-day 40). However, this study has 
demonstrated a much higher rate of increase in the back fat thickness of 
protein supplemented mothers during late gestation; this increase is 
comparable to the growth seen in early gestation. Despite this, back fat is 
identical between sows at 108 days of gestation. This increase in back fat 
coincides with a decrease in plasma NEFA concentration in these animals at 
108 days of gestation, perhaps due to utilisation of the NEFA to convert to 
triglycerides for storage.  
 
3.4.2.2 Reproductive performance 
In contrast to previous findings, this study has shown no effects of protein 
supplementation, with a protein source rich in arginine, on litter size, 
number of live-born piglets produced, or piglet birth-weight. This is 
probably due to the reduced amount of arginine in the diets in comparison 
to other studies which fed around 1 percent arginine as a concentrated, 
crystalline amino acid (Mateo et al., 2007, Zeng et al., 2008).  Another 
point to note is that previous investigations did not add any arginine to 
their control diets (Mateo et al., 2007, Zeng et al., 2008), this is in 
accordance with the minimum amino acid requirements during pregnancy 
in swine (NRC, 1988). Therefore, it is possible that the results produced 
are actually detrimental effects from the lack of arginine in the control 
group rather than positive effects on the supplemented group.  
 
The key finding from this study is that protein supplementation until day 
110 of gestation resulted in a rise in neonatal mortality rates, although this 
increase was not as high as with fat supplementation. The reasons for this 
mortality are as yet unclear, although it is possible that it may be linked to 
the increase in maternal back fat and reduction in NEFA plasma 
concentrations, seen at 108 days of gestation.  
 
These results contradict previous investigations where no detrimental 
effects of arginine supplementation on mortality have been recorded 
(Mateo et al., 2007, Zeng et al., 2008). However, it must be noted that 
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previous studies have solely been looking at the influence of arginine 
supplementation and so the control diet has been balanced for nitrogen 
content by the addition of alanine. This study was designed to look at the 
effects of global protein supplementation and so sows were fed 16.3 
percent protein as opposed to the control diet which contained 12.3 
percent protein. Therefore, nitrogen content is clearly increased in the 
supplemented diet. In addition, as with fat supplementation, not all 
macronutrient components could stay the same to maintain energy content 
and health of the sow. As a result, protein supplemented sows received 1.2 
percent more fat and 1.4 percent less fibre than those fed the control diet 
and this may influence postnatal mortality. 
 
It is also important to consider the differences in the time course for 
protein supplementation between these experiments. This is the only study 
to investigate the effects of supplementation throughout the majority of 
the gestational period. In addition, the only other study in pigs, which 
supplemented arginine from the first day of gestation, produced negative 
effects, shown by a reduction in litter size at 25 days when pregnancy was 
terminated (Li et al., 2010).  Therefore, it may be, the long-time period of 
protein supplementation, particularly early in gestation, the increased 
protein or fat content, or the reduction in fibre content which causes the 
high piglet mortality rates seen in this study.  
 
3.4.3 Conclusions 
In conclusion, this study has demonstrated that fat supplementation 
throughout pregnancy, reduces maternal glucose tolerance towards term 
and decreases the survival rate of piglets after birth, possibly due to the 
development of hypoglycaemia in these offspring. Furthermore, 
supplementing the maternal diet with protein also increased the incidence 
of postnatal mortality. These findings may have consequences for the pig 
industry where reducing piglet mortality is of key economical importance 
and where fat and protein supplementation were previously considered to 
be beneficial practice (Pettigrew, 1981, Wu et al., 2010). In addition, 
glucose intolerance in the mother is thought to be a risk factor for 
development of metabolic disease in the offspring (Chapter 1.3.1) (Boney 
et al., 2005, Franks et al., 2006), and so the aim of next chapter is to 
follow up the effects of maternal fat supplementation by observing the 
outcomes of the offspring.  
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Chapter 4 - The effect of maternal fat supplementation 
on offspring development 
 
4.1 Introduction 
The consequences of supplementing the pig diet with fat during pregnancy 
on the programming of piglet development have thus far not been 
investigated. Studies have instead focussed on changing the fatty acid 
profile of the offspring by altering the polyunsaturated fatty acid content of 
the maternal diet (Chapter 1; Section 1.6.3.2.1) (Rooke et al., 1998, 
Rooke et al., 2001a, Rooke et al., 2001b). Or, on the supposed beneficial 
effects of fat supplementation on increasing offspring survival rate, which 
is of key economical importance in the pig industry (Chapter 3) (Seerley et 
al., 1974, Pettigrew, 1981, Boyd et al., 1978, Seerley et al., 1981, Azain, 
1993). Despite this, the present study has previously reported detrimental 
effects of fat supplementation during pregnancy on maternal glucose 
tolerance and neonatal mortality (Chapter 3). Briefly, fat supplementation 
caused a reduction in maternal glucose tolerance at term, perhaps leading 
to hypoglycaemia in the piglets, providing the link to the increase in 
neonatal mortality that was observed within the first 24 hours after birth. 
 
4.1.1 Maternal fat supplementation and programming of offspring 
metabolism 
It has been well documented that offspring born to mothers who develop 
gestational diabetes, often due to intake of a high fat diet and/or maternal 
obesity, have increased risk of developing metabolic complications such as 
obesity and impaired glucose tolerance at an early age (Chapter 1; Section 
1.3.2) (Boney et al., 2005, Franks et al., 2006). However, these offspring 
are usually of very high-birth weight due to fetal macrosomia caused by 
hyperglycaemia in the mother (Jovanovic and Pettitt, 2001, Schmidt et al., 
2001, Franks et al., 2006).  
 
In addition, investigations into high-fat feeding during pregnancy in rats 
have demonstrated similar detrimental effects on the metabolism of the 
offspring, despite there being no effect on birth weight (Chapter 1; Section 
1.3.2) (Khan et al., 2003, Khan et al., 2005, Taylor et al., 2005). These 
findings are similar to those seen in the offspring of maternal protein 
restricted or nutrient restricted rats and sheep (Chapter 1; Section 
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1.2)(Langley-Evans et al., 1996, Langley-Evans et al., 1998, Bertram et 
al., 2001, Whorwood et al., 2001). 
 
Due to the similarities seen between the high-fat and low-protein models 
of developmental programming, which leads to a phenotype with features 
of the metabolic syndrome, it has been proposed that a there is a common 
underlying mechanism such as perturbed glucocorticoid (GC) activity and 
insulin resistance (Khan et al., 2003, Taylor et al., 2003). This is supported 
by the elevation in plasma corticosterone seen at 20 days of gestation in 
fat supplemented dams (Taylor et al., 2003). Furthermore, feeding a high-
fat diet to non-pregnant rats leads to both basal and stress-induced 
activation of the hypothalamic pituitary adrenal (HPA) axis, thus elevating 
adrenal GC production (Pascoe et al., 1990, Tannenbaum et al., 1997). 
However, male offspring of coconut oil-fed dams, which is high in saturated 
fatty acids (Chapter 1; Section 1.6.1.3), show increased blood pressure 
but do not show evidence of altered HPA axis activation in the 
hypothalamus or liver (Langley-Evans, 1996), suggesting perhaps that 
another mechanism may be involved.  
 
4.1.2 Birth weight and offspring development 
Pigs exhibit the most severe naturally occurring intrauterine growth 
retardation (IUGR) of all livestock species (Wu et al., 2006),8*5RUµUXQW¶
piglets are defined as weighing 1 kg or less, and less than 65 percent of 
the birth weight of the larger litter-mate controls (Hegarty and Allen, 
1978). Studies have shown that the within-litter weight distribution seen at 
birth is already established by the end of the embryonic stage of 
pregnancy (day 35) (Van der Lende et al., 1990, Finch et al., 2002).  
 
As previously reported in this thesis, low birth weight piglets have a higher 
incidence of mortality (Chapter 3). Those small piglets that do survive will 
grow more slowly than their heavier litter mates, often due to their 
inability to compete with larger piglets (McGlone et al., 2001, Gondret et 
al., 2006). Thus it is normal husbandry practice, as demonstrated in this 
study,  to separate litters after weaning and group them according to birth 
weight (McGlone et al., 2001). It is then possible to feed these animals 
appropriately so that they achieve their target weight and body 
composition in the shortest time possible (McGlone et al., 2001). However, 
keeping pigs in groups based on body weight decreases their ability to 
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establish a hierarchy and leads to increased fighting and stress often 
resulting in reduced feed intake and growth, wounds, and occasionally 
death (McGlone et al., 2001). And often, despite this grouping, growth rate 
is still reduced in very low-birth weight piglets when compared to their 
litter mates (Hegarty and Allen, 1978, Powell and Aberle, 1980).  
 
In addition, it has been documented that piglets weighing less than 1 Kg at 
birth, not only grow more slowly, but also less efficiently, meaning that 
they are more likely to produce a carcass with a higher proportion of fat 
and less muscle than their larger birth weight piglets who were slaughtered 
at the same weight (96 Kg) (Powell and Aberle, 1980). This was 
demonstrated by a higher marbling score and percentage lipid in the 
longissimus muscle of the runt piglets (Powell and Aberle, 1980), despite 
no differences in back fat depth or longissimus muscle area between birth 
weight groups (Powell and Aberle, 1980). 
 
4.1.2.1 Accelerated postnatal growth  
It is well documented in humans that low-birth weight infants, who 
experienced growth restriction in utero, have a greater risk of obesity and 
developing metabolic disorders such as impaired glucose tolerance and 
hypertension in later life (Erikson et al., 2000, Forsen et al., 2000, Hales 
and Barker, 2001). This relationship between low-birth weight and/or 
thinness at birth and the increased risk of metabolic disease in later life 
has been associated with accelerated growth during childhood (Hales and 
Barker, 2001). It can be best explained by examining birth weight and 
growth data from a cohort study of 7086 men and women born between 
1924 and 1933 in Helsinki, Finland (Forsen et al., 2000). Figure 1.2 from 
this article shows the childhood growth of 471 men and women who 
developed type 2 diabetes. Height, weight and body mass index (BMI; 
weight/height2) are expressed as Z-scores, which represent the 
differences, expressed as standard deviations, from the mean value of the 
entire cohort, which is set at zero. Small or large children who grow at a 
steady rate, relative to the mean, would follow a horizontal path on the 
figure. Children, who later developed type 2 diabetes, having been small or 
thin at birth, continued to have low rates of growth in infancy but from 7 
years onwards showed accelerated growth in both weight and height 
(Forsen et al., 2000). By the age of 15 years, both boys and girls who later 
developed type 2 diabetes, were above average for the cohort (Forsen et 
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al., 2000). One explanation for this effect is that fetal growth restriction 
lead to a reduction in pancreatic cell number and that subsequent 
accelerated growth and weight gain during childhood, leads to excessive 
metabolic demand on this limited cell mass (Hales and Barker, 2001).  
 
 
Figure 4.1 Height (solid line), weight (dashed line), and body mass index (dotted 
line) during childhood of 286 men and 185 women who later developed type 2 
diabetes (Forsen et al., 2000) 
 
4.1.3 Aims and hypothesis 
In summary, maternal fat supplementation of rats throughout pregnancy, 
by the addition of fats containing a high proportion of saturated fatty acids 
to the diet, has been shown to produce offspring with metabolic 
abnormalities at 6 months and 1 year of age (Khan et al., 2003, Khan et 
al., 2005, Taylor et al., 2005). This is similar to the effects seen in protein 
restricted or nutrient restricted rats and sheep (Langley-Evans et al., 1996, 
Langley-Evans et al., 1998, Bertram et al., 2001, Whorwood et al., 2001), 
thus indicating a similar mechanism such as altered GC sensitivity or 
insulin resistance in the offspring. At present there are currently no follow-
up investigations into the effects of maternal fat supplementation on piglet 
outcomes in later life, either for the development of the pig industry or 
when using the piglet as a model for human infants.  
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The present study has already described how fat supplementation of pigs 
throughout pregnancy, by the addition of palm oil in the diet, increased 
maternal glucose tolerance and increased the rate of neonatal mortality 
(Chapter 3). This chapter will therefore focus on the effects of maternal fat 
supplementation on piglet development until 6 months of age that is 
hypothesised that fat supplementation to no effects on the offspring at one 
week of age, but, by 6 months of age, these offspring could show signs of 
developing metabolic disease. Primary markers would be an increased 
body weight due to a higher fat mass, with perturbed glucose/lipid 
homeostasis shown by raised circulating plasma levels of glucose, insulin 
and triglycerides (TAG).  
 
To elucidate the mechanism behind this, this chapter will focus on the 
effects of maternal fat supplementation on the piglet liver due to its 
importance in whole body energy balance and metabolism. It was 
hypothesised that by 6 months of age, expression of genes involved in GC 
sensitivity such as GC receptor (GR) and 11beta-Hydroxysteroid 
'HK\GURJHQDVHǃ-HSD) type 1 will be increased in offspring born to fat 
supplemented sows. In addition there will be an increase in liver 
triglycerides with a reduction in genes involved in fatty acid oxidation and 
uptake such as peroxisome proliferator-DFWLYDWHG UHFHSWRU DOSKD 33$5Į
and fatty acid-binding protein 1 (FABP1). Finally, insulin sensitivity may be 
reduced and so gene expression of insulin receptor (IR) might be lower. 
 
Compensatory growth is encouraged in the pig industry and so it is 
hypothesised that by 6 months of age, the low-birth piglets will be of 
similar body weight to their median-birth weight litter mates. Low-birth 
weight offspring have been shown to be at a higher risk of obesity and 
metabolic complications, due to accelerated postnatal growth (Erikson et 
al., 2000, Forsen et al., 2000, Hales and Barker, 2001). This chapter will 
also investigate the effects of maternal fat supplementation in piglets of 
low-birth weight. It is hypothesised that the low-birth weight piglets will be 
most affected by maternal diet, shown by an exaggerated response to fat 
supplementation, when compared to their average birth weight litter 
mates. 
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4.2 Methods 
4.2.1 Method overview 
A full description of the study design and laboratory protocols is described 
in Chapter 2. Briefly, one low and one median-birth weight piglet in each 
litter born to sows fed either the control or fat supplemented gestational 
diets were selected for tissue sampling at 1 week ± 2 days and 6 months 
of age. Plasma and liver tissue samples were taken and processed as 
described in Chapter 2, Section 2.3.1. Plasma was auto-analysed for 
glucose, nonesterified fatty acids (NEFA), TAG and cholesterol as described 
in Chapter 2, Section 2.4. In addition, fasting plasma insulin concentrations 
were determined at 6 months of age by Dr Hernan P. Fainberg (Chapter 2; 
Section 2.4.5). Liver samples were analysed for lipid and glycogen content 
as described in Chapter 2, Section 2.5. Glycogen analysis was carried out 
by Miss Mehreen Azhar ,Q DGGLWLRQ OLYHU JHQH H[SUHVVLRQ RI *5 ǃ-
+6'33$5Į )$%3 DQG ,5ZDVPHDVXUHG &KDSWHU6HFWLRQV-
2.5.6). In pigs that were not selected for tissue sampling, back fat 
thickness was measured at 6 months of age (Chapter 2; Section 2.2). 
 
4.2.2 Statistical analysis 
Full details of all statistical tests performed are described in Chapter 2.6.  
 
For this chapter, in order to examine the effect of maternal diet on the 
offspring selected for tissue sampling at 1 week or 6 months of age, either 
the low or median-birth weight piglets from the control group were 
compared with the appropriate low or median piglets from the fat 
supplemented group (Table 4.1). This was carried out using either an 
unpaired T-test or a Mann-Whitney test, depending on whether the data 
was parametric or non-parametric. In addition, to compare differences 
between piglet birth weights, data from both low and median-birth weight 
piglets were compared for either the control or fat supplemented groups 
(Table 4.1), again using T-tests of Mann-Whitney Tests. It was not 
appropriate to statistically compare data obtained at 1 week and 6 months 
of age as, although all techniques were kept the same, these tissues were 
analysed separately in the lab due to a delay between the tissues arriving.  
 
3HDUVRQ¶V FRUUHODWLRQ FRHIILFLHQW ZDV XVHG WR GHPRQVWUDWH UHODWLRQVKLSV
between birth weight, growth rate, and back fat thickness. For this 
calculation all piglets born to sows from either the control or fat 
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supplemented groups, which were not selected for tissue sampling at 6 
months of age, were used.   
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Table 4.1 Outline of groups that were compared in this chapter 
 C (L ) 
1 week 
C (M) 
1 week 
C (L) 
6 months 
C (M) 
6 months 
FS (L) 
1 week 
FS (M) 
1 week 
FS (L) 
6 months 
FS (M) 
6 months 
C (L ) 
1 week 
n/a Yes 
(weight) 
No No Yes 
(diet) 
No No No 
C (M) 
1 week 
Yes 
(weight) 
n/a No No No Yes 
(diet) 
No No 
C (L) 
6 months 
No No n/a Yes 
(weight) 
No No Yes 
(diet) 
No 
C (M) 
6 months 
No No Yes 
(weight) 
n/a No No No Yes 
(diet) 
FS (L) 
1 week 
Yes 
(diet) 
No No No n/a Yes 
(weight) 
No No 
FS (M) 
1 week 
No Yes 
(diet) 
No No Yes 
(weight) 
n/a No No 
FS (L) 
6 months 
No No Yes 
(diet) 
No No No n/a Yes 
(weight) 
FS (M) 
6 months 
No No No Yes 
(diet) 
No No Yes 
(weight) 
n/a 
Yes (weight) = Groups that have the same maternal diet but were in different birth weight categories (L = Low-birth weight; M = Median-birth weight) can be compared to 
examine the effect of birth weight; Yes (diet) = Groups that have different maternal diets (C = control; FS = Fat supplemented) but were in the same birth weight category 
were compared to determine the effect of maternal diet. 
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4.3 Results 
4.3.1 Sex ratio  
Unfortunately, sex was not equally distributed amongst dietary groups 
(Table 4.2). This was due to the method of the piglet selection process 
(See Chapter 2; Section 2.31) which resulted in uneven sex distribution in 
the control group, with more female piglets selected for sampling at 1 
week of age then males (Table 4.2). This occurred because, in this group 
despite sex distribution being equal amongst the litter (Chapter 3; Table 
3.8), females tended to have a lower birth weight (Chapter 3; Table 3.8), 
with a higher proportion of female piglets weighing less than 800 g 
(Chapter 3; Figure 3.5.a). In addition to this, in this group, male piglets 
that were of low-birth weight had a decreased survival rate when 
compared to their female, low-birth weight litter mates (Chapter 3; Table 
3.9). These factors meant that, on most occasions, the low-birth weight 
piglet selected for sampling at 1 week of age was more likely to be female 
than male (Table 4.2). The median-birth weight piglets that were then 
selected were matched for sex with these animals (Table 4.2). In this 
control group, there were more male piglets between the birth weight 
categories of 801-1000 g (Chapter 3; Figure 3.5.a), meaning that when 
piglets were selected for sampling at 6 months of age the next lowest birth 
weight piglet was usually within this category and therefore, was more 
likely to be male. This meant that there were more male piglets selected in 
this group, with a lower number of females (Table 4.2).  
 
In the fat supplemented group, there was a higher ratio of male piglets to 
female piglets within the litters (Chapter 3; Table 3.8). This meant that 
although, as with the control group, there were a higher proportion of low-
birth weight females (Chapter 3; Figure 3.5.b) and the males had a slightly 
higher risk of postnatal mortality (Chapter 3; Table 3.9), sex ratio was 
fairly balanced between the groups of piglets that were selected for 
sampling at 1 week and 6 months of age (Table 4.2).  
 
For this chapter, except where otherwise shown, males and females were 
considered together. 
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Table 4.2 Sex ratio of piglets selected for tissue and plasma sampling 
  Number of males Number of females 
  Low-birth 
weight 
Median-birth 
weight 
Low-birth 
weight 
Median-birth 
weight 
C 1 week 1 1 7 7 
6 month 6 6 2 2 
FS 1 week 4 5 4 3 
6 month 3 5 5 3 
C = Control; FS = Protein supplemented 
 
4.3.2 Body weight and accelerated growth 
Despite there being no significant difference in body weight at 6 months, 
between male and female pigs, or with fat supplementation (Table 4.3), 
male piglets that had been castrated tended to have increased back fat 
thickness at 6 months of age when compared to their female litter mates 
(Table 4.3). However, back fat thickness of the offspring, measured at 6 
months of age, was unaffected by maternal fat supplementation 
throughout pregnancy (Table 4.3). In addition, back fat thickness was not 
correlated with offspring growth rate from birth to 6 months (C: r=0.17, 
P=0.30; FS: r=-0.46, P=0.75).  
 
Table 4.3 Body weight and back fat thickness at 6 months of age in piglets not 
selected for tissue sampling 
 C FS 
 Females Males Females Males 
BW at 6 months (Kg) 116.10±0.73 113.97±0.88 114.69±0.73 116.14±0.71 
Back fat (mm) 14.51±0.55 17.73±0.94* 13.67±0.45 15.85±0.49* 
Values are means ± SEM for control (C; n=8) and fat supplemented (FS; n=8) gestational 
groups; Data was statistically tested for each gestational group using unpaired T-tests 
between the male and female piglets, differences are: *P<0.05; BW = Body weight 
 
Birth weight of piglets selected for tissue sampling was not different 
between dietary groups at 1 week or 6 months of age (Table 4.4). 
However, due to the study design, birth weight of piglets selected at 1 
week of age was often lower than that of piglets selected at 6 months of 
age (Table 4.4). In accordance with the study design, low-birth weight 
piglets weighed significantly less than the median-birth weight piglets at 1 
week of age (Table 4.4). However, by 9 weeks of age, there was no 
significant difference in body weight between the low and median-birth 
weight piglets selected for sampling (Table 4.4), this continued to 6 
months of age. This is due to accelerated growth in the low-birth weight 
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animals, demonstrated by strong negative correlation between birth weight 
and growth rate to 6 months of age, in both control and fat supplemented 
gestational groups (Figure 4.2). 
 
Table 4.4 Birth weight, body weight at 9 weeks of age and body weight at 
euthanasia in piglets sampled at 1 week and 6 months of age 
   Birth weight  
(Kg) 
BW at 9 weeks 
(kg) 
BW at euthanasia 
(Kg) 
C 1 week Low  
(n=8) 
0.72±0.07 n/a 1.12±0.13 
Median  
(n=8) 
 1.25±0.06* n/a  2.13±0.13* 
6 
month 
Low  
(n=7) 
0.99±0.07 22.44±0.93 115.21±5.92 
Median  
(n=7) 
 1.37±0.05* 24.77±1.46 120.14±3.27 
FS 1 week Low 
(n=8) 
0.90±0.07 n/a   1.65±0.20** 
Median 
(n=8) 
 1.27±0.12* n/a  2.61±0.25* 
6 
month 
Low  
(n=7) 
1.05±0.10 23.85±2.23 115.86±5.06 
Median  
(n=7) 
 1.38±0.05* 27.33±2.20 125.86±4.81 
Values are means ± SEM for control (C) and fat supplemented (FS) gestational groups; Data 
was statistically tested at 1 week and 6 months using unpaired T-tests between the low and 
median-birth weight piglets and differences are: *P<0.05; In addition, differences between C 
and FS, low or median groups are denoted by: ** P<0.05 (T-test); BW = Body weight 
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Figure 4.2 Relationship between piglet birth weight and fractional growth rate (FGR) to 6 months of age in piglets born to sows fed (a) the control 
(n=8) (r=-0.92; P<0.001) or (b) the fat supplemented (n=8) (r=-3JHVWDWLRQDOGLHW3HDUVRQ¶VFRUUHODWLRQFRHIILFLHQW 
a) b) 
111 
 
4.3.3 Plasma analysis 
Plasma concentrations of glucose, TAG, NEFA, and cholesterol, were raised 
at 1 week, when compared to samples taken at 6 months of age (Table 
4.5). Maternal fat supplementation did not affect plasma metabolite 
concentrations in the offspring, at either 1 week or 6 months of age (Table 
4.5). Plasma metabolite concentrations were unaffected by birth weight, 
except cholesterol, which was raised at 1 week in the low-birth weight 
offspring born to control diet fed mothers (Table 4.5). Concentrations were 
then decreased in comparison to the median-birth weight piglets by 6 
months of age (Table 4.5).  
 
Maternal dietary supplementation with fat did not affect fasting plasma 
insulin concentrations (µg/ml) in offspring at 6 months of age (Low: C: 
0.16±0.03; FS: 0.15±0.03; Median: C: 0.22±0.08; FS: 0.22±0.08). 
Unfortunately, low and median-birth weight piglets could not be compared 
as due to the number of samples, they were analysed on separate 96-well 
plates, with two different insulin kits. When inter-assay variation was 
determined with one sample on both plates the CV was large (16.3 %) and 
so therefore, it would not be appropriate to compare these groups. 
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Table 4.5 Fasted plasma concentrations of glucose, triglycerides (TAG), 
nonesterified fatty acids (NEFA) and cholesterol in low and median-birth weight 
piglets, sampled at 1 week and 6 months of age 
   Glucose 
(mM) 
TAG 
(mM) 
NEFA 
(mM) 
Cholesterol 
(mM) 
C 1 week Low 
(n=7) 
7.52±0.40 3.64±0.71 1.18±0.15 4.77±0.34 
Median 
(n=8) 
7.97±0.23 3.16±0.58 0.99±0.11 3.60±0.36* 
6 month Low 
(n=8) 
4.22±0.47 1.14±0.22 0.96±0.14 2.36±0.37 
Median 
(n=8)  
4.71±0.41 1.26±0.09 0.94±0.15 3.16±0.08* 
FS 1 week Low 
(n=8) 
7.37±0.46 4.12±1.27 1.14±0.24 4.39±0.34 
Median 
(n=8) 
8.14±0.45 3.78±0.96 1.17±0.32 4.17±0.18 
6 month Low 
(n=8) 
4.23±0.31 1.51±0.12 0.79±0.17 2.94±0.11 
Median 
(n=8) 
4.28±0.24 1.10±0.22 0.98±0.18 2.06±0.48 
Values are means ± SEM for control (C) and fat supplemented (FS) gestational groups; Data 
was statistically tested at 1 week and 6 months using Mann-Whitney tests between the low 
and median-birth weight piglets and differences are: *P<0.05 
 
4.3.4 Liver analysis 
4.3.4.1 Liver weight and composition 
Maternal fat supplementation had no effect on the liver weight or liver fat 
and glycogen content of offspring at 1 week or 6 months of age (Table 
4.6). It was not possible to measure liver glycogen content at 6 months of 
age as these animals were fasted over night and so glycogen content was 
below the level of detection and therefore, could not be measured on the 
standard curve. As would be expected, low-birth weight piglets had smaller 
livers than median-birth weight piglets (Table 4.6). However, when liver 
weight was assessed as a proportion of body weight, there were no birth 
weight differences (Table 4.6). By 6 months, liver weight was similar 
between low and median-birth weight piglets (Table 4.6); this corresponds 
to the similarity in body weight of these animals seen at this time (Table 
4.4). There was no relationship between piglet birth weight and liver TAG 
or glycogen content at 1 week or 6 months of age in the control or fat 
supplemented groups (Table 4.6). 
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Table 4.6 Liver weight, triglyceride (TAG) and glycogen content in piglets at 1 
week and 6 months of age 
   Liver weight 
(Kg) 
Liver weight 
(% of BW) 
Liver TAG 
(mg/g) 
Liver glycogen 
(mg/g) 
C 1 week Low  
(n=8) 
0.05±0.008 4.41±0.40 1.98±0.40 75.8±19.6 
Median 
(n=8) 
 0.10±0.008* 4.82±0.19 1.17±0.37 91.8±13.8 
6 month Low  
(n=8) 
2.48±0.12 2.11±0.10 0.84±0.17 - 
Median 
(n=8)  
2.51±0.12 2.03±0.06 0.97±0.18 - 
FS 1 week Low  
(n=8) 
0.07±0.010 4.42±0.25 1.25±0.40 92.7±17.9 
Median 
(n=8) 
 0.12±0.008* 4.53±0.23 0.80±0.11 50.2±16.9 
6 month Low  
(n=8) 
2.44±0.12 2.11±0.07 0.95±0.22 - 
Median 
(n=8) 
2.56±0.10 2.07±0.05 0.60±0.14 - 
Values are means ± SEM for control (C) and fat supplemented (FS) gestational groups; Data 
was statistically tested at 1 week and 6 months using Mann-Whitney tests between the low 
and median-birth weight piglets and differences are: *P<0.01; BW = Body weight 
 
4.3.4.2 Liver gene expression 
*HQHH[SUHVVLRQRI*5ǃ-+6'33$5ĮDQG,5LQWKHSLJOHWOLYHUDW
week and 6 months of age was unaffected by maternal fat 
supplementation and offspring birth weight (Figure 4.3, 4.4, 4.5 and 4.7).  
 
FABP1 liver mRNA expression was increased at 1 week of age in median-
birth weight piglets born to sows fed a control diet when compared to 
those fed fat supplemented gestational diets (Figure 4.6). However, by 6 
months of age, fat supplementation or weight at birth had no effect on 
gene expression (Figure 4.6).    
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Figure 4.3 Liver Glucocorticoid receptor (GR) mRNA expression in low  and median  birth weight piglets, born to sows fed control (C; n=8) or fat 
supplemented (FS; n=8) gestational diets, sampled at (a) 1 week and (b) 6 month of age; Relative quantification of GR mRNA using the genorm 
strategy; 18S, ribosomal phosphoprotein (RPO) and cyclophylin were used as housekeeping genes, and results are given in arbitrary units; Values are 
means ± SEM 
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Figure 4.4 Liver 11beta-Hydroxysetroid DHK\GURJHQDVH W\SH ǃ-HSD1) mRNA expression in low  and median  birth weight piglets, born to 
sows fed control (C; n=8) or fat supplemented (FS; n=8) gestational diets, sampled at (a) 1 week and (b) 6 month of age; Relative quantification of 
ǃ-HSD1 mRNA using the genorm strategy. 18S and cyclophylin were used as housekeeping genes, and results are given in arbitrary units. Values are 
means ± SEM 
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Figure 4.5 Liver Peroxisome proliferator-DFWLYDWHGUHFHSWRUDOSKD33$5Į LQ ORZ  and median  birth weight piglets, born to sows fed control (C; 
n=8) or fat supplemented (FS; n=8) gestational diets, sampled at (a) 1 week and (b) 6 month of age; Relative quantification oI33$5ĮP51$XVLQJWKH
genorm strategy; 18S and cyclophylin were used as housekeeping genes, and results are given in arbitrary units; Values are means ± SEM 
a) b) 
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Figure 4.6 Liver Fatty acid-binding protein 1 (FABP1) mRNA expression in low  and median  birth weight piglets, born to sows fed control (C; n=8) 
or fat supplemented (FS; n=8) gestational diets, sampled at (a) 1 week and (b) 6 month of age; Relative quantification of FABP1 mRNA using the 
genorm strategy; 18S, ribosomal phosphoprotein (RPO) and cyclophylin were used as housekeeping genes, and results are given in arbitrary units; 
Values are means ± SEM; Statistical differences between C and FS groups are denoted by ** P<0.05 (T-Test) 
a) b) 
** 
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Figure 4.7 Liver Insulin receptor (IR) mRNA expression in low  and median  birth weight piglets, born to sows fed control (C; n=8) or fat 
supplemented (FS; n=8) gestational diets, sampled at (a) 1 week and (b) 6 month of age; Relative quantification of IR mRNA using the genorm 
strategy; 18S, ribosomal phosphoprotein (RPO) and cyclophylin were used as housekeeping genes, and results are given in arbitrary units; Values are 
means ± SEM 
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4.4 Discussion 
4.4.1 Maternal fat supplementation and offspring development 
In rats, feeding a high-fat diet throughout pregnancy, has been 
demonstrated to produce offspring with a greater risk of developing 
metabolic complications such as obesity, hyperlipidemia, hypertension, 
impaired glucose tolerance and insulin resistance by 6 months to a year of 
age (Khan et al., 2003, Khan et al., 2005, Taylor et al., 2005). These 
conditions are characterised by an increase in abdominal fat mass, raised 
plasma TAG, glucose and insulin concentrations, and an increase in liver 
triglyceride content in the offspring (Khan et al., 2003, Khan et al., 2005, 
Taylor et al., 2005), often by the time of weaning (Guo and Jen, 1995).  
 
Previously, this study has demonstrated reduced maternal glucose 
tolerance at term and increased postnatal mortality with moderate, dietary 
fat supplementation (Chapter 3). In humans, reduced glucose tolerance 
during pregnancy has been linked with a higher risk of obesity and insulin 
resistance in the offspring (Boney et al., 2005, Franks et al., 2006).  
 
This study was the first in pigs to investigate the effects of maternal fat 
supplementation throughout pregnancy on growth and development of the 
offspring, and in contrast, did not show any differences in body weight or 
fat mass at 1 week or 6 months of age. However, fat mass in these 
animals was only measured as back fat thickness and the deposition of fat 
in other fat depots was not measured. Often in the high-fat, rat studies, 
the area of fat that was increased was the abdominal fat (Buckley et al., 
2005, Khan et al., 2005, Taylor et al., 2005), thus accounting for the 
overall increase in fat mass and potentially explaining why no differences 
were seen in this study. However, in addition, maternal fat 
supplementation had no affect on plasma glucose, TAG, NEFA, cholesterol 
or insulin levels in the offspring. Similarly, no differences were detected in 
liver TAG content; suggesting that in this study, maternal fat intake during 
pregnancy had no effect on offspring metabolism. 
 
In order to elucidate the mechanisms behind the effects of maternal fat 
supplementation in rats, it was hypothesised that they may be due to 
perturbed GC metabolism, similar to the effects demonstrated by feeding a 
low-protein diet or nutrient restricting mothers during pregnancy (Bertram 
et al., 2001, Whorwood et al., 2001), although to date, no studies have 
120 
 
tested this hypothesis. These offspring demonstrated an increase in gene 
expression of GR in tissues such as the liver and lungs, and a reduction in 
ǃ-HSD2 in tissues such as the kidney. This hypothesis was further 
supported by studies which demonstrated an increase in plasma GC when 
a high-fat diet is consumed (Pascoe et al., 1990, Tannenbaum et al., 1997, 
Taylor et al., 2003).  
 
As would be expected, due to the lack of difference between fat mass, 
plasma profile, and TAG content of the liver, this study demonstrated no 
difference in GC sensitivity in offspring born to fat supplemented sows. 
This was concluded as there was no difference in gene expression of GR or 
11ǃ-HSD1 in the livers of these animals. It was not possible to measure 
expression of ǃ-HSD2 mRNA in the livers of these offspring, as it is 
expressed at such low levels. In addition, expression of genes involved in 
OLSLG PHWDEROLVP VXFK DV 33$5Į DQG DOVR genes involved in insulin 
sensitivity in the liver such as the insulin receptor, were unaffected by 
maternal diet.       
 
FABPs are the most abundant proteins in the cytosol of cells and play an 
important role in fatty acid uptake, oxidation and storage (Chapter 1; 
Section 1.7.2.2) (Atshaves et al., 2010). At 1 week of age mRNA 
expression of FABP1 was increased in the median-birth weight offspring, 
born to sows that were fed the control diet, in comparison to those who 
were fat supplemented. The reason for this could be that it is a normal up-
regulation of gene expression, caused by commencement of suckling in 
order to allow the offspring to take up and process the increase in 
circulating lipids through milk digestion. This is supported by Gordon et al. 
(1985) who demonstrated an increase in liver and intestinal FABP1 mRNA 
expression during the first 24 hours after birth in rats (Figure 4.8). It is 
possible that those offspring born to sows that were fat supplemented 
throughout gestation do not show the same up-regulation as they are 
already adapted to a high-fat diet. However, it is unclear as to why this 
expression pattern is only demonstrated in the median-birth weight piglets 
and not those of low-birth weight. In agreement with the expression 
profiles of other genes tested, by the age of 6 months, piglet FABP1 was 
unaffected by maternal fat supplementation. 
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Figure 4.8 Developmental regulation of liver FABP (FABP1) mRNA accumulation in 
the liver (solid line) and small intestine (dashed line) of rats (Gordon et al., 1985)   
 
Aside from the obvious species differences, there are a number of potential 
reasons for the contrasting outcomes demonstrated between this study 
and previous rat studies, which are outlined below. 
 
4.4.1.1 Fatty acid composition of supplemented diets  
The type of fat which is used to supplement the maternal diet is crucial in 
determining the outcome on the offspring and one reason for the 
contrasting results between study outcomes could be due to the different 
type of fat used. In most rat studies the high-fat diet is prepared through 
the addition of lard, which is high in saturated fatty acids (Chapter 1; 
Section 1.6.1.3) (Khan et al., 2003, Taylor et al., 2003, Taylor et al., 
2005). This is probably because diets high in saturated fat have been 
demonstrated, in both humans and rats, to be detrimental to health by 
increasing the risk of obesity, reducing insulin sensitivity, and increasing 
the risk of cardiovascular disease (Maron et al., 1991, Parker et al., 1993, 
Guo and Jen, 1995, Hu et al., 1999, Taylor et al., 2003). In agreement 
with this, studies investigating the effects of fat supplementation on 
growing-finishing pigs (20 to 100 Kg), which used fat from animal sources 
that were high in saturated fat, demonstrated that fat supplementation, by 
as little as 5 to 6 percent of the pig diet, results in increased daily weight 
gain to feed ratio, although this also correlates with an unfavourable 
increase in back fat thickness of these animals (Stahly and Cromwell, 
1979, De la Llata et al., 2001). 
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In contrast to rat studies, investigations into the effects of additional fat 
supplementation in the diet of pregnant sows tended to use fat sources 
that were rich in polyunsaturated fatty acids, such as corn oil and soy bean 
oil (Chapter 1; Section 1.6.1.3) (Seerley et al., 1974, Boyd et al., 1978, 
Seerley et al., 1981, Azain, 1993), and so potentially providing a link 
between the differential findings observed. Diets with a high ratio of 
polyunsaturated fatty acids, such as linoleic and linolenic acid, to saturated 
fatty acids, have been demonstrated to provide beneficial health effects, 
such as reducing cardiovascular disease risk in humans (Hu et al., 1999, 
Siscovick et al., 2000), perhaps due to their mechanism of lowering plasma 
cholesterol levels (Hegsted et al., 1965, Mattson and Grundy, 1985). This 
is further supported by another study which demonstrated that diets high 
in saturated fat produce the most severe insulin resistance  in rats and, 
supplementation with fish oils, which are high in omega-3 fatty acids, has 
been shown to completely alleviate this effect (Storlien et al., 1987). In 
addition, dietary supplementation of growing pigs with linoleic acid has also 
been shown to be beneficial by reducing obesity, shown by a reduction in 
back fat, and also results in an increase in daily weight gain to feed ratio 
(Ostrowska et al., 1999), this has also been demonstrated in mice (West et 
al., 1998).  
 
This study used palm oil, which has an equal ratio of saturated to 
unsaturated fatty acids (Chapter 1; Section 1.6.1.3), to supplement the 
diet of the sows. Therefore, this could potentially be a factor to explain 
why no detrimental effects were seen in the piglets in terms of increased 
back fat or glucose and lipid homeostasis.  
 
4.4.1.2 Severity and timing of nutritional manipulation 
Another factor which may explain the difference in outcomes between this 
investigation and the rat high-fat feeding studies is the severity of the 
nutritional manipulation, which in the rats is much more severe. This has 
previously been discussed in Chapter 3; Section 3.4.1. In addition, as 
previously mentioned (Chapter 3; Section 3.4.1), the high energy content 
of the rat diets, and the low starch ratio of the fat-supplemented diets in 
this study, may also play a role the outcome in the offspring. Therefore, it 
could be the reduced protein intake of the fat-fed dams during gestation, 
due to a reduction in food intake that may result in the programming 
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effects demonstrated on the offspring. This would further explain why the 
phenotype of the offspring is similar to that of those born to mothers who 
consumed a low-protein diet throughout pregnancy. In this study, protein 
intake remained the same between the control and fat supplemented 
mothers and so could explain why no detrimental effects were seen in 
these offspring.    
 
The period of nutritional intervention in the majority of the rat studies 
persisted throughout gestation and lactation (Guo and Jen, 1995, Khan et 
al., 2003, Khan et al., 2005, Taylor et al., 2005). Pups were then weaned 
onto a standard chow diet, usually containing around 5 percent fat. This 
period was longer than demonstrated in this study, where, at 110 days of 
gestation, the intervention stopped and all sows received the same diet 
until piglets were weaned. As previously discussed, in this study, maternal-
fat supplementation had no effect on the composition of the sow¶V milk 
during lactation (Chapter 3). It could be that fat supplementation of the 
maternal diet during the gestation and lactation period may have a more 
significant effect on the programming of the offspring than feeding a high-
fat diet during the gestation period alone. This is demonstrated by Khan et 
al. (2005) who showed that endothelial function in rats was most severely 
compromised in those offspring born to dams who consumed a fat-rich diet 
during the lactation period alone. This may be due to an effect of fat 
supplementation on increasing milk yield and fat content (Seerley et al., 
1974, Pettigrew, 1981).  
 
4.4.1.3 Sex and age of offspring sampled 
Most rat studies which have demonstrated that maternal fat-rich diets 
leads to the programming of hypertension and reduced glucose tolerance 
have only demonstrated these effects in female offspring (Khan et al., 
2003, Khan et al., 2005, Taylor et al., 2005). Results from this study 
contain data from both male and female offspring as there was no 
significant difference between outcomes in males and females. This lack of 
significance may reflect the reduced number of animals, especially males, 
in some of the groups. In addition, when you consider females by 
themselves, there are no differences between piglets from the control and 
fat supplemented maternal groups. However, this study was not powered 
to investigate sex differences and so it is possible that more animals per 
group would be required to see such differences. 
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This study investigated the offspring at 1 week and 6 months of age. Gilts 
generally reach puberty at around 6 to 7 months of age (Bazer et al., 
2001). In boars pubertal development begins around 3 months of age, and 
sperm production is maximal around 2 years of age (Bazer et al., 2001). 
Therefore, sampling the pigs at 6 months of age is the equivalent to the 
beginning of adolescence in humans. This time point for tissue sampling 
was chosen because in the pig industry, 6 months coincides with the time 
that these animals are nearing/or have reached their optimal slaughter 
weight of around 110-115 Kg (McGlone et al., 2001). Therefore, piglet 
development and body composition up until this time is crucial.    
 
Studies in rats which have shown significant programming effects of high-
fat feeding during gestation have investigated the offspring at 6 months or 
1 year of age (Khan et al., 2003, Khan et al., 2005, Taylor et al., 2005). In 
contrast to pigs and humans, development in rats is much faster as they 
have a much shorter life-span, around 2.5 to 3 years in captivity (Anne, 
2010). By the age of 6 weeks, rats are sexually mature (Anne, 2010).  This 
means that this sampling period of 6 months and 1 year is equivalent to 
around 18 and 30 years of age in a human (Anne, 2010), which is much 
later than in this study, possibly providing another factor to explain the 
difference in outcomes between studies.   
 
4.4.1.4 Link to piglet mortality 
Chapter 3 of this thesis has already described how maternal fat 
supplementation throughout pregnancy decreased sow glucose tolerance at 
term and increased offspring postnatal mortality. This may provide an 
important explanation as to why no programming effects were observed 
between offspring born to control or fat supplemented mothers. It is 
possible that those piglets that were more severely affected by maternal 
fat supplementation died within a few hours after birth. This phenomenon 
is not seen in the rat studies, where increases in offspring mortality are not 
noted with high-fat feeding (Guo and Jen, 1995, Khan et al., 2003, Taylor 
et al., 2003, Buckley et al., 2005, Khan et al., 2005, Taylor et al., 2005).  
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4.4.2 The effects of accelerated postnatal growth in low-birth 
weight animals 
In the pig industry, a high postnatal growth rate is encouraged and, after 
weaning, piglets are separated by weight and fed in order to achieve the 
optimal slaughter weight and body composition in the shortest time 
possible (McGlone et al., 2001).  This commercial husbandry practice was 
used in this study. However, often the low-birth animals grow less 
efficiently, and are more likely to produce a carcass with a higher 
proportion of fat than their larger birth weight piglets (Powell and Aberle, 
1980, Gondret et al., 2006).  
 
This study has observed a relative increase in growth rate of low-birth 
weight infants so that, by the age of 9 weeks, there was no significant 
difference in body weight between low and median-birth weight animals. 
However, in contrast to what might have been expected, a higher growth 
rate was not associated with an increase in back fat thickness in these 
animals. However, measuring body fat by examining back fat thickness 
may not be the best indicator of fat mass and carcass composition in pigs. 
This is supported by Powell and Aberle (1980), who demonstrated that 
often back fat thickness is unchanged between piglets of different birth 
weights at slaughter, but these animals may show increased lipid in the 
muscle, demonstrated by a higher marbling score. Therefore, the piglets in 
this study may have adverse effects of rapid postnatal growth but it is 
possible that this is not reflected in terms of back fat thickness.      
 
Low-birth weight and accelerated postnatal growth has also been linked to 
a higher risk of obesity and metabolic complications in later life in the 
human population (Erikson et al., 2000, Forsen et al., 2000, Hales and 
Barker, 2001). Similarly, maternal nutrient restriction in rats produces low-
birth weight offspring with similar detrimental metabolic outcomes 
including hypertension and reduced glucose tolerance (Langley-Evans et 
al., 1996, Langley-Evans et al., 1999, Bertram et al., 2001,). Therefore, it 
was hypothesised that the low-birth weight piglets would be at increased 
risk of obesity and show increased GC sensitivity than their median-birth 
weight litter mates. However this was not demonstrated to be the case, 
with no differences between low and median-birth weight offspring in any 
of the variables tested.  
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4.4.3 Conclusions  
This was the first study in pigs to investigate the programming effects of a 
fat supplemented maternal diet during gestation, and demonstrated no 
effects on offspring growth or liver metabolism up to 6 months of age. 
These results are in contrast to those studies which have fed high-fat diets 
to rats and demonstrated significant programming effects on the offspring, 
such as increased fat mass, reduced glucose tolerance and hypertension 
(Khan et al., 2003, Khan et al., 2005, Taylor et al., 2005). This was 
surprising considering that it has previously been demonstrated that fat 
supplementation reduced maternal glucose tolerance and increased the 
rate of offspring postnatal mortality (Chapter 3). 
 
In addition, this study has not demonstrated any negative effects of 
accelerated postnatal growth which was encouraged through husbandry 
practice. By 6 months of age the low-birth weight piglets had reached the 
same body weight as their litter mates, but with no increases in back fat 
thickness or GC sensitivity as might have been expected. Future work will 
determine whether there are more subtle differences in carcass quality 
through analysis of the muscle composition. This could have important 
implications on the normal commercial practice in the pig industry of 
encouraging rapid growth by grouping pigs based on their body weights at 
weaning.    
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 Chapter 5 - The effect of maternal protein 
supplementation on offspring development 
 
5.1 Introduction 
5.1.1 Low-protein maternal diets 
Maternal protein restriction has been demonstrated in the rat to reduce 
offspring birth weight and programme offspring to have a greater risk of 
developing metabolic complications such as obesity, hypertension and 
insulin resistance in later life (Chapter 1; Section 1.2) (Langley-Evans et 
al., 1996, Langley-Evans et al., 1999, Bertram et al., 2001, Ehruma et al., 
2007). The mechanism behind this is thought to be due to a reduction in 
SODFHQWDOǃ-K\GUR[\VWHURLGGHK\GURJHQDVHǃ-HSD) 2, which normally 
serves to protect the fetus from overexposure to maternal glucocorticoids 
(GC) (Chapter 1; Section 1.2.1) (Langley-Evans et al., 1996, Langley-
Evans et al., 1999, Bertram et al., 2001). Consequently, the fetus is 
exposed to excess maternal GC which in turn, increases the offspring¶V 
sensitivity to GC at a tissue specific level by increasing the gene expression 
of GC receptor (GR) DQG ǃ-+6' DQG GHFUHDVLQJ H[SUHVVLRQ RI ǃ-
HSD2 (Chapter 1; Section 1.2.1) (Bertram et al., 2001). Similar outcomes 
have also been demonstrated through global maternal under-nutrition in 
the sheep model, although differences in offspring birth weight were not 
observed (Whorwood et al., 2001). 
 
5.1.2 Maternal protein supplementation 
In the Western World, dietary protein intake exceeds the recommended 
levels, especially amongst young people (Rolland-Cachera et al., 2000). It 
is therefore, crucial to investigate the impacts of high-protein maternal 
diets on fetal programming. Following on from the low-protein studies, it is 
conceivable that increasing the protein ratio in the maternal diet may have 
beneficial effects on the offspring. However, this appears to not be the 
case although investigations into the influence of protein supplementation 
during pregnancy are limited, with conflicting outcomes between studies 
(Chapter 1; Section 1.4.1).  
 
This study has previously demonstrated that maternal protein 
supplementation throughout pregnancy in the sow, increases offspring 
postnatal mortality with no effects on piglet birth weight (Chapter 3). 
Conversely, in rats, a reduction in offspring birth weight, similar to that 
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observed with protein restriction, has been demonstrated when dams were 
fed an isocaloric, high-protein diet (40 %) throughout gestation (Daenzer 
et al., 2001). These offspring showed accelerated postnatal growth and by 
the age of 9 weeks had increased fat mass in comparison to those born to 
mothers fed an adequate amount of protein (20 %) during gestation 
(Daenzer et al., 2001). In contrast, other rat studies have not seen any  
effects of maternal protein supplementation on offspring birth weight 
(Zimanyi et al., 2002, Thone-Reineke et al., 2000), but have shown an 
increase in blood pressure of the male pups by 4 weeks of age (Thone-
Reineke et al., 2006).  
 
As yet, no studies have demonstrated the effects of increased dietary 
protein content on GC sensitivity in the offspring to examine whether it 
mimics the effects of maternal protein restriction. This is probably due to 
the contrasting results of protein supplementation in both humans and rats 
(Mathews et al., 1999, Daenzer et al., 2001, Zimanyi et al., 2002, Kramer 
and Kakuma, 2003, Thone-Reineke et al., 2006). In addition, to date, 
there are currently no investigations into the effects of maternal protein 
supplementation on piglet development.  
 
5.1.3 Aims and hypothesis 
In summary, consuming a low-protein diet throughout gestation is 
associated with a reduction in birth weight and an increased risk of 
metabolic disease in the offspring (Langley-Evans et al., 1996, Langley-
Evans et al., 1999, Bertram et al., 2001, Ehruma et al., 2007). At present, 
there are conflicting results to demonstrate the effects of high-protein diets 
during pregnancy (Mathews et al., 1999, Daenzer et al., 2001, Zimanyi et 
al., 2002, Kramer and Kakuma, 2003, Thone-Reineke et al., 2006). To 
date, no studies have investigated the effects of an increased protein 
intake on GC sensitivity or metabolism in the offspring. 
 
This study has previously described how maternal protein supplementation 
of sows, by the addition of protein sources which were rich in arginine and 
glutamine, increased neonatal mortality (Chapter 3). The present chapter 
will focus on the effects of protein supplementation throughout pregnancy 
on the programming of piglet development until 6 months of age, 
particularly focussing on GC sensitivity to determine whether protein 
supplementation has similar or contrasting effects to the protein restricted 
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rat model. For this the liver was investigated, due to its importance in 
whole body energy balance and metabolism, and also because previous 
VWXGLHV KDYH GHPRQVWUDWHG GLIIHUHQFHV LQ *5 DQG ǃ-HSD1 gene and 
protein expression in this tissue with protein or nutrient restriction 
(Bertram et al., 2001, Whorwood et al., 2001).  
 
As protein supplementation had no effects on average birth weight 
(Chapter 3) it was hypothesised that there would be no subsequent 
differences in body weight or growth rate of these piglets. It has previously 
been demonstrated that low-birth weight piglets grow at a faster rate than 
their median-birth weight piglets and so by 6 months of age are of a 
similar body weight (Chapter 4). This practice is encouraged in the pig 
industry by grouping of piglets according to body weight and encouraging 
growth accordingly (Chapter 4) (McGlone et al., 2001). It is hypothesised 
that this accelerated postnatal growth will also be demonstrated in those 
low-birth weight piglets born to protein supplemented sows.  
 
As previously described, low-birth weight offspring often have increased 
risk of obesity and metabolic complications, due to accelerated postnatal 
growth (Erikson et al., 2000, Forsen et al., 2000, Hales and Barker, 2001). 
In addition, metabolic complications in offspring born to protein restricted 
mothers, is accompanied by a reduction in birth weight followed by 
accelerated growth (Langley-Evans et al., 1996, Langley-Evans et al., 
1999, Bertram et al., 2001). Therefore it is hypothesised that the low-birth 
piglets born to protein supplemented sows will be at increased risk of 
developing metabolic complications in later life, similar to those effects 
demonstrated with protein restriction. These offspring may have increased 
fat mass, demonstrated by an increase in back fat thickness. Insulin 
sensitivity may be reduced and so plasma insulin, glucose and triglycerides 
(TAG) will be increased, possibly with a reduction in gene expression of 
insulin receptor (IR). In addition, these piglets will show increased GC 
sensitivity in their liver, demonstrated by a higher mRNA expression of GR 
DQG ǃ-HSD1 in the low-birth weight, protein supplemented group. 
However, an increase in circulating plasma cortisol is not expected in these 
animals. In addition there will be an increase in liver triglycerides with a 
reduction in genes involved in fatty acid oxidation and uptake such as 
Peroxisome proliferator-DFWLYDWHG UHFHSWRU DOSKD 33$5Į DQG )DWW\ DFLG-
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binding protein 1 (FABP1). It is further hypothesised that median-birth 
weight offspring will be unaffected by maternal protein supplementation. 
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5.2 Methods 
5.2.1 Method overview 
A full description of the study design and laboratory protocols is described 
in Chapter 2. Briefly, one low and one median-birth weight piglet in each 
litter born to sows fed either the control or protein supplemented 
gestational diets were selected for tissue sampling at 1 week ± 2 days and 
6 months of age. Plasma and liver tissue samples were taken and 
processed as described in Chapter 2, Section 2.3.1. Plasma was auto-
analysed for glucose, nonesterified fatty acids (NEFA), TAG and cholesterol 
as described in Chapter 2, Section 2.4. In addition, fasting plasma insulin 
concentrations were determined at 6 months of age by Dr Hernan P. 
Fainberg (Chapter 2; Sections 2.4.5). Liver samples were analysed for lipid 
and glycogen content as described in Chapter 2, Section 2.5. Glycogen 
analysis was carried out by Miss Mehreen Azhar. In addition, liver gene 
H[SUHVVLRQ RI *5 ǃ-+6' 33$5Į )$%3 DQG ,5 ZDV PHDVXUHG
(Chapter 2; Sections 2.5.3-2.5.6). In pigs that were not selected for tissue 
sampling, back fat thickness was measured at 6 months of age (Chapter 2; 
Section 2.2). 
 
5.2.2 Protein extraction from frozen tissue 
Due to the significant result seen with GR gene expression between the 
median-birth weight piglets at 6 months of age (Section 5.3), total protein 
was extracted from the liver of these piglets and analysed for GR protein 
expression. In addition, in order to act as a positive control for each 
VDPSOHǃ-actin protein expression was also determined for each sample. 
Actin is expressed in all eukaryotic cells and is the major component of the 
F\WRVNHOHWRQǃ-actin is known as the cytoplasmic actin, and is expressed 
predominantly in non-muscle cells such as the liver.    
 
The extraction of cell proteins requires efficient cell lysis and protein 
solubilisation, whilst avoiding protein degradation and interference with 
protein immuno-reactivity and biological activity. For this study, we have 
used CelLyticTMMT mammalian tissue lysis/extraction reagent to enable the 
extraction of whole cell tissue proteins. The lysis buffer consists of a 
dialyzable mild detergent at a low concentration, for minimal interference 
with protein interactions and biological activity. The reagent also contains 
bicine, a buffer which is preferable for biological activity. Crude cell 
extracts contain a number of endogenous enzymes, such as proteases, 
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which are capable of degrading the proteins of interest. A protease 
inhibitor cocktail is also added to the buffer which contains inhibitors of 
these enzymes to increase the protein yield.  
 
5.2.2.1 Whole-cell lysate procedure 
Between 100±200 g of frozen liver tissue was used for this assay. To each 
100 mg of tissue 1 ml of CelLyticTMMT mammalian tissue lysis/extraction 
reagent and 5 µl of Protease Inhibitor Cocktail were added. The tissues 
were then completely disrupted using a Dispomix® closed system 
homogeniser. The homogenate was transferred to 1.5 ml sterile eppendorf 
tubes and centrifuged at 7840 g for 10 minutes at 4 °C. The supernatant 
was then transferred to a fresh 1.5 ml eppendorf tube and stored at -20 °C 
until subsequent analysis.  
 
5.2.3 Protein concentration determination 
The protein concentrations were determined using the bicinchoninic acid 
(BCA) assay (Smith et al., 1985, Wiechelman et al., 1988). The assay is 
based on changes in absorbance produced by reactions between the BCA 
reagent and the protein, resulting in a colour change in the sample from 
green to purple, proportional to the protein concentration. The benefit of 
using this assay is that it is less susceptible to interference from detergents 
and buffers used in the homogenisation of the protein sample. The BCA 
assay measures the reduction of Cu2+ to Cu+ by the amino acids cysteine, 
tryptophan and tyrosine in alkaline solutions of protein. The BCA reagent 
forms a purple complex with Cu1+, which has a strong absorbance at 562 
nm.  
 
5.2.3.1 Bicinchoninic (BCA) assay procedure 
Protein samples were diluted to 1 in 20 using 0.9 % saline to ensure 
concentrations fell within the linear range. A standard curve (0±1 mg/ml) 
was prepared using bovine serum albumin (BSA) in 0.9 % saline. Solutions 
A (1 % BCA, 2 % sodium carbonate, 0.16 % sodium tartrate and 0.4 % 
NaOH, pH 11.25 with 10 % sodium bicarbonate) and B (4 % copper 
sulphate) were prepared and a ratio of 100A:2B was mixed on the day of 
the assay. 2 µl of the correct concentration of standard or protein of the 
unknown samples was carefully pipetted into each well of a sterile 96-well 
plate and 200 µl of A: B mix added, ensuring no bubbles were formed. All 
samples were run in duplicate in order to establish intra-assay variability. 
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Plates were incubated at 37 ºC whilst being gently agitated for 30 minutes. 
Absorbance was then measured at 570 nm using the automated plate 
reader. Protein concentrations were determined following linear regression 
analysis of the standard curve and corrected for the initial dilution.  
 
5.2.4 Western blotting 
The abundance of selected proteins can be measured using sodium dodecyl 
sulphate-polyacryalmide gel electrophoresis (SDS-PAGE) (Burnette, 1981). 
During the first step the proteins are separated by their molecular weight 
using electrophoresis. After the separation, the proteins are transferred to 
a membrane (usually nitrocellulose or polyvinylidene fluoride (PVDF)) and 
detected by specific antibodies. The second antibody is conjugated with an 
enzyme and visualised using an enhanced chemiluminescence detection 
system. In order to prove the reproducibility of the assay, each Western 
blot was performed in duplicate for these studies. 
 
Sodium dodecylsulphate (SDS) is an ionic detergent which gives a negative 
charge and denatures proteins, thus allowing the complete separation of 
proteins by their molecular weight (Burnette, 1981). In addition, SDS 
binds specifically in a mass ratio of 1.4 g SDS:1 g protein. In so doing, 
SDS confers a negative charge to the polypeptide in proportion to its 
molecular weight (Burnette, 1981). It is usually necessary to reduce 
disulphate bridges before they adopt the random-coil configuration 
necessary for separation by size (Burnette, 1981), this is done by adding 
ǃ-mercaptoethanol. To ensure complete denaturation, it is also necessary 
to boil this mixture at 100 ºC for 10 minutes.  
 
Once the proteins have been denatured and are negatively charged, they 
are loaded into the wells of a polyacrylamide gel. Together with the 
samples, a reference sample and protein marker or ladder (Bio-Rad 
Laboratories Ltd. Hertfordshire, UK) are also loaded. The reference sample 
used is a single protein sample used for all gels and enables the calculation 
of intra-assay coefficient of variance. The marker is a mixture of proteins, 
with known molecular weights and is used to confirm the target protein 
size. The SDS-protein complexes are then electrophoresed, with proteins 
moving towards the anode at a rate inversely related to their molecular 
weight. The resolution of the gel depends on the concentration of the 
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acrylamide. This determines the pore size, which can increase the 
separation between lower molecular weight proteins.  
 
Proteins separated by SDS-PAGE can be transferred to a nitrocellulose or 
PVDF membrane for immunoblotting analysis. For this procedure, an 
electric current is applied to the gel so that the separated proteins transfer 
through the gel and onto the membrane in the same pattern as they 
separated on the SDS-PAGE. The efficiency of the transfer can be tested by 
staining the membrane with Ponceau S dye and the gel with Coomassie 
blue 
 
To detect a specific antigen blotted on the membrane, a primary antibody 
is added at an appropriate dilution and incubated with the membrane. To 
reduce non-specific binding, the membrane is rinsed at the end of the 
incubation in order to remove unbound or unspecific antibodies. The 
membrane is then exposed to a secondary antibody in order to detect the 
complex antibody target protein. Secondary antibodies are produced from 
a different animal species and are able to bind to the heavy chains of the 
primary antibody. In addition, the secondary antibody is commonly 
attached to a reporter enzyme such as horseradish peroxidise (HPR). 
Finally, after excess secondary antibody is washed free of the membrane, 
a chemiluminescent substrate is added which emits light upon reaction 
with the enzyme/antibody conjugate, resulting in a visible band where the 
primary antibody bound to the protein.  
 
5.2.4.1 Western blot procedure 
Gel preparation 
Polyacrylamide gels were cast using a dual gel caster. This casting system 
consists of two glass plates: a small one sits on top of the larger one with a 
gap between. Both plates were vertically assembled within the casting 
apparatus aFFRUGLQJWRWKHPDQXIDFWXUHU¶VLQVWUXFWLRQVPLQL-PROTEAN® 3 
cell, BioRad laboratories Ltd). The 12 % acrylamide resolving gel (10 ml of 
resolving gel: 3.3 ml dH2O, 4.0 ml of 30 % acrylamide-bisacrylamide 
solution, 2.5 ml 1.5M Tris (pH 8.8), 100 µl 10 % (w/v) SDS, 100 µl 10 % 
ZY DPPRQLXP SHUVXOSKDWH DQG  O 111¶1¶-
tetramethylethylenediamine (TEMED)) was poured between the plates to a 
level of 3 cm below the top. To avoid gel-oxidation and to ensure a uniform 
surface, 2 ml of water-saturated butanol was placed on top of the gel. The 
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polymerisation of the resolving gel was conducted at room temperature for 
45 minutes. After this time, the butanol was decanted and the gel surface 
rinsed with dH20 and blotted dry. Stacking gel (10 ml of stacking gel: 6.8 
ml dH2O, 1.7 ml of 30 % acrylamide-bisacrylamide solution, 1.25 ml 1.0M 
Tris (pH 6.8), 100 µl 10 % (w/v) SDS, 100 µl 10 % (w/v) ammonium 
persulphate and 4 µl TEMED) was poured on top of the resolving gel and a 
15 well comb inserted in order to produce the loading wells. This was then 
left to polymerise at room temperature for 15 minutes.  
 
The polymerised gels were transferred to a vertical electrophoresis unit 
(BioRad laboratories Ltd.). The reservoir and sample wells were filled with 
1 x running buffer (25 M Tris, 250nM Glycine and 0.1 % (w/v) SDS).  
 
Sample preparation and electrophoresis 
The protein concentrations of whole cell samples were determined using 
the BCA assay. Aliquots of each sample were diluted in homogenisation 
buffer (celLyticTM MT), to a concentration of 6.3 mg protein/ml in a final 
volume of 20 µl, this concentration equates to 15 µg protein in each well 
and ensures an equal protein load for each sample. 50 µl of protein 
dissociation buffer (10 % (v/v) glycerol, 2 % (w/v) SDS and 5 % (v/Yǃ-
mercaptoethanol made up to volume in 50 mM Tris (pH 6.8)) and 14 µl 
glycerol-bromophenol blue (16 % (v/v) glycerol and 0.001 % (w/v) 
bromophenol blue in dH2O) was added to each sample which was then 
incubated at 100 ºC for 10 minutes.  
 
Before loading the protein samples, the wells were cleansed of un-
polymerised acrylamide using a Pasteur pipette and the running buffer. 10 
µl of sample, reference or molecular weight marker was loaded into each 
lane; empty lanes were loaded with 10 µl of glycerol-brompohenol blue to 
ensure even running. The gels were then electrophoresed at 200 V for 45 
minutes, or until the dye front was sufficiently near the bottom of the gel.  
 
Electrophoresis transfer onto PVDF membrane 
Proteins from the polyacrylamide gel were transferred to a PVDF 
membrane (Immobilon®-P Transfer Membrane, Millipore, MA, USA) using 
electroblotting. Before blotting, the PVDF membrane was immersed in 100 
% methanol for 15 seconds and transferred to dH2O for 2 minutes. After 
this period, the membrane was transferred, along with blotting paper, to 
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transfer buffer to equilibrate (25 mM Tris, 192 mM glycine, 10 % methanol 
made up to volume with dH2O). The gel and the membrane were 
sandwiched between a layer of blotting paper soaked in transfer buffer and 
supported by two scotch- Brite pads (3M, Bracknell, UK). 7KLV µVDQGZLFK¶
was placed in a cassette and inserted into the blotting tank (BioRad 
laboratories Ltd) in the order cathode ± gel ± membrane ± anode (Figure 
5.1), to allow the negatively charged polypeptides onto the membrane. 
The tank was filled with transfer buffer and electrophoresed at 80 V for 1 
hour. A cool water stream was passed through the high voltage transfer 
tank so that the proteins were not denatured by the blotting process.   
  
(+) Positive electrode (Anode) 
****************** Plastic cassette  
IIIIIIIIIIIIIIIIIIIIIIIIIII Scotch-Brite pads 
1 Sheet blotting paper 
PVDF membrane 
Polyacrylamide gel 
1 Sheet blotting paper 
IIIIIIIIIIIIIIIIIIIIIIIIIII Scotch-Brite pads 
****************** Plastic cassette  
(-) Negative electrode (Cathode) 
 
Figure 5.1 Schematic diagram of a western blotting transfer unit 
 
Protein staining 
Following electrophoresis and blotting, the proteins on the PVDF membrane 
were reversibly stained and visualised. The membrane was incubated for 1 
minute at room temperature with 10 % Ponceau-S red stain (2 % (w/v) 
Ponceau- S, 30 % (w/v) trichlroacetic acid, 30 % (w/v) sulphosalicylic acid 
in dH2O, further diluted prior to use to 1:10 with dH2O). Ponceau- S stain 
binds to protein and reveals a series of multiple bands arising vertically in 
lanes from each well, thus allowing verification of even blotting. Following 
the visualisation, it is possible to de-stain the Ponceau-S by rinsing the 
membrane with 0.1 M NaOH. The final confirmation of the efficiency of the 
transfer was assessed by staining the gel with Coomassie brilliant blue (0.1 
% Simple BlueTM, Invitrogen, CA, USA, in 50 % methanol and 7 % acetic 
acid in dH2O) for 2 minutes. This procedure stains any proteins remaining 
on the gel after electroblotting and so confirms the complete transfer of 
polypeptides.  
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Immunodetection 
In order to perform rapid immunodetection without blocking to prevent 
potential non-specific binding, the PVDF membrane must be dried 
thoroughly. To do this the membrane was soaked in 100 % methanol for 
10 seconds to drive out the water, and then placed on a piece of filter 
paper to allow the methanol to evaporate for 15 minutes. Once dried the 
membrane was incubated overnight at 4 °C with 10 ml of primary antibody 
diluted in blocking buffer (1 % BSA in PBS (phosphate-buffered saline; 10 
mM NA-phosphate, pH 7.2, 0.9 % NaCl) containing 0.05% (v/v) Tween-
20). 
 
Each antibody was validated by measuring the band that it generated 
against the protein ladder. If the identified band was a similar molecular 
weight to the protein interest as published in the literature then the 
antibody was used. In addition, the result of this assay was compared with 
the non-specific bands produced by immunoblots incubated with non-
immune rabbit serum. To optimise the incubation conditions of the 
antibodies, identical gels were exposed to different concentrations of 
primary antibodies, incubation times and temperatures (Table 5.1).  
 
Table 5.1 Technical details of the antibodies used  
Antibody Supplier Catalogue 
number 
Protein 
type 
Protein 
size (kDa) 
Primary antibody 
dilution factor 
ǃ-Actin Source Bioscience 
AUTOGEN, UK 
ABE933 Cytosol 43 1:2000 
GR Thermo Fisher 
Scientific Ltd, UK 
PA1-511A Nuclear 97 Variety tested 
 
 At the end of the incubation with the primary antibody, the membrane 
was washed twice in PBS, before the addition of the secondary antibody 
(1:5000 dilution of Protein G (BioRad laboratories Ltd.) in 1 % BSA in PBS 
containing 0.05% (v/v) Tween-20) and incubated for 30 minutes at room 
temperature. The secondary antibody was discarded and the membrane 
was washed twice in PBS. 
 
Enhanced Chemiluminescence   
The membrane was incubated in chemiluminescent substrate reagents (1:1 
of reagents 1 and 2, Millipore) for 5 minutes. The excess reagent was 
drained and the membrane placed in the CDD camera to generate a digital 
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image. The optimum time of exposure for all immunoblots was 30 seconds. 
The image created by this process was analysed by densitometry (Aida 
version n2.0, Raytek Scientific Ltd., Sheffield, UK), which evaluates the 
density of the bands. The intensity value of each band reflects the 
abundance of the polypeptide within the initial sample.  
 
5.2.5 Plasma cortisol 
Due to the significant GLIIHUHQFHVLQ*5DQGǃ-HSD1 mRNA expression in 
the liver, plasma cortisol expression was analysed at 6 months of age 
using a GammaCoatTM Cortisol radioimmunoassay (RIA) kit (GammaCoatTM 
[125I] Cortisol Radioimmunoassay Kit, Diasorin, Minnesota, USA). RIA is a 
very sensitive technique, first developed by Yallow and Berson (1960) to 
measure concentrations of antigens, such as hormones, in the blood. This 
technique works by mixing a known amount of radioisotope-tagged cortisol 
or tracer with a specific antibody, where the antibody is immobilised onto 
the lower inner wall of the GammaCoat tube. The tracer and antibody 
chemically bind together. Unknown plasma samples and calibrators of 
known concentrations are then added to the tubes. The cortisol in the 
samples competes with the radiolabelled antigen for binding sites and 
displaces some of the I125-tagged cortisol. The radioactivity of the free-
tagged cortisol can then be measured using a gamma counter. Using 
known standards, a binding curve can then be generated, which allows the 
unknown concentrations of cortisol in the plasma to be determined.  
 
5.2.5.1 Cortisol radioimmunoassay (RIA) procedure 
All reagents were allowed to reach room temperature and were mixed 
thoroughly prior to use. With all assays, a standard curve (1-60 µg/dL) 
was used to determine the cortisol concentrations of the samples. All 
samples were run in duplicate in order to establish intra-assay variability. 
A co-efficient of variance (CV) of less than 5 % was considered acceptable 
and samples were repeated if the CV was higher than this (see section 
2.6). For all assays the first 2 tubes were left blank as these were the Total 
Count tubes. 10 µl of Cortisol Serum Blank (GammaCoatTM [125I] Cortisol 
Radioimmunoassay Kit, Diasorin), Cortisol Serum Calibrator (GammaCoatTM 
[125I] Cortisol Radioimmunoassay Kit, Diasorin), or unknown plasma 
sample were carefully pipetted into the correct tubes, and 1 ml of tracer-
buffer reagent (GammaCoatTM [125I] Cortisol Radioimmunoassay Kit, 
Diasorin) added. Tubes were then vortexed for a few seconds at a low 
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speed, and incubated for 45 minutes in a water bath maintained at 37 °C. 
All tubes, expect the Total Counts, were aspirated, ensuring all liquid 
traces were removed. All tubes were then counted in a gamma counter 
(WizardTM 1470 Automatic Gamma Counter, PerkinElmer, Massachusetts, 
USA) for 1 minute in a window suitable adjusted for iodine-125. Cortisol 
concentrations were determined following analysis of the standard curve. 
 
5.2.6 Statistical analysis 
Full details of all statistical tests performed are described in Chapter 2.6.  
 
For this chapter, in order to examine the effect of maternal diet on the 
offspring selected for tissue sampling at either one week or 6 months of 
age, either the low or median-birth weight piglets from the control group 
were compared with the appropriate low or median piglets from the protein 
supplemented group (Table 5.2). This was carried out using either an 
unpaired T-test or a Mann-Whitney test, depending on whether the data 
was parametric or non-parametric. In addition, to compare differences 
between piglet birth weights, data from both low and median-birth weight 
piglets were compared for either the control or protein supplemented 
groups (Table 5.2), again using T-tests of Mann-Whitney Tests. As 
previously mentioned in Chapter 4, it was not appropriate to statistically 
compare data obtained at 1 week and 6 months of age as, although all 
analysis techniques were kept the same, these tissues were analysed 
separately in the lab.  
 
3HDUVRQ¶V FRUUHODWLRQ FRHIILFLHQW ZDV XVHG WR GHPRQVWUDWH UHODWLRQVKLSV
factors such as birth weight, growth rate to 6 months of age, and back fat 
thickness.  For this calculation all piglets born to sows from either the 
control or protein supplemented groups, which were not selected for tissue 
sampling at 6 months of age, were used.   
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Table 5.2 Outline of groups that were compared in this chapter 
 C (L ) 
1 week 
C (M) 
1 week 
C (L) 
6 months 
C (M) 
6 months 
PS (L) 
1 week 
PS (M) 
1 week 
PS (L) 
6 months 
PS (M) 
6 months 
C (L ) 
1 week 
n/a Yes 
(weight) 
No No Yes 
(diet) 
No No No 
C (M) 
1 week 
Yes 
(weight) 
n/a No No No Yes 
(diet) 
No No 
C (L) 
6 months 
No No n/a Yes 
(weight) 
No No Yes 
(diet) 
No 
C (M) 
6 months 
No No Yes 
(weight) 
- No No No Yes 
(diet) 
PS (L) 
1 week 
Yes 
(diet) 
No No No n/a Yes 
(weight) 
No No 
PS (M) 
1 week 
No Yes 
(diet) 
No No Yes 
(weight) 
n/a No No 
PS (L) 
6 months 
No No Yes 
(diet) 
No No No n/a Yes 
(weight) 
PS (M) 
6 months 
No No No Yes 
(diet) 
No No Yes 
(weight) 
n/a 
Yes (weight) = Groups that have the same maternal diet but were in different birth weight categories (L = Low-birth weight; M = Median-birth weight) can be compared to 
examine the effect of birth weight; Yes (diet) = Groups that have different maternal diets (C = control; PS = Protein supplemented) but were in the same birth weight 
category were compared to determine the effect of maternal diet. 
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5.3 Results 
5.3.1 Sex ratio 
As described in Chapter 4, Section 4.3.1, offspring sex was not equally 
distributed amongst dietary groups, due to the method of selection process 
of low and median-birth weight piglets for tissue and plasma sampling. The 
reasons for unequal sex ratio, in the control group have previously been 
discussed (Chapter 4, Section 4.3.1). In contrast to both the control, and 
fat supplemented groups, there was no difference between male and 
female average birth weight for the litter in the protein supplemented 
group (Chapter 3; Table 3.8). In addition, there was a slightly higher ratio 
of very low-birth weight (<800 g) males to females in the litters from 
protein supplemented mothers (Chapter 3; Figure 3.5.c). This meant that 
when piglets were selected for sampling at one week of age, the lowest 
birth weight piglet of the litter was usually male (Table 5.3). In contrast to 
this, of the piglets that were selected for sampling at 6 months of age, a 
greater proportion was female (Table 5.3). This resulted in a reversal of 
sex ratio when comparing the control group with the protein supplemented 
group at both 1 week and 6 months of age (Table 5.3).  
 
For this chapter, except where shown, males and females were considered 
together. 
 
Table 5.3 Sex ratio of piglets selected for tissue and plasma sampling 
  Number of males Number of females 
  Low-birth 
weight 
Median-birth 
weight 
Low-birth 
weight 
Median-birth 
weight 
C 1 week 1 1 7 7 
6 month 6 6 2 2 
PS 1 week 7 6 1 2 
6 month 2 3 5 4 
C = Control; PS = Protein supplemented 
 
5.3.2 Body weight and accelerated growth 
Despite there being no significant difference in body weight at 6 months 
between male and female pigs or with protein supplementation (Table 
5.4), male piglets that had been castrated tended to have increased back 
fat thickness at 6 months of age when compared to their female litter 
mates (Table 5.4). However, back fat thickness of the offspring, measured 
at 6 months of age, was unaffected by maternal protein supplementation 
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throughout pregnancy (Table 5.4). In addition, there was no correlation 
between back fat thickness and offspring growth rate from birth to 6 
months (C: r=0.17, P=0.30; PS: r=0.23, P=0.12). 
 
Table 5.4 Body weight and back fat thickness at 6 months of age in piglets not 
selected for tissue sampling 
 C PS 
 Females Males Females Males 
BW at 6 months (Kg) 116.10±0.73 113.97±0.88 115.76±0.76 115.97±1.14 
Back fat (mm) 14.51±0.55 17.73±0.94* 14.28±0.46 17.73±0.78* 
Values are means ± SEM for control (C; n=8) and fat supplemented (PS; n=8) gestational 
groups; Data was statistically tested for each gestational group using unpaired T-tests (C 
group) or Mann-Whitney tests (PS group) between the male and female piglets, differences 
are: *P<0.05; BW = Body weight 
 
Birth weight of piglets selected for tissue sampling at 6 months of age was 
not different between dietary groups (Table 5.5). In those piglets selected 
for sampling at 1 week of age, birth weight was slightly higher in the low-
birth weight piglets born to protein supplemented sows when compared to 
the control group, although this is not significant (Table 5.5). However, by 
1 week of age this difference in body weight had become significant (Table 
5.5). In accordance with the study design, low-birth weight piglets weighed 
significantly less than the median-birth weight piglets at 1 week of age 
(Table 5.5). However, by 9 weeks of age, there was no significant 
difference in body weight between the low and median-birth weight piglets 
selected for sampling (Table 5.5), this continued to 6 months of age. As 
described in chapter 4, it is thought that this is due to accelerated growth 
in the low-birth weight animals, demonstrated by strong negative 
correlation between birth weight and growth rate to 6 months of age, in 
both control (Chapter 4; Figure 4.2a) and protein supplemented 
gestational groups (Figure 5.2).  
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Table 5.5 Birth weight and body weight at euthanasia in piglets at 1 week and 6 
months of age 
   Birth weight  
(Kg) 
BW at 9 weeks 
(kg) 
BW at euthanasia 
(Kg) 
C 1 week Low  
(n=8) 
0.72±0.07 n/a 1.12±0.13 
Median  
(n=8) 
 1.25±0.06* n/a  2.13±0.13* 
6 month Low  
(n=7) 
0.99±0.07 22.44±0.93 115.21±5.92 
Median  
(n=7) 
 1.37±0.05* 24.77±1.46 120.14±3.27 
PS 1 week Low 
(n=8) 
0.90±0.04 n/a   1.66±0.17** 
Median 
(n=8) 
 1.30±0.06* n/a  2.53±0.20* 
6 month Low  
(n=7) 
1.11±0.08 25.33±2.17 119.92±2.45 
Median  
(n=7) 
 1.34±0.07* 28.97±2.32 128.92±4.11 
Values are means ± SEM for control (C) and fat supplemented (PS) gestational groups; Data 
was statistically tested at 1 week and 6 months using unpaired T-tests or Mann-Whitney tests 
between the low and median-birth weight piglets and differences are: *P<0.05; In addition, 
differences between C and PS, low or median groups are denoted by: ** P<0.05 (T-test); 
BW= Body weight 
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Figure 5.2 Relationship between piglet birth weight and fractional growth rate 
(FGR) to 6 months of age in piglets born to sows fed the protein supplemented 
(n=8) (r= -3JHVWDWLRQDOGLHW3HDUVRQ¶VFRUUHODWLRQFRHIILFLHQW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5.3.3 Plasma analysis 
Plasma concentrations of glucose, TAG, NEFA, and cholesterol, were raised 
at 1 week, when compared to samples taken at 6 months of age, in both 
the control and protein supplemented groups (Table 5.6). Maternal protein 
supplementation or offspring birth weight did not affect plasma metabolite 
concentrations in the offspring, at either 1 week or 6 months of age (Table 
5.6). In addition, maternal protein supplementation did not affect fasting 
plasma insulin concentrations (µg/ml) in offspring at 6 months of age 
(Low: C: 0.16±0.03; PS: 0.15±0.02; Median: C: 0.22±0.08; PS: 
0.26±0.07). As previously explained (Chapter 4; Section 4.3.3), it was not 
possible to compare low and median-birth weight plasma samples as these 
were carried out on separate assay plates with different kits. 
 
It was not possible to determine cortisol concentrations for these piglets at 
6 months of age. This was due to a problem with the standard curve that 
was generated, which meant that the counts per minute (CPM) reading for 
each of the calibrators was much lower (around half) than the expected 
values given in the literature. The reasons for this are unclear as the 
protocol was followed, and the calibrators all came as part of the kit 
readymade up to the correct concentrations, so there was no dilution 
involved where it may have been possible to make a mistake. This meant 
that the CPM which were read for the unknown plasma samples were all 
too high to be read on the curve generated, which went up to around 
8,500 CPM for the 1 µg/dL cortisol calibrator. Analysis of the raw data 
generated for each sample demonstrates similar CPM values to the 
examples provided in the instruction manual for this kit. Unfortunately, due 
to time constraints it was not possible to repeat this assay. In addition, as 
there was no difference between CPM values generated (C: low: 
7432.81±598.71, median:  7680.69±327.49; PS: low: 8976.86±620.21, 
median: 7436.57±649.28), this suggested that maternal protein 
supplementation had no effect on cortisol concentrations at 6 months of 
age. 
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Table 5.6 Fasted plasma concentrations of glucose, triglycerides (TAG), 
nonesterified fatty acids (NEFA) and cholesterol in low and median-birth weight 
piglets, sampled at 1 week and 6 months of age 
   Glucose 
(mM) 
TAG 
(mM) 
NEFA 
(mM) 
Cholesterol 
(mM) 
C 1 week Low 
(n=7) 
7.52±0.40 3.64±0.71 1.18±0.15 4.77±0.34 
Median 
(n=8) 
7.97±0.23 3.16±0.58 0.99±0.11 3.60±0.36* 
6 month Low 
(n=8) 
4.22±0.47 1.14±0.22 0.96±0.14 2.36±0.37 
Median 
(n=8)  
4.71±0.41 1.26±0.09 0.94±0.15 3.16±0.08* 
PS 1 week Low 
(n=8) 
8.18±0.60 3.73±0.43 1.04±0.17 4.16±0.33 
Median 
(n=8) 
8.36±0.59 3.08±0.42 0.93±0.12 3.44±0.30 
6 month Low 
(n=7) 
4.42±0.35 1.58±0.14 0.83±0.19 2.53±0.37 
Median 
(n=7) 
4.40±0.61 1.41±0.13 1.04±0.19 2.64±0.38 
Values are means ± SEM for control (C) and protein supplemented (PS) gestational groups; 
Data was statistically tested at 1 week and 6 months using Mann-Whitney tests between the 
low and median-birth weight piglets and differences are: *P<0.01 
 
5.3.4 Liver analysis 
5.3.4.1 Liver weight and composition 
At 1 week of age low-birth weight piglets, born to sows fed protein 
supplemented diets, had heavier livers than those born to control mothers 
(Table 5.7). This is probably accounted for by the higher body weight of 
these animals (Table 5.5) as this difference disappears when liver weight is 
expressed as a percentage of body weight (Table 5.7). Despite no 
significant differences in body weight at 6 months of age (Table 5.5), liver 
weight, expressed as a percentage of body weight is increased in median-
birth weight piglets born to sows that were protein supplemented (Table 
5.7). As previously shown, low-birth piglets had smaller livers than 
median-birth weight piglets, with no difference in liver weight being noted 
at 6 months of age (Table 5.7). Liver triglyceride and glycogen content 
were unaffected by maternal protein supplementation or piglet birth weight 
(Table 5.7). As previously explained in Chapter 4, it was not possible to 
measure liver glycogen content at 6 months of age in these animals as it 
was below the level of detection. 
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Table 5.7 Liver weight, triglyceride (TAG) and glycogen content in piglets at 1 
week and 6 months of age 
   Liver weight 
(Kg) 
Liver weight 
(% of BW) 
Liver TAG 
(mg/g) 
Liver glycogen 
(mg/g) 
C 1 week Low  
(n=8) 
0.05±0.008 4.41±0.40 1.98±0.40 75.8±19.6 
Median 
(n=8) 
 0.10±0.008* 4.82±0.19 1.17±0.37 91.8±13.8 
6 month Low  
(n=8) 
2.48±0.12 2.11±0.10 0.84±0.17 n/a 
Median 
(n=8)  
2.51±0.12 2.03±0.06 0.97±0.18 n/a 
PS 1 week Low  
(n=8) 
 0.08±0.001** 4.76±0.30 1.17±0.23 58.9±14.0 
Median 
(n=8) 
 0.11±0.010* 4.49±0.21 0.82±0.20 85.4±15.3 
6 month Low  
(n=8) 
2.47±0.09 2.08±0.06 0.62±0.13 n/a 
Median 
(n=8) 
2.81±0.16   2.24±0.08** 0.61±0.14 n/a 
Values are means ± SEM for control (C) and fat supplemented (PS) gestational groups; Data 
was statistically tested at 1 week and 6 months using Mann-Whitney tests between the low 
and median-birth weight piglets and differences are: *P<0.01; In addition, differences 
between C and PS, low or median groups are denoted by: ** P<0.05 (T-test); BW = Body 
weight 
 
5.3.4.2 Liver gene expression 
At 6 months of age there was an inverse relationship between birth weight 
and the effects of protein supplementation on GR mRNA expression. In the 
low-birth weight piglets, maternal protein supplementation reduced gene 
expression of GR (Figure 5.3.b). Conversely, in the median-birth weight 
piglets, maternal protein supplementation increased GR expression when 
compared to the control piglets (Figure 5.3.b). This resulted in significantly 
higher mRNA GR expression in the median-birth weight piglets born to 
protein supplemented sows, when compared to their low-birth weight litter 
mates (Figure 5.3.b). Similar, GR expression patterns are seen in piglets at 
1 week of age; however, there was no significant difference (Figure 5.3.a). 
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Figure 5.3 Liver Glucocorticoid receptor (GR) mRNA expression in low  and median  birth weight piglets, born to sows fed control (C; n=8) or 
protein supplemented (PS; n=8) gestational diets, sampled at (a) 1 week and (b) 6 month of age; Relative quantification of GR mRNA using the genorm 
strategy; 18S, ribosomal phosphoprotein (RPO) and cyclophylin were used as housekeeping genes, and results are given in arbitrary units; Values are 
means ± SEM; Data was statistically tested at 1 week and 6 months using Mann-Whitney tests between the low and median-birth weight piglets and 
differences are: *P<0.05; In addition, statistical differences between C and PS groups are denoted by ** P<0.05 (Mann-Whitney (low-birth weight); T-
Test (median-birth weight)) 
a) b) 
* 
** 
** 
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ǃ-HSD1 showed similar gene expression patterns in piglets at 1 week 
and 6 months of age (Figure 5.4.a and 5.4.b). Similar to its effects on GR 
expression, maternal protein supplementation increased mRNA expression 
RIǃ-HSD1 in median-birth weight piglets, although, small birth weight 
piglets were unaffected (Figure 5.4.a and 5.4.b). This resulted in higher 
H[SUHVVLRQ RI ǃ-HSD1 in median-birth weight piglets, born to mothers 
fed a protein supplemented diet, when compared to their low-birth weight 
litter mates (Figure 5.4.a and 5.4.b). 
 
0DWHUQDO SURWHLQ VXSSOHPHQWDWLRQ KDG QR HIIHFW RQ 33$5Į mRNA 
expression in the liver at 1 week or 6 months of age (Figure 5.5.a and 
5.5.b). In low-birth weight piglets at 1 week of age, gene expression of 
FABP1 was decreased when sows were fed a protein supplemented diet 
throughout gestation (Figure 5.6.a). In addition, FABP1 expression is 
higher in median-birth weight piglets at 1 week of age, when compared to 
low-birth weight piglets (Figure 5.6.a). Birth weight or maternal diet had 
no effect on offspring FABP1 mRNA expression at 6 months of age (Figure 
5.6.b).  
 
Maternal diet had no effect on piglet mRNA expression of IR at 1 week or 6 
PRQWKV RI DJH )LJXUH D DQG E 6LPLODU WR *5 DQG ǃ-HSD1 
expression, expression of the IR gene was increased at 6 months of age in 
median-birth weight piglets, born to sows fed a protein supplemented diet, 
than their low-birth weight liWWHU PDWHV )LJXUH E ǃ-HSD2 gene 
expression was measured in liver tissue at both 1 week and 6 months but 
ZDVWRRORZWREHGHWHFWHG7KLVZDVH[SHFWHGDVǃ-HSD2 is not highly 
expressed in the liver.  
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Figure 5.4 Liver 11beta-+\GUR[\VHWURLG'HK\GURJHQDVH W\SH ǃ-HSD1) mRNA expression in low  and median  birth weight piglets, born to 
sows fed control (C; n=8) or protein supplemented (PS; n=8) gestational diets, sampled at (a) 1 week and (b) 6 month of age; Relative quantification of 
ǃ-HSD1 mRNA using the genorm strategy. 18S and cyclophylin were used as housekeeping genes, and results are given in arbitrary units. Values are 
means ± SEM; Data was statistically tested at 1 week and 6 months using Mann-Whitney tests between the low and median-birth weight piglets and 
differences are: *P<0.05; In addition, statistical differences between C and PS groups are denoted by ** P<0.05 (Mann-Whitney) 
a) b) 
* 
** 
** 
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Figure 5.5 Liver Peroxisome proliferator-DFWLYDWHGUHFHSWRUDOSKD33$5ĮmRNA expression in low  and median  birth weight piglets, born to sows 
fed control (C; n=8) or protein supplemented (PS; n=8) gestational diets, sampled at (a) 1 week and (b) 6 month of age; Relative quantification of 
33$5ĮP51$XVLQJWKHJHQRUPVWUDWHJ\6DQGF\FORSK\OLQZHUHXVHGDVKRXVHNHHSLQJJHQHVDQGUHVXOWVDUHJLYHQ LQDUELWUDU\ units; Values are 
means ± SEM 
a) b) 
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Figure 5.6 Liver Fatty acid-binding protein 1 (FABP1) mRNA expression in low  and median  birth weight piglets, born to sows fed control (C; n=8) 
or protein supplemented (PS; n=8) gestational diets, sampled at (a) 1 week and (b) 6 month of age; Relative quantification of FABP1 mRNA using the 
genorm strategy. 18S and cyclophylin were used as housekeeping genes, and results are given in arbitrary units. Values are means ± SEM; Data was 
statistically tested at 1 week and 6 months using Mann-Whitney tests between the low and median-birth weight piglets and differences are: *P<0.05; In 
addition, statistical differences between C and PS groups are denoted by ** P<0.05 (T-test) 
a) b) 
** 
* 
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Figure 5.7 Liver Insulin receptor (IR) mRNA expression in low  and median  birth weight piglets, born to sows fed control (C; n=8) or protein 
supplemented (PS; n=8) gestational diets, sampled at (a) 1 week and (b) 6 month of age; Relative quantification of IR mRNA using the genorm 
strategy; 18S, ribosomal phosphoprotein (RPO) and cyclophylin were used as housekeeping genes, and results are given in arbitrary units; Values are 
means ± SEM; Data was statistically tested at 1 week and 6 months using T-tests between the low and median-birth weight piglets and differences are: 
*P<0.05 
a) b) 
* 
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5.3.4.3 Protein expression of glucocorticoid receptor (GR) 
The GR antibody used in this study has been demonstrated to detect a 
protein which is around 97 kDa (Fan et al., 2010). Unfortunately, despite 
previously published data suggesting that the primary GR antibody used 
worked in pigs (Weaver et al., 2000) and also rats (Fan et al., 2010) and 
that the amino acid sequence was 100 percent homologous to pigs, 
demonstrated by a sequence search using BLAST 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi), it was not possible to determine 
GR protein expression in the liver of these piglets at 6 months of age. This 
was due to the antibody creating a series of multiple protein bands which 
were visible on the membrane even when the antibody was used at a 
variety of dilutions (Figure 5.8). In addition, the strongest of these bands 
was not at 97 kDa but was instead around 50 kDa, suggesting that further 
dilution of the primary antibody would not have been appropriate (Figure 
5.8).  
 
Figure 5.8 Representative image of a Western blot for glucocorticoid receptor 
(GR); 3 dilutions of primary antibody tested: 1:1000, 1:500, 1:50; 1:5000 dilution 
of secondary antibody (Protein G); 15 µg protein in each lane 
 
In order to test the qXDOLW\ RI WKH H[WUDFWHG OLYHU SURWHLQV D ǃ-actin 
antibody was used.  This worked for all the samples, demonstrated by a 
strong band around 44 kDa (Figure 5.9), further suggesting that there was 
a problem with the GR antibody used in this study, rather than the protein 
extractions.  
 
Due to time constraints it was not possible to order another GR antibody 
and test this with the 6 month liver samples.  
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Figure 5.9 5HSUHVHQWDWLYHLPDJHRID:HVWHUQEORWIRUǃ-actin; 1:2000 dilution of 
primary antibody; 1:5000 dilution of secondary antibody (Protein G); 15 µg protein 
in each lane; C = control; PS = Protein supplemented 
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5.4 Discussion 
Despite the increase in dietary protein in the Western population (Rolland-
Cachera et al., 2000), investigations into protein supplementation during 
pregnancy are limited, with conflicting outcomes between studies (Daenzer 
et al., 2001, Zimanyi et al., 2002, Thone-Reineke et al., 2006). This is the 
first study in pigs to investigate the effects of maternal protein 
supplementation during gestation on offspring development. Previous 
studies have instead focussed on the function of dietary protein during 
pregnancy on offspring survival and litter size as this is of key economical 
importance in the pig industry. This is demonstrated by studies in both rats 
and pigs which have suggested a role for specific amino acid 
supplementation, particularly arginine, during pregnancy, in improving 
offspring survival rate (Mateo et al., 2007, Zeng et al., 2008). In contrast 
to this, this study has previously demonstrated an increase in neonatal 
mortality, particularly of low-birth weight offspring, when sows were 
protein supplemented with an arginine rich source (Chapter 3).    
 
5.4.1 Growth and development of the offspring 
This study demonstrated no effects of maternal protein supplementation on 
the body weight of the piglets at 6 months of age. This was expected as no 
differences in birth weight or litter size were previously observed (Chapter 
3). A link between a maternal protein rich diet and offspring adiposity has 
previously been demonstrated, but this was probably linked with 
accelerated postnatal growth due to a reduction in birth weight of the 
offspring (Daenzer et al., 2001).  
 
As hypothesised, and as previously observed (Chapter 4), low-birth weight 
offspring demonstrated accelerated postnatal growth so that by 9 weeks  
of age, there were no significant differences in body weight between 
piglets. This increase in growth rate, however, was not associated with an 
increase in fat mass, measured by back fat thickness, in the low-birth 
weight offspring as might have been expected from evidence in both the 
pig industry (Powell and Aberle, 1980) and human cohort studies (Erikson 
et al., 2000, Forsen et al., 2000, Hales and Barker, 2001). However, it is 
possible that back fat thickness is not a good indicator for an increase in 
fat composition of the pig and that another method for the measurement 
of adiposity may have been more appropriate (Chapter 4; Section 4.4.2). 
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5.4.2 Glucocorticoid (GC) sensitivity 
Offspring born to sows fed a protein rich diet throughout pregnancy 
demRQVWUDWHGDQLQFUHDVHLQJHQHH[SUHVVLRQRIERWK*5DQGǃ-HSD1 at 
6 months of age, suggesting that these animals were more sensitive to GC. 
Similar affects have been observed in offspring born to mothers who were 
protein restricted or that were under-nourished during pregnancy (Bertram 
et al., 2001, Whorwood et al., 2001). It is thought that this is due to 
enhanced transfer of maternal GC to the fetus, resulting in an increase in 
GC sensitivity in the peripheral tissues of the offspring (Bertram et al., 
2001, Whorwood et al., 2001). Unfortunately, it was not possible to 
measure fasting plasma cortisol in these animals to see if this was raised. 
However, previous studies that have measured offspring plasma cortisol 
have demonstrated that it is usually unaffected by maternal nutrient 
restriction (Gilbert et al., 2005, Gardner et al., 2006), suggesting perhaps 
that similar results may have been noted in this study. Analysis of the CPM 
data obtained from the cortisol assay, suggests that this may be the case. 
However, this is not conclusive as there was obviously a problem with the 
assay and although it seemed only to be concerned with the standard 
curve, it is possible that it was a problem with the assay as a whole and so 
this data should be interpreted with caution.  
 
GC have important functions within the body, such as increasing blood 
pressure and increasing plasma glucose concentration (Chapter 1; Section 
1.2.1) (Tangalakis et al., 1992, Dimitriadis et al., 1997a), and are crucial 
to controlling whole body metabolism. As a result, an increase in GCs 
and/or GC sensitivity has been linked to an increased risk of metabolic 
disease such as obesity, hypertension and insulin resistance (Covar et al., 
2000, Bertram et al., 2001, Whorwood et al., 2001, Arnaldi et al., 2003). 
Therefore, it would have been expected that those animals demonstrating 
an increase in GC sensitivity, would have an increase in fat mass and 
perhaps, perturbed lipid and glucose homeostasis, demonstrated by an 
increase in circulating insulin, glucose and triglycerides, and perhaps a 
reduction in genes involved in the lipid uptake and oxidation pathways. 
However, the consequences of this increase in GC sensitivity where not 
apparent in the variables that were measured in these animals, at 6 
months of age, with no difference observed back fat thickness, plasma 
insulin RU PHWDEROLWHV DQG H[SUHVVLRQ RI )$%3 33$5Į DQG ,5 P51$
Despite this, liver weight was increased in the median-birth piglets born to 
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sows that were protein supplemented, although the reason for this 
increase is not known. It was previously thought to perhaps be due to 
hepatic accumulation of lipids, as hepatic steatosis is common in patients 
with metabolic syndrome (Marceau et al., 1999), however this was proven 
not to be the case as the triglyceride content of the liver was not 
statistically different between dietary groups.  
 
There are several possible reasons as to why no consequences of the 
increased GC sensitivity were noted in these animals. The first explanation 
is that these differences in gene expression may not translate into 
differences in protein expression. It was not possible to test this hypothesis 
as the antibody for GR did not produce specific bands with these tissue 
samples. Unfortunately, due to time constraints, it was not appropriate to 
test any other antibodies, especially as the antibody used in this study was 
100 percent homologous to the pig amino acid sequence. In addition, the 
GR antibody tested had previously been demonstrated to work in pigs, 
although this study was investigating brain tissue expression (Weaver et 
al., 2000). However, in this paper, multiple bands were also detected, at 
95 and 87 kDa, and it is unclear whether these coded for the functional GR 
protein (Weaver et al., 2000). Another investigation which claimed to have 
detected GR in rats may also be called into question as, in this study, the 
membrane was divided into sections before immunodetection and only the 
area of interest, around 97 kDa, was exposed to the GR antibody (Fan et 
al., 2010). Therefore, multiple bands may not have been detected (Fan et 
al., 2010).          
 
Increases in gHQHH[SUHVVLRQRI*5DQGƨ-HSD1 were observed at both 
1 week and 6 months of age, although GR expression at 1 week of age was 
not significant, suggesting that this is a programming effect of the protein 
rich diet fed to the mothers of these piglets. The second explanation as to 
why no consequences of GC sensitivity were noted in this study could be 
that these piglets were analysed at 6 months of age and that they were 
still relatively young. Often, detrimental programming effects such as 
increased blood pressure, cardiovascular disease, and insulin resistance, in 
both humans and rats, are not observed until adulthood (Erikson et al., 
2000, Forsen et al., 2000, Hales and Barker, 2001, Khan et al., 2003, Khan 
et al., 2005, Taylor et al., 2005, Ehruma et al., 2007). Therefore, as these 
animals were analysed during puberty (6 months of age), as this is when 
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they have reached commercial sale weight, it is possible that the potential 
negative effects of increased GC sensitivity such as an increase in 
circulating triglycerides and an increase in fat mass, may not have been 
noted until they were much older. 
 
In addition, programming effects are often only demonstrated when there 
is a mismatch between the fetal and the postnatal environment, perhaps 
caused by under-nutrition or growth restriction in utero (Hales et al., 1991, 
Langley-Evans et al., 1996, Langley-Evans et al., 1999, Erikson et al., 
2000, Forsen et al., 2000, Bertram et al., 2001, Ehruma et al., 2007). In 
this study, the diets fed to these animals post-weaning contained around 
16 to 17 percent crude protein, to provide optimal growth of the piglets 
during this period. And so, those animals born to sows subjected to protein 
supplementation, actually received similar dietary protein levels in 
postnatal life. It is therefore possible that although these animals were 
programmed in utero to be more sensitive to GC by the feeding of a 
protein rich diet, actually these animals were not subjected to any 
detrimental effects of this because they went on to receive similar protein 
levels as neonates and post-weaning.         
 
The low-birth weight offspring who demonstrated accelerated postnatal 
JURZWKKDG ORZHUP51$H[SUHVVLRQ RI*5 ǃ-HSD1, and IR than their 
median-birth weight litter mates of the same body weight. Therefore, it 
seems that the median-birth weight animals are more affected by maternal 
protein supplementation than the low-birth weight animals. This was 
surprising considering the evidence linking low-birth weight and 
accelerated growth to an increase in metabolic abnormalities in adulthood 
(Langley-Evans et al., 1996, Langley-Evans et al., 1999, Erikson et al., 
2000, Forsen et al., 2000, Bertram et al., 2001, Hales and Barker, 2001) 
and studies which  show an increase in GC sensitivity in the offspring, 
demonstrated by an increase in G5DQGǃ-HSD1 in certain tissues such 
as the liver (Bertram et al., 2001). However, it is probable that these 
effects are mediated through the low-protein maternal diet or under-
nutrition during pregnancy, rather than just the effects of low-birth weight 
alone. This is further supported by Whorwood et al. (2001) who 
demonstrated an increase in GC sensitivity at birth in the offspring of 
under-nourished sheep, despite there being no differences in offspring 
weight.   
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5.4.3 Effect of piglet sex 
Piglet sex is an important determinant of adult body composition. 
Generally, the amount of fat is less in intact males or boars, than in intact 
females or gilts, with castrated males or barrows having the most amount 
of fat (Siers, 1975, Mitchell et al., 2001). In addition, gilts grow at a slower 
rate than boars and barrows, and so the time taken for gilts to reach a 
slaughter weight of around 99 Kg from a starting weight of 27 Kg is 
significantly longer (Siers, 1975).  
 
In this study there was a mixture of males and females. The males that 
were used for tissue and plasma analysis at 6 months of age were not 
castrated; this was in order to try to balance out some of the effects of sex 
that might be demonstrated, as all females remained intact. Male piglets 
that were not used for tissue analysis were castrated as is normal practice 
in the pig industry (Chapter 2; Section 2.3.1). As expected, this study 
demonstrated an increase in back fat thickness in castrated males at 6 
months of age in comparison to the females. This effect was noted 
regardless of the diet that the mothers received (see also Chapter 4). 
Unfortunately, back fat thickness was not measured in those animals 
selected for sampling so it is unclear as to whether the males would have 
had reduced thickness in comparison to the females as would be expected 
(Siers, 1975). 
 
Knowing that sex has significant effect on piglet body composition, it is 
also possible that it could also play a fundamental role in determining the 
effects of nutritional programming. This is further supported by studies in 
rats which have demonstrated a protective role for female sex hormones 
against the development of diet-induced insulin resistance and associated 
disorders such as hypertension (Galipeau et al., 2002, Hevener et al., 
2002).  
 
Unfortunately, male and female ratio of piglets selected for further tissue 
and plasma analysis was not equal between the control and protein 
supplemented groups at 1 week or 6 months of age. There was a high ratio 
of males at 1 week of age and a higher ratio of females at 6 months of age 
in the median-birth weight piglets born to protein supplemented mothers, 
relative to the control group. Therefore, it is possible that sex could have 
had an effect on the results so that the significant differences observed 
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between the gene expression of control and protein supplemented groups, 
could be a factor of sex rather than dietary intervention. In order to try to 
disprove this, sex differences between dietary groups for all variables were 
measured and there was no difference between males and females. In 
addition, if males and females were examined separately there were no 
effect of maternal diet on gene expreVVLRQ RI *5 DQG ǃ-HSD1 as 
previously demonstrated. However, the reason that no differences were 
noted was probably because this study was not powered to look at sex 
differences and some groups had relatively low numbers of males or 
females. If both the effects of sex and birth weight had been investigated 
the number of animals needed in this study would have been significantly 
higher, also resulting in a lot of animal wastage. Despite this, as this study 
demonstrated similar results at both 1 week and 6 months of age in terms 
of gene expression, and within these groups at this time the ratio of males 
to female was reversed, it should be concluded that this was more likely to 
be an effect of maternal protein supplementation rather than offspring sex.  
 
5.4.4 Conclusions 
This was the first study to investigate the programming effects of feeding a 
protein rich diet to pigs throughout pregnancy. It has demonstrated an up-
UHJXODWLRQRIJHQHVLQYROYHGLQ*&VHQVLWLYLW\VXFKDV*5DQGǃ-HSD1, 
in the liver, but has as yet, not detected any other significant changes in 
these piglets, with no differences observed in body weight, back fat 
thickness or liver metabolism. Surprisingly, these effects were only 
observed in the median-birth weight piglets. This increase in GC sensitivity 
was similar to the programming effects observed by maternal protein 
restriction or global under-nutrition during pregnancy (Bertram et al., 
2001, Whorwood et al., 2001). Possibly suggesting that the type of 
nutritional insult pregnancy is not important and that maternal under-
nutrition may cause similar programming effects as over-nutrition.   
 
In both humans and animal models, alterations in GC sensitivity have been 
associated with a higher risk of developing metabolic abnormalities (Walker 
et al., 1998, Bertram et al., 2001, Whorwood et al., 2001, Rask et al., 
2002). Therefore, these findings could have important implications in 
determining the programming effects of maternal diet on human disease 
risk. 
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The importance of these findings for the pig industry are not clear, because 
no phenotypic consequences were observed in the parameters measured 
between offspring of protein supplemented, compared to control fed 
mothers. Therefore, it is likely that meat quality would not be affected by 
such minor alterations in maternal dietary composition, although further 
work is currently being carried out to investigate the effects on muscle 
quality to validate this. However, this study may have important 
implications if these offspring were to become breeding stock and were 
allowed to grow and develop past 6 months of age.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
162 
 
Chapter 6 - Conclusions 
 
6.1 General conclusions 
The aim of this study was to demonstrate the effects of moderate changes 
in the macronutrient ratio of the maternal diet, whilst still maintaining 
energy content, on offspring development and metabolism until 
adolescence. This was achieved by assessing body composition, the 
expression of key genes involved in glucocorticoid (GC) sensitivity and 
metabolism in the liver, as well as analysing the metabolic profile of the 
plasma. In addition, the effect of piglet birth weight and subsequent 
postnatal growth on liver metabolism was investigated. This chapter 
outlines the key findings from this study and aims to determine why some 
of these outcomes may have been different from what was previously 
expected.   
 
6.1.1 Fat supplementation 
One of the main findings of this study was the effect of maternal fat 
supplementation on glucose tolerance of the sow at term and the 
implications for offspring mortality (Chapter 3). Recent investigations in 
pigs have demonstrated the negative effects of fat supplementation during 
pregnancy on maternal glucose tolerance (van der Peet-Schwering et al., 
2004). This is similar to the effects of obesity and/or fat consumption 
during pregnancy in both humans and rats on the increased risk of 
developing abnormal glucose homeostasis (Guo and Jen, 1995, Taylor et 
al., 2003) and/or gestational diabetes (Chu et al., 2007). In agreement, 
with these findings, this study has demonstrated that an increased fat ratio 
of the diet from mating until day 110 of gestation results in a reduction in 
maternal glucose tolerance.  
 
Previously, fat supplementation was considered beneficial during 
pregnancy to reduce piglet mortality, although the intervention period of 
these studies were only during the last few days of gestation and 
throughout lactation (Seerley et al., 1974, Boyd et al., 1978, Pettigrew, 
1981, Seerley et al., 1981, Azain, 1993). However, in contrast to these 
previous observations, piglet mortality was increased in the litters of fat 
supplemented mothers. The reason for this increase in mortality was 
hypothesised to be due to enhanced supply of maternal glucose to the 
fetus, causing hyperinsulinemia which leads to hypoglycaemia in these 
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offspring at birth (Pere and Dourmad, 2000, van der Peet-Schwering et al., 
2004). This was further supported by the finding that the majority of the 
piglet deaths occurred within the first 24 hours after birth, and that those 
animals that died were of low-birth weight (Lubchenco and Bard, 1971). 
However, we were unable to prove or disprove this, as plasma samples 
were not taken from these animals at birth due to the financial and time 
constraints with such a large sample size in a commercial pig environment.   
 
In order to further develop this study, the effects of maternal fat 
supplementation on postnatal piglet development were examined (Chapter 
4). Investigations in rats have demonstrated that feeding a high-fat diet 
during pregnancy increases the risk of metabolic abnormalities such as 
obesity, hypertension and impaired glucose tolerance in the pups (Khan et 
al., 2003, Khan et al., 2005, Taylor et al., 2005). Similar effects have been 
noted in offspring born to mothers with impaired glucose tolerance (Boney 
et al., 2005, Franks et al., 2006). Following on from the previous 
observations noted in this study, demonstrating reduced glucose tolerance 
and increased neonatal mortality, it was hypothesised that maternal fat 
supplementation would result in piglets who had increased fat mass and 
perturbed glucose and lipid homeostasis. However, this study 
demonstrated no differences between piglets born to sows fed a control or 
fat supplemented diet in the parameters measured at 6 months of age.  
 
6.1.2 Protein supplementation 
Despite the tendency for dietary protein intake to exceed recommended 
values in the Western world, particularly in younger women (Rolland-
Cachera et al., 2000), investigations into the outcomes of a high-protein 
diet during pregnancy are limited, with conflicting results between studies 
(Mathews et al., 1999, Daenzer et al., 2001, Zimanyi et al., 2002, Kramer 
and Kakuma, 2003, Thone-Reineke et al., 2006). It is often not the 
amount of dietary protein which is important in determining the outcomes, 
but the amino acid composition of the diet (Burrin, 2001). Therefore, 
previous studies have focussed on the effects of supplementing the 
maternal diet with specific amino acids, particularly arginine (Mateo et al., 
2007, Zeng et al., 2008), on increasing litter size and reducing the number 
of stillborn offspring.  
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Surprisingly, this study demonstrated an increase in postnatal mortality 
when sows were fed a diet with an increased ratio of a protein source that 
was rich in arginine, with no effect on litter size or number of stillborn 
piglets (Chapter 3). The reasons for this increase in neonatal mortality are 
unclear, although it may be linked to an increase in maternal back fat and 
decrease in plasma non-esterified fatty acids (NEFA) during late gestation. 
 
The final important finding of this study was an increase in GC receptor 
*5 DQG ǃ-K\GUR[\VWHURLG GHK\GURJHQDVH  ǃ-HSD1) gene 
expression in the livers of the offspring born to sows that were fed a 
protein rich diet, thus suggesting increased GC sensitivity in these animals 
(Chapter 5). These results were similar to the programming effects 
demonstrated by under-nutrition and protein restriction in both the rat and 
sheep models (Bertram et al., 2001, Whorwood et al., 2001). Despite the 
apparent increase in GC sensitivity in this study, no consequential effects 
on offspring metabolism seemed to accompany this as might have been 
expected (Covar et al., 2000, Bertram et al., 2001, Whorwood et al., 2001, 
Arnaldi et al., 2003), perhaps because the animals were too young at 6 
months of age for any detrimental effects to have become apparent 
(Chapter 5).  
 
6.2 Study limitations and future perspectives 
6.2.1 Maternal dietary manipulations 
This study was unique in that the manipulations in the maternal diet were 
subtle and energy content was maintained. The primary reason for this 
was because this study, as with a high proportion of large animal 
investigations, relied on collaboration with industry. Therefore, extreme 
manipulations of the maternal diet which have the potential to be 
GHWULPHQWDO WR WKH VRZ¶V health and welfare, and the meat quality of the 
offspring, would not be economically viable. This could provide a plausible 
reason as to why there were differences between the more severe 
programming outcomes demonstrated in rat studies.  
 
In order to maintain energy content between diets it was necessary to 
adjust the ratio of other dietary components such as starch content 
(Appendix C). For example, in the fat supplemented diet, starch content 
was reduced by half in comparison to the control diet (FS: 161 g/Kg; C: 
316 g/Kg), due to a reduction in the tapioca content. This was further 
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complicated by the use of whole food sources in the diet. The bulk of pig 
feed is usually supplied in the form of cereal grains which contain mainly 
starch, but some protein. In order to increase the protein content of the 
diet, by-products of the oilseed industry are often used, such as soybean 
and rapeseed meal. These different oilseed meals contain different 
quantities of fibre, starch and oils. This meant that when the diet was 
protein supplemented with lupins and sunflower seed meal, the quantities 
of other ingredients were reduced such as rapeseed oil, soy bean hulls and 
sugar beet pulp. This resulted in slight alterations in the fat and fibre ratio 
between the control and protein supplemented diet. Therefore, it is 
possible that it is perhaps not the increased fat or protein in the diet which 
has caused these effects, but it is actually the differing ratio of other key 
nutrients in the diets. This is further supported by population studies in 
humans which demonstrate an increased risk of developing non-insulin-
dependent type 2 diabetes mellitus when a high-fat, low-carbohydrate diet 
is consumed (Marshall et al., 1991).    
 
6.2.2 Dietary intervention period 
The dietary intervention period for this study was from 0 to 110 days of 
gestation. From day 110 of gestation all sows then received the same diet 
until the end of lactation. This meant that there was no difference in milk 
composition between dietary treatments (Chapter 3). Maternal diet is 
known to affect milk composition (Burrin, 2001) and it has been suggested 
by several studies that fat supplementation of sows during late gestation 
and lactation improve milk yield and fat content of the milk, which may 
account for a reduction in offspring mortality rate (Chapter 3) (Seerley et 
al., 1974, Boyd et al., 1978, Pettigrew, 1981, Seerley et al., 1981, Azain, 
1993). Therefore, it is possible that the large increase in piglet mortality 
may have been reduced by extending the period of fat supplementation 
throughout lactation and this could be the focus of future studies. 
 
6.2.3 Sex ratio 
As previously discussed, sex ratio amongst offspring selected for tissue 
analysis at 1 week and 6 months of age was not equal (Chapter 5). This 
was due to the selection method which, due to constraints on the number 
of animals that could be included, was based entirely on birth weight, 
where the lowest birth weight piglet was always selected regardless of sex. 
It is unlikely that piglet sex was a factor contributing to the significant 
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outcomes observed in the offspring born to sows who received the protein 
supplemented diet, although this cannot be ruled out. Therefore, a further 
study would be required to elucidate whether sex had a role to play in 
these programming mechanisms. This could be done by only selecting 
male or female offspring to analyse, or to include more animals in the 
study so that there would be an increased likelihood of having a more even 
male to female offspring ratio. However, there would be potential ethical 
concerns with conducting this kind of trial as a large number of animals 
would be required and the amount of wastage would be high if both birth 
weight and animal sex were piglet selection criteria.  
 
6.2.4 Different tissue responses 
Patients who have the metabolic syndrome have been demonstrated to 
have greater risk of non-alcoholic fatty liver disease (Hamaguchi et al., 
2005). It has been proposed that this reflects a failure of the normal 
partitioning of excess fat exclusively to the adipose tissue, resulting in 
ectopic fat storage in the liver, muscle and pancreas (Hamaguchi et al., 
2005). It has previously been discussed how an increase in GCs and/or GC 
sensitivity is linked to an increased risk of metabolic disease (Covar et al., 
2000, Bertram et al., 2001, Whorwood et al., 2001, Arnaldi et al., 2003). 
For this reason, this study focussed on the effects of dietary 
supplementation during gestation on the livers of the offspring, particularly 
focussing on GC sensitivity. Despite demonstrating changes in gene 
expressioQ RI *5 DQG ǃ-HSD1 with protein supplementation no other 
effects were noted in the liver. It is possible that these effects may not 
have been noted until the offspring were older or had begun to consume a 
diet which was lower in protein content once optimal growth was no longer 
the key objective (Chapter 5) (Burrin, 2001). However, differences of 
maternal diet manipulation in other offspring tissues may be noted at an 
earlier age; one such tissue is the muscle. For example, one study in rats 
has demonstrated that feeding a cafeteria diet, which consists of ad libitum 
intake of highly palatable high-fat or high-sugar foods, to rats throughout 
gestation and lactation resulted in pups who had a 25 percent reduction in 
muscle cross-sectional area with an increase in intramuscular lipid content 
at weaning, despite no effects on birth weight or growth rate (Bayol et al., 
2005). However, food intake of the dams was not measured and so overall 
maternal energy and fat intake, which would normally increase, could not 
be taken into account (Bayol et al., 2005).  
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The ultimate goal of meat animal production is the economical production 
of muscle tissue that is both a nutritious and palatable source of dietary 
protein for human consumption (Mitchell et al., 2001). By the time of birth, 
the number of muscle fibre cells in the pig is fixed (Mitchell et al., 2001). 
However, during postnatal growth, the muscle fibres increase in both 
length and width, this is also accompanied by an increase in intramuscular 
lipid content, which should be limited (Mitchell et al., 2001). Previous 
studies in pigs have focussed on trying to improve muscle quality by 
increasing maternal food intake during mid-gestation, but have found no 
effects of on muscle characteristics or meat quality (Nissen et al., 2003). 
In addition, low-birth weight piglets have been shown to have reduced 
muscle weights and increased muscle lipid content when compared to their 
higher birth weight littermates at slaughter (Gondret et al., 2006). 
Therefore, future work is currently underway to determine the effects of 
maternal fat and protein intake, and offspring birth weight, on the gene 
expression and composition of the muscle.  
 
6.3 Concluding remarks 
This study has demonstrated the role of fat and protein supplementation 
during pregnancy. The findings from this study could have consequences 
for the pig industry, particularly when trying to reduce piglet mortality. In 
addition, these findings could have important implications in determining 
the programming effects of maternal diet on human disease risk. 
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A. Abstracts and conferences attended 
The effect of increased maternal dietary intake during pregnancy 
on offspring birth weight and neonatal survival. By Kayleigh Almond1, 
Paul Bikker2, Michael Lomax1, Michael Symonds1 and Alison Mostyn1, 
1University of Nottingham, Nottingham, UK and 2Schothorst Feed 
Research, Lelystad, The Netherlands 
Poster presentation ± Nutrition Society Annual Summer meeting, 
Nottingham, UK, July 2008 
 
Altering maternal nutrition affects fetal development and may have long-
lasting effects on the offspring, potentially predisposing them to later 
disease such as diabetes and obesity. Studies have shown that these 
effects may take place without alterations in birth weight (1), although 
smaller-birth-weight offspring appear to be at increased risk (2). There is 
limited literature on the effects of increasing the fat and protein content of 
the gestational diet on birth weight and postnatal survival. 
 
Pregnant sows were fed one of six isoenergetic diets (Table) that differed 
only in composition and quantity fed during the first and final trimester of 
gestation. Sows fed on a low±high feeding scheme were fed 2.7 kg/d 
between day 0 and day 70 of gestation and 3.5 kg/d between day 70 and 
day 110 of gestation. Sows fed on a high±low feeding scheme were fed 3.5 
kg/d between day 0 and day 40 of gestation and 2.7 kg/d between day 40 
and day 110 of gestation. All sows received a standard diet from day 110 
and throughout lactation. All sows delivered naturally and all piglets were 
weighed. At 7 ±3 d one small and one median piglet per sow were selected 
and weighed. All preliminary data was analysed using SPSS version 15 
(SPSS Inc., Chicago, IL, USA). 
 
Treatment Diet 
description 
Feeding 
scheme 
No. of sows 
1 (Control) High starch Low±high 8 
2 High fat Low±high 8 
3 High protein Low±high 8 
4 High starch High±low 8 
5 High fat High±low 8 
6 High protein High±low 8 
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There was no effect of diet on piglet birth weight or litter size. Maternal 
diet had no effect on the growth rate of the small piglets. Median-birth-
weight piglets born to sows fed diet 5 (151.4g (SEM 10.4)) had a 
significantly reduced (P<0.05) growth rate up to 7 d when compared to 
sows fed diet 1 (control diet, 188.5g (SEM 12.7)) and diet 2 (226.2g (SEM 
15.2)). Median-birth-weight piglets had a significantly increased (P<0.05) 
growth rate up to 7 d when compared with the smaller piglets born to sows 
fed diet 1 (control diet; small, 91.0g (SEM 19.8); median, 188.5 (SEM 
12.9)), diet 2 (small, 126.5g (SEM 18.3); median, 226.2g (SEM 15.2)), 
diet 4 (small, 108.8g (SEM 17.1); median, 189.4g (SEM 14.8)) and diet 5 
(small, 98.3g (SEM 15.6); median, 151.4g (SEM 10.4)). Maternal diet had 
no effect on the percentage of stillborn piglets per litter. There was a 
significant increase (P<0.05) in the percentage of postnatal deaths per 
litter in sows fed diet 2 (16.81 (SEM 5.87)), diet 3 (1.88 (SD 0.52)) and 
diet 6 (8.83 (SEM 1.72)) when compared with diet 1 (control, 3.95 (SEM 
1.66)). 
 
Maternal nutrition during gestation appears to have no major effect on 
offspring birth weight or growth rate up to 1 week of age. This outcome 
may be a result of the sow compensating for any dietary change by 
compromising her own metabolism in order to avoid any detrimental 
effects on offspring birth weight. It may be interesting to compare sow 
body condition and glucose tolerance during pregnancy to confirm this 
notion. Smaller-birth-weight piglets tend to grow more slowly than median 
piglets during the first week of life (3). High fat feeding of the sow during 
late gestation and high protein feeding in either early or late gestation 
increases the percentage of piglet mortalities in the litter. The prospective 
findings from the ongoing study will inform further on the influence of 
increasing dietary components during pregnancy. 
 
1. Whorwood CB, Firth KM, Budge H & Symonds ME (2001) Endocrinology 
142, 2854±2864. 
2. Phillips DIW, Barker DJP, Fall CHD, Seckl JR, Whorwood CB, Wood PJ & 
Walker BR (1998) J Clin Endocrinol Metab 83, 757±760. 
3. Mostyn A, Litten JC, Perkins KS, Euden PJ, Corson AM, Symonds ME & 
Clarke L (2005) Am J Physiol Regul Integr Comp Physiol 288, R1536±R15 
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The influence of changes in macronutrient intake during gestation 
on gene expression of on glucocorticoid receptor (GR) and 11-beta-
hydroxysteroid dehydrogenase 1 and 2 (11ǃhsd1 and 2) in the 
livers of neonatal pigs; effect of size at birth By Kayleigh Almond1, 
Paul Bikker2, Michael Lomax1, Michael Symonds1 and Alison Mostyn1, 
1University of Nottingham, Nottingham, UK and 2Schothorst Feed 
Research, Lelystad, The Netherlands 
Poster presentation ± The Society for Endocrinology Annual meeting, 
Harrogate, UK, March 2009 
 
Background 
Altering maternal nutrition affects fetal development, potentially 
predisposing them to later metabolic disease. Tissue sensitivity to cortisol 
is regulated, in part, by GR and 11ǃhsd1 and 2, and GR and 11ǃhsd1 
expression is known to be raised both with obesity and type 2 diabetes. 
 
Objectives 
To examine whether gestational diet influences GR and11ǃhsd1 and 2 
mRNA expression in the neonatal liver. 
 
Methods 
Pregnant sows were fed one of six isoenergetic diets (Table). Sows fed on 
a low±high feeding scheme were fed 2.7 kg/d between day 0 and day 40 of 
gestation and 3.5 kg/d between day 70 and day 110 of gestation. The 
dietary regimes were reversed for sows fed on a high±low feeding scheme. 
At 7 days one small and one median piglet per litter were selected, 
humanely euthanized and its liver sampled. GR and 11ǃhsd1 and 2 mRNA 
expression was quantified by real-time PCR. Values are presented as 
arbitrary units. 
 
 Control 
 (n=8) 
2 
(n=8) 
3 
(n=8) 
4 
(n=8) 
5 
(n=8) 
6 
(n=8) 
Diet 
description 
High  
starch 
High  
fat 
High 
protein 
High  
starch 
High  
fat 
High 
protein 
Feeding 
scheme 
Low-high Low-high Low-high High-low High-low High-low 
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Results 
Median size piglets born to sows fed high protein had increased (p<0.05) 
expression of GR (control: 0.57±0.15; 3: 1.05±0.19; 6: 1.70±0.44) and 
11ǃhsd1 (control: 2.47±0.76; 3: 6.53±1.44; 6: 12.12±2.20) compared to 
controls. In contrast, expression of 11ǃhsd2 in the liver of the small piglets 
born to sows fed high levels of the high fat diet during late gestation (diet 
5) was increased (p<0.05) when compared to sows fed the same diet at 
high levels during early gestation (diet 2) (2: 0.10±0.04; 5: 0.30±0.06). 
 
Conclusion 
Changes in GR and 11ǃhsd1 expression indicate increased sensitivity to 
glucocorticoids in the liver at 1 week of age in piglets born to sows fed a 
high protein diet during gestation. Further studies are currently in progress 
to investigate whether these changes persist into adulthood. 
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The effect of increased maternal dietary fat intake during 
pregnancy on glucose tolerance near term and offspring birth 
weight By Kayleigh Almond1, Paul Bikker2, Michael Lomax1, Michael 
Symonds1 and Alison Mostyn1, 1University of Nottingham, Nottingham, UK 
and 2Schothorst Feed Research, Lelystad, The Netherlands 
Poster presentation ± Nutrition Society Scottish meeting, Edinburgh, UK, 
April 2009 
 
Diabetes during pregnancy in humans has been linked to adverse effects 
on the offspring such as fetal macrosomia, and impaired glucose tolerance 
and obesity in later life (Dabelea et al., 2000). Previous studies in pigs 
have shown that high fat feeding during late gestation can reduce glucose 
tolerance at term (van der Peet-Schwering et al., 2004), but the long term 
effects on the offspring are not known. This study examines whether 
increased fat intake during pregnancy influences glucose tolerance near to 
term and offspring birth weight. 
 
Pregnant sows were fed one of four isoenergetic diets (Table) that differed 
only in composition and quantity fed during the first and final trimester of 
gestation. Sows fed on a low±high feeding scheme were fed 2.7 kg/d 
between day 0 and day 70 of gestation and 3.5 kg/d between day 70 and 
day 110 of gestation. Sows fed on a high±low feeding scheme were fed 3.5 
kg/d between day 0 and day 40 of gestation and 2.7 kg/d between day 40 
and day 110 of gestation. On day 108 of gestation glucose (0.5 g/kg; i.v.) 
was administered, via a catheter inserted into the sows ear, and regular 
blood samples were taken for 1 hour. Blood from each time point was 
tested using a glucometer, in order to determine the rate of glucose 
clearance.  
 
Diet description High starch 
(low-high) 
(n=8) 
High fat 
(low-high) 
(n=5) 
High starch 
(high-low) 
(n=7) 
High fat 
(high-low) 
(n=8) 
Basal glucose 
conc. (mmol/l) 
4.14±0.17 4.6±0.09 4.13±0.12 4.06±0.13 
Glucose AUC  
(mmol min-1) 
112.75±6.53a 140.80±3.65b 134.57±10.83a 165.88±11.47b 
Birth weight of 
offspring (kg) 
1.20±0.06 1.28±0.06 1.23±0.09 1.21±0.06 
All results are expressed as means±SEM. Different letters denote values that are significantly 
different from each other (Mann-Whitney U test) 
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Gestational diet had no effect on basal glucose concentrations, but resulted 
in glucose intolerance in mothers, irrespective of the timing of the 
additional fat. Birth weight was unaffected by gestational diet or sow 
glucose tolerance.  
 
Feeding a high fat diet throughout gestation impairs glucose tolerance 
without any immediate effects on birth weight. The prospective findings 
from this ongoing study will inform further on the long-term effects that 
impaired maternal glucose tolerance may have on her offspring.  
 
1. Dabelea D, Knowler WC, Pettit DJ: Effects of diabetes in 
pregnancy on offspring: follow up research in Pima Indians 
Journal of maternal-fetal medicine 2000, 9(1):83-88. 
2. van der Peet-Schwering CMC, Kemp B, Binnendijk GP, den Hartog 
LA, Vereijken PFG, Verstegen MWA: Effects of additional starch 
or fat in late-gestating high nonstarch polysaccharide diets 
on litter performance and glucose intolerance in sows. 
Journal of Animal Science 2004, 82:2964-2971. 
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The effect of stage of gestation on feeding high-protein on hepatic 
glucocorticoid sensitivity in the neonate and later metabolic 
homeostasis in the young adult offspring By Kayleigh Almond1, Paul 
Bikker2, Michael Lomax1, Michael Symonds1 and Alison Mostyn1, 1University 
of Nottingham, Nottingham, UK and 2Schothorst Feed Research, Lelystad, 
The Netherlands 
Poster presentation ±6th International Conference on Developmental 
Origins of Health and Disease, Santiago, Chile, Nov 2009 
 
Objectives Altering maternal nutrition affects fetal development, 
potentially predisposing offspring to later metabolic disease. Glucocorticoid 
(GC) excess has been linked to the clinical observations associated with 
the metabolic syndrome. Tissue sensitivity to cortisol is regulated, in part, 
E\ *5 DQG ǃKVG DQG  6HYHUDO VWXGLHV KDYH VKRZQ WKH HIIHFWV RI
maternal nutrition on the programming of GC action in the offspring 
(Gnanaligham et al., 2005, Whorwood et al., 2001). The hypothesis is that feeding a high 
protein diet during gestation alters development of GC sensitivity. 
 
Methods Pregnant sows were fed one of four isoenergetic diets (Table) 
that differed in composition and quantity fed during the first and final 
trimester of gestation. Sows fed on a low±high feeding scheme were fed 
2.7 kg/d between day 0 and day 40 of gestation and 3.5 kg/d between day 
70 and day 110 of gestation. The dietary regimes were reversed for sows 
fed on a high±low feeding scheme. At 7 days and 6 months, one median 
piglet per litter were selected, humanely euthanized, a blood sample taken 
DQG LWV OLYHU VDPSOHG *5 DQG ǃKVG DQG  P51$ H[SUHVVLRQ ZDV
quantified by real-time PCR (Values are presented as arbitrary units). 
Plasma concentrations of glucose and non-esterified fatty acids (NEFA) 
were assessed using enzymatic-colorimetric assays. Offspring that were 
not selected for tissue sampling were raised commercially and body 
composition was recorded at the slaughterhouse.  
 
 C 
(n=8) 
HP(L-H) 
(n=8) 
C(H-L) 
(n=8) 
HP(H-L) 
(n=8) 
Diet 
description 
High starch High protein High starch High protein 
Feeding 
scheme 
Low-high Low-high High-low High-low 
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Results Piglets born to sows fed high protein had increased (p<0.05) liver 
H[SUHVVLRQRI*5DQGǃKVG1 at 1 week. At 6 months of age these piglets 
born to sows with reduced feed intake in late gestation had decreased 
glucose and increased NEFA plasma concentrations and diameter of the 
longissimus dorsi muscle (table).  
 
 C HP(L-H) C(H-L) HP(H-L) 
GR/18S  
(arbitrary units) 
0.57 ± 0.11a 1.05 ± 0.19b 0.83 ± 0.18 1.70 ± 0.44b 
ƨ+6'-1/18S 
(arbitrary units) 
2.47 ± 0.76a 6.53 ± 1.44b 4.74 ± 1.05a 12.12 ± 2.20b 
Glucose  
(mmol/l) 
4.71 ± 0.41a 4.40 ± 0.61 4.55 ± 0.23 3.75 ± 0.16b 
NEFA  
(mmol/l) 
0.93 ± 0.15a 1.04 ± 0.19 1.17 ± 0.14 1.41 ± 0.07b 
Muscle diameter  
(mm) 
56.35 ± 0.84a 58.30 ± 0.89 58.99 ± 0.94b 61.79 ± 1.15b 
All results are expressed as means ± SEM.  Different letters denote significant differences 
(P<0.05) between groups (Mann-Whitney U test). 
 
Conclusions Feeding a high-protein diet during pregnancy programs 
increased hepatic cortisol sensitivity in the newborn. Surprisingly this was 
not associated with any major long term adverse metabolic outcomes. 
Indeed, it appeared to improve glucose tolerance, an adaptation possibly 
mediated by increased muscle growth. Studies are currently in progress to 
further investigate the potential effects on insulin responsiveness together 
with liver and muscle metabolism. 
 
1. M. G. Gnanaligham et al., Am J Phys., 289: 1407-1415, 2005. 
2. C. B. Whorwood et al., Endocrinology., 142(7): 2854-2864, 2001.   
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Glucose tolerance near term and offspring birth weight; effect of 
high-fat feeding during pregnancy By Kayleigh Almond1, Paul Bikker2, 
Michael Lomax1, Michael Symonds1 and Alison Mostyn1, 1University of 
Nottingham, Nottingham, UK and 2Schothorst Feed Research, Lelystad, The 
Netherlands 
Poster presentation ±6th International Conference on Developmental 
Origins of Health and Disease, Santiago, Chile, Nov 2009 
 
Introduction Diabetes during pregnancy in humans has been linked to 
adverse effects on the offspring such as fetal macrosomia, and impaired 
glucose tolerance and obesity in later life (Dabelea et al., 2000). Previous 
studies in pigs have shown that high fat feeding during late gestation can 
reduce glucose tolerance at term (van der Peet-Schwering et al., 2004), 
but the long term effects on the offspring are not known. This study 
examines whether increased fat intake during pregnancy influences 
glucose tolerance near to term and offspring birth weight. The hypothesis 
is that increased fat intake will decrease glucose tolerance without 
effecting birth weight. 
 
Methods Pregnant sows were fed one of four isoenergetic diets (Table). 
Sows fed on a low±high feeding scheme were fed 2.7 kg/d between day 0 
and day 40 of gestation and 3.5 kg/d between day 70 and day 110 of 
gestation. The dietary regimes were reversed for sows fed on a high±low 
feeding scheme. On day 108 of gestation glucose (0.5 g/kg; i.v.) was 
administered, via a catheter inserted into the sows ear, and regular blood 
samples were taken for 1 hour. Blood from each time point was tested 
using a glucometer, in order to determine the rate of glucose clearance.  
 
 C 
(n=8) 
HF(L-H) 
(n=8) 
C(H-L) 
(n=8) 
HF(H-L) 
(n=8) 
Diet 
description 
High starch High fat High starch High fat 
Feeding 
scheme 
Low-high Low-high High-low High-low 
 
Results Gestational diet had no effect on basal glucose concentrations, but 
resulted in glucose intolerance in mothers, irrespective of the timing of the 
additional fat. Birth weight was unaffected by gestational diet or sow 
glucose tolerance.  
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 C HF(L-H) C(H-L) HF(H-L) 
Basal glucose 
conc. (mmol/l) 
4.14 ± 0.17 4.6 ± 0.09 4.13 ± 0.12 4.06 ± 0.13 
Glucose AUC  
(mmol min-1) 
112.75 ± 6.53a 140.80 ± 3.65b 134.57 ± 10.83a 165.88 ± 11.47b 
Birth weight of 
offspring (kg) 
1.20 ± 0.06 1.28 ± 0.06 1.23 ± 0.09 1.21 ± 0.06 
All results are expressed as means±SEM. Different letters denote values that are significantly 
different from each other (Mann-Whitney U test) 
 
Conclusions Feeding a high fat diet throughout gestation impairs glucose 
tolerance without any immediate effects on birth weight. The prospective 
findings from this ongoing study will inform further on the long-term 
effects that impaired maternal glucose tolerance may have on her 
offspring.  
 
1. D. Dabelea et al., J Matern Fetal Med., 9(1): 83-88, 2000. 
2. C. M. C. van der Peet-Schwering., J Anim Sci., 82: 2964-2971, 
2004.   
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The influence of changing the macronutrient content of the 
maternal diet on offspring development and liver metabolism By 
Kayleigh Almond1, Paul Bikker2, Michael Lomax1, Michael Symonds1 and 
Alison Mostyn1, 1University of Nottingham, Nottingham, UK and 
2Schothorst Feed Research, Lelystad, The Netherlands 
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Objectives Altering maternal nutrition affects fetal development, 
potentially predisposing offspring to later metabolic disease. Glucocorticoid 
(GC) excess has been linked to the clinical observations associated with 
the metabolic syndrome. Tissue sensitivity to cortisol is regulated, in part, 
by glucocorticoid receptor (GR) and 11-beta- hydroxysteroid-
GHK\GURJHQDVHƨ+6'W\SHVDQG6HYHUDOVWXGLHVKDYHVKRZQWKH
effects of maternal nutrient restriction on the programming of GC action in 
the offspring (Gnanaligham et al., 2005, Whorwood et al., 2001), however, dietary excess is 
far more characteristic of the diets consumed by a substantial number of 
pregnant women.  The hypothesis of this study is that consuming a high-
fat or protein diet during gestation decreases maternal glucose tolerance 
and increases offspring liver GC sensitivity potentially altering lipid 
metabolism. 
 
Methods Pregnant sows were fed one of three isoenergetic diets (Table 1), 
that altered only in starch, protein and fat content, between days 0 and 
110 of gestation (term = 115 days). Glucose tolerance tests were carried 
out on day 108 of gestation in sows who received high fat and control 
diets. All sows delivered naturally and piglets were weighed at birth.  At 7 
days, one median piglet per litter were selected, humanely euthanized, a 
EORRG VDPSOH WDNHQ DQG LWV OLYHU VDPSOHG *5 ƨ+6'-1 and 2, and 
peroxisome-proliferator-activated-UHFHSWRUDOSKD33$5ĮJHQHH[SUHVVLRQ
were quantified by real-time PCR. Triglyceride (TAG) content was 
measured  using spectrophotometric analysis following Folch extraction [3]. 
Plasma concentrations of glucose, non-esterified fatty acids (NEFA) and 
TAG were assessed using enzymatic-colorimetric assays. Offspring that 
were not selected for tissue sampling were raised commercially and body 
weight and composition was recorded at the slaughterhouse. All results 
were expressed as means ± SEM.  Significant differences between groups 
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were determined using either a T-test (parametric) or Mann-Whitney U test 
(non-parametric).  
Maternal diet Starch (%) Fat (%) Protein (%) 
Control 31.6 2.5 12.3 
High fat 16.1 8.9 12.2 
High protein 31.7 3.7 16.3 
Table 1: Maternal diets 
 
Results Consuming a high fat gestational diet reduced (p<0.05) maternal 
glucose tolerance at term. Offspring mortality was increased (p<0.05) 
when mothers consumed a high fat or protein diet. Birth weight, body 
weight at 6 months and growth rate was unaffected by maternal diet. 
Offspring born to mothers receiving a high protein diet had increased 
S OLYHU H[SUHVVLRQ RI*5 DQGƨ+6'-1 at 1 week. Although not 
significant there was a trend towards a decrease in TAG content and 
LQFUHDVH LQ33$5ĮJHQHH[SUHVVLRQ LQ WKH OLYHUVRIRIIVSULQJDWZHHNRI
age born to mothers who consumed either the high fat or protein diets.  
 
Conclusions Feeding a high-fat diet reduces glucose tolerance in the 
mothers at term; it is unclear what effect high protein feeding has. 
Neonatal survival appears to be compromised when mothers consume a 
high-fat, or protein diet throughout gestation. Feeding a high-protein diet 
during pregnancy programs increased hepatic cortisol sensitivity in the 
newborn. Future work will further determine the effect of high-fat or 
protein maternal diets on offspring liver metabolism at 6 months of age.  
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B. Details of suppliers 
Abbot Laboratories, 100 Abbot Park Road, Abbot Park, Illinois 60064-
3500, USA; www.abbot.com  
ABgene Limited UK, ABgene House, Blenhem Road, Epsom, KT19 9AP; 
www.abgene.com    
Alfasan International BV, Kuipersweg 9, JA 3440, Woerden, The 
Netherlands, PO Box 78 3440 AB; www.alfasan.com  
AVEBE, 9640 AA Veendam, The Netherlands; www.avebe.com  
Bibby Scientific Ltd. Beacon Road, Stone, Staffordshire, UK, ST15 O5A; 
www.bibby-scientific.com  
BioRad Laboratories Ltd. Bio-Rad House, Maxted Road, Hemel 
Hempstead, Hertfordshire, HP2 7DX; www.bio-rad.com  
Bio Tek Instruments Inc. 100 Tigan Street, Winoski, Vermont 05404, 
USA; www.biotek.com   
Diasorin Inc. 1951 Northwestern Avenue, P. O Box 185, Stillwater, 
Minnesota, USA, 55082-0285; http://www.diasorin.com/en  
FOSS, Slangerupgade 69, Postbox 260, DK-3400, Hillerød, Denmark; 
www.foss.co.uk  
Fuji Photo Film Co. Ltd. 7-3, Akasaka 9-chome, Minato-ku, Tokyo 107-
0052, Japan; www.fujifilm.com  
Intervet, Wim de Körverstraat 35, 5831 AN Boxmeer, The Netherlands; 
www.intervet.com  
Invitrogen Ltd, 3 Fountain Drive, Inchinnan Buisness Park, Paisley, 
United Kingdom, PA4 9RF; www.invitrogen.com  
Labtech International Ltd. Acorn House, The Broyle, Ringmer, East 
Sussex, UK, BN8 5NN; www.labtech.co.uk  
Mercodia A B, Sylveniusgatan 8A, SE-754 50 Uppsala, Sweden; 
http://www.mercodia.se  
Millipore, 290 Concord Road, Billerica, Massachusetts 01821 USA; 
www.millipore.com  
PerkinElmer, 940 Winter Street, Waltham, Massachusetts 02451, USA; 
http://www.perkinelmer.co.uk  
Qiagen, Qiagen House, Fleming Way, Crawley, West Sussex, RH10 9NQ; 
www.qiagen.com 
Randox Laboratories Ltd, 55 Diamond Road, Crumlin, Co. Antrim, 
United Kingdom, BT29 4QY; www.randox.xom  
Raytek Scientific Ltd. 26 Norton Park View, Sheffield, UK, S8 8GS; 
www.raytek.co.uk  
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Renco Corp. 116 3rd Ave. N. Minneapolis, Minnesota, USA, 55401; 
www.rencocorp.com  
Roche Co. Konzern-Hauptsitz, Grenzacherstrasse 124, CH-4070 Basel, 
Switzerland; www.roche.com 
Sigma-Aldrich Company Ltd, The Old Brickyard, New Road, Gillingham, 
Dorset, SP8 4XT; www.sigm-aldrich.com  
Sigma-Genosys Ltd, Sigma-Aldrich House, Homefield Business Park, 
Homefield Road, Haverhill, Suffolk, CB9 8QP; www.sigma-genosys.com  
SPSS inc. 233 S. Wacker Drive, 11th floor, Chicago, Illinois 60606, USA; 
www.spss.com  
Source Bioscience AUTOGEN, 1 Orchard Place, Nottingham Business 
Park, Nottingham, UK, NG8 6PX; www.autogenbioclear.com  
Thermo Fisher Scientific Ltd/Across Ltd, Bishop Meadow Road, 
Loughborough, Leicestershire, LE11 5RG; www.fisher.co.uk  
Thistle Scientific Ltd. DFDS House, Goldie Road, Uddingston, Glasgow, 
G71 6NZ; www.thistlescientific.co.uk  
3M United Kingdom PLC, 3M Centre, Cain Road, Bracknell, UK, RG12 
8HT; www.solutions.3m.co.uk  
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C. Full composition of experimental diets 
  C FS PS Lactation 
     
Feed stuff %/Kg of 
diet 
%/Kg of 
diet 
%/Kg of 
diet 
%/Kg of 
diet 
     
Tapioca 28.1 3.1 28.1 - 
Rapeseed meal 10.0 10.0 5.0 4.0 
Lupins - - 12.0 - 
Sunflower seed meal 4.0 4.0 16.4 2.0 
Soybean hulls 13.0 17.0 3.0 2.0 
Sugar beet pulp 10.0 10.0 - 2.0 
Palm oil - 6.6 - 3.1 
Soybean oil 0.5 0.5 1.1 0.97 
Maize - - - 10.0 
Soybean meal - - - 11.7 
Wheat  10.0 10.0 10.0 26.4 
Barley 10.0 10.0 10.0 15.0 
:KHDWPLGGOLQJ¶V 15.0 15.0 15.0 15.0 
Molasses 4.0 4.0 4.0 4.0 
Monocalciumphosphate 0.22 0.22 0.22 0.48 
Salt - - - 0.37 
Limestone 0.50 0.60 0.73 1.56 
Premix vit. + min. 0.5 0.5 0.5 0.5 
Lysine (25%) 0.17 0.17 - - 
Lysine-HCl (L, 79%) - - - 0.17 
Threonine (L, 98%) - - - 0.02 
Phytase 0.5 0.5 0.5 0.5 
Threonine 15% 2390* 0.01 0.01 - - 
Sodium bicarbonate 0.6 0.6 0.6 0.16 
     
Diet composition g/Kg g/Kg g/Kg g/Kg 
     
Nutrients     
Ash 64 52 63 61 
Crude protein 123 122 163 161 
Crude fat 25 89 37 63 
Crude fibre 120 121 106 52 
ID starch + sugar 368 212 361 367 
Sugar 61 60 56 59 
Starch 316 161 317 319 
AID LYS 4.03 4.12 4.99 7.10 
AID MET 1.57 1.58 2.11 2.14 
AID M+C 3.20 3.24 4.29 4.47 
AID THR 2.62 2.68 4.01 4.29 
AID TRP 0.98 0.99 1.36 1.53 
LYS 5.92 5.98 6.63 8.58 
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MET 2.07 2.04 2.60 2.55 
CYS 2.46 2.46 2.98 3.05 
M & C 4.53 4.50 5.59 5.60 
THR 4.54 4.50 5.78 5.87 
TRP 1.48 1.46 1.84 1.96 
ILE 4.37 4.35 6.16 6.13 
ARG 7.10 7.04 12.39 9.83 
FEN 5.05 5.02 6.88 7.35 
HIS 3.16 3.13 4.08 4.09 
LEU 7.81 7.76 10.59 11.46 
TYR 3.81 3.86 4.93 5.15 
VAL 5.84 5.79 7.42 7.49 
ALA 5.39 5.27 6.75 7.07 
ASP 9.57 9.53 13.82 13.53 
GLU 22.04 21.74 32.46 32.66 
GLY 6.17 6.26 7.94 7.09 
PRO 7.66 7.64 9.01 11.08 
SER 5.44 5.46 7.25 7.49 
Ca 6.78 6.70 6.78 9.31 
Na 2.00 1.98 1.90 2.17 
Ferm CHO 235 234 187 145 
Ind. CHO 122 110 132 80 
Dig. P 2.47 2.41 2.63 3.27 
NSP 343 330 300 209 
dig. NSP 224 223 173 132 
dEB 301 280 302 220 
C18:2 7.7 14.6 13.2 15.7 
C18:3 1.04 1.22 1.49 1.46 
C18:2+3 8.8 15.8 14.7 17.1 
C16+18>0 12.59 44.20 20.76 33.83 
C16+18.0 2.42 30.26 3.44 16.92 
Control (C); fat supplemented (FS); protein supplemented (PS)  
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D. Nutrient composition (g/kg) of piglet diets 
  Creep Post-weaning Grower Finisher 
Net energy (MJ) 10.42 10.04 9.70 9.50 
Ash 57.25 55.54 55.56 48.79 
Crude protein 175.61 175.15 169.98 160.03 
Crude fat 75.08 59.45 49.12 45.74 
Crude fibre 29.11 39.75 44.26 58.09 
ID starch + sugar 402.20 409.71 416.18 409.96 
Starch 332.54 359.84 378.95 376.09 
AID LYS 11.33 10.26 8.80 7.16 
AID MET 4.32 3.54 3.03 2.38 
AID M+C 6.67 5.95 5.40 4.68 
AID THR 6.57 5.86 5.23 4.28 
AID TRP 2.20 1.94 1.64 1.34 
Ca 7.96 7.01 7.01 4.84 
Dig. P 3.87 3.57 2.85 1.88 
NSP 152.33 172.10 179.20 213.70 
 
 
